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Summary 
Mesenchymal stem cells (MSCs) can undergo self-renewal and differentiation into a 
variety of mature cell types. Thus, using MSCs for tissue engineering and other 
medical applications holds many promising advantages over normal somatic cells. 
However, exactly these characteristics make MSCs more difficult to grow and 
control in vitro. The aim of this research project was to investigate ditTerent culture 
systems for their utility to expand bone marrow derived MSCs in large quantities. A 
large scale expansion of MSCs is especially of interest since only a small number of 
bone marrow derived MSCs are present in donor derived samples, which do not meet 
the demand for medical applications. 
In this thesis three different culture systems, static monolayer cultures, stirred 
suspension cultures, and pour-otT cultures, were compared with each other for their 
ability to support MSCs proliferation while allowing them to keep their full 
differentiation capacity. Cell samples derived from these cultures were used for cell 
count, to start a CFU-f assay and to start osteogenic and adipogenic differentiation 
assays. The highest MSC numbers obtained from the static monolayer cultures were 
about 460% of the initial cells. The differentiation capacity of these ceIls was 
restricted, so they only formed osteoblasts. Furthermore, MSC samples obtained 
from this culture system were used for proteomic analysis on an electrospray 
ionisation quadrupol (ESI-qQ-STAR) mass spectrometer with the isobaric tag for 
relative and absolute quanti tat ion (iTRAQ) method. This analysis revealed a 
difference in the proteome of MSCs from ditTerent passage levels which is involved 
in a changing proliferation and differentiation behaviour. 
In stirred suspension cultures, the increase in MSC number varied for the ditTerent 
culture media. The best result was achieved in MyeloCult® medium with Pluronic F-
68, IL-3 and SCF, however, reaching only 140% of the initial cell density, this result 
was significantly worse than in the control monolayer cultures. The pour-otT cultures 
supported an increase in MSC number, which resulted in 860% of the initial cell 
number. In addition, MSCs expanded in this culture system were able to differentiate 
into ostoblasts and adipocytes. Thus, pour-otT cultures are the most promising culture 
system for large scale expansion of MSCs with high differentiation potential. 
xi 
Chapter 1 
Introduction and Hypothesis Statement 
11 
1.1 Introduction 
This introductory chapter gives a general background to the research described in 
this thesis and the context in which such research will contribute to a better 
understanding of the field of stem cell science and engineering. Furthermore, the 
overall goal of the studies conducted will be detailed and finally, the subject of each 
chapter of this thesis will be summarised. 
1.2 Tissue engineering and cell culture 
Organ transplantation and implantation of synthetic prosthesis is the state-of-the-art 
medical treatment available for patients with injured or lost organs and body parts. 
However, the current quantity of organs available for transplantation cannot meet the 
needs of patients', resulting in organ waiting lists (Fentiman, 1994). Furthermore, not 
all organs can be replaced by a synthetic prosthesis, and tissue engineered constructs 
are believed to be more efficient and reliable (Fentiman, 1994). Hence, there is a 
growing need for biologicalIy active tissues, which is not being met by 
transplantation. This has led to the development of tissue engineering. 
The engineering of living tissue aims to develop biological constructs for 
implantation into the body, and also to support the regeneration of tissue after 
damage or injury. The purpose is to repair, replace or maintain the function of a 
particular tissue or organ. Tissue engineered constructs include e.g. artificial skin, 
engineered cardiovascular substitutes, metabolic organs such as the artificial 
pancreas and liver, and even artificial neurons used for nerve regeneration and pain 
killers. The functional basic element of a tissue engineered construct is that the living 
cells have a desired, system specific function. This can be secretion of extracellular 
matrix, biosynthesis and secretion of proteins in response to specific stimuli, or 
interaction with other cells or extracellular polymers to construct specific three 
dimensional structures. Cell sources include human and animal tissues, from where 
the cells are isolated before being amplified in vitro. 
The challenges arising from cell culture for tissue engineering are to harvest cells in 
sufficient quantity to fabricate bio-artificial tissues for clinical applications, maintain 
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the cell function throughout the entire in vitro culture time, and a sufficient period of 
time after being implanted, and not to cause immune reactions in the patient when 
implanting the engineered construct. Cells originating from human tissues have the 
advantage of good immunocompatibility, especially if the patient's own cells are 
used as auto grafts after isolation from another part of their body (Fentiman, 1994). 
The cell availability depends not only on the numbers of cells present in the original 
tissue, but also on the extent to which the isolated cells can be grown in culture. Cell 
growth can be stimulated by identifying and supplying the necessary growth factors 
and controlling the state of cellular differentiation (Zandstra and Nagy, 2001). This, 
however, can be challenging, especially if the control mechanism for the 
differentiation pathways is poorly understood. A typical example in this area is the 
attempt to grow ex vivo a bone marrow analog for tissue engineering a 
haematopoietic system in vivo (Koller et at., 1993). 
Cells within the human body reside in a complex environment which is controlled 
biochemically and biomechanically. The biochemical impact of culture condition has 
long been recognised. However, many tissues or organs function in the presence of a 
mechanical stress environment, and therefore the biomechanical i'nfluence should not 
be underestimated either. It is the totality of the environment that influences the cell 
function. 
In this thesis, existing cell culture techniques will be used to investigate the 
possibility for amplifying bone marrow derived mesenchymal stem cells (MSCs) in 
vitro. Mesenchymal stem cells are multi potent and can develop into a variety of fully 
differentiated connective tissues, thus they are ideal candidates for tissue 
engineering. Developing and optimising a protocol to produce large numbers of 
MSCs in an economical way, will allow their multisided usage in clinical 
applications. 
The following chapters will highlight the main challenges in the development of 
different mesenchymal stem cell (MSC) cultures, and focus on the improvement of 
the culture conditions in order to obtain high quantities of mesenchymal stem cells 
with full differentiation potential. Given the extent of the parameters important in the 
control of mesenchymal stem cell self-renewal and differentiation, an exhaustive 
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analysis of all potential culture parameters was not possible. However, the results 
obtained by the following studies can help to improve and develop clinically relevant 
mesenchymal stem cell-based technologies. 
1.3 Research aims 
The overall goal of this thesis is to establish an improved culture system for the in 
vitro expansion of MSCs. With this culture system, a greater fold increase in MSC 
numbers should be obtained than compared with existing culture methods. This goal 
will be achieved through the following key objectives: 
• Determine the proliferation and differentiation potential of MSCs in static 
monolayer cultures under different culture conditions 
• Establish a protocol for expanding MSCs in stirred suspension bioreactors 
• Optimise the growth of MSCs in stirred suspension cultures by changing the 
culture conditions 
• Determine the proliferation and differentiation capacity of MSCs in pour-off 
cultures under different culture conditions and compare these findings with 
the results from the static and stirred suspension cultures 
• Implement an iTRAQ method for analysing the proteome ofMSCs 
• Identify possible proteomic changes of sub-cultured MSCs 
Chemical as well as physical stimuli can trigger differentiation of mesenchymal stem 
cells into early progenitor cells. These progenitor cells may have a similar phenotype 
and can still differentiate into one fully matured cell type only. However, this would 
limit the multisided usage of MSCs and since the stem cells themselves are the 
desired product, the expansion process must not affect or change the cell phenotype 
and function. This requires the development of a culture system that has low stress 
levels for MSCs .. Therefore, the improved culture technique has to fulfil three 
criteria: 1) It must support the amplification of large cell numbers, 2) the cells must 
maintain a high stem cell quality and 3) the process must be able to be automated and 
upscale. The aim, however, was not only to prove the possibility of a large scale 
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MSCs expansion but rather to implement a protocol that exhibit an improvement to 
the already existing culture systems and would allow the production of MSCs for the 
application in regenerative medicine. Therefore, the main focus was also on the cost 
efficiency of the process. 
1.4 Thesis outline 
An outline of the thesis structure with experiments carried out in the chapters is 
given in Figure 1.1 . An overview of each chapter is summarised below. 
------------------------------------
Chapter 5 
(proteomic analysis) 
Chapter 7 
(pour-off cultures) 
----------------~----------------
ChapterS 
(Final conclusion) 
Figure 1.1: An overview of the format of studies in this thesis. 
Chapter 2: The aim of this chapter is to describe the nature of mesenchymal stem 
cells, and summarise the research conducted on them so far. This is achieved by 
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giving a brief introduction on the historical development of (stem) cell culture and on 
the definition and classification of stem cells in general. This is followed by a review 
on MSCs, including their in vivo niche, their characteristics, culture systems, and 
therapeutic applications. The last section presents a discussion on the proteome 
analysis of MSCs, and the latest findings achieved with this analysis. 
Chapter 3: The materials and the general methods for culturing and analysing MSCs 
used throughout this thesis are described in this chapter. This includes the protocols 
for isolation MSCs from rat femurs and tibia, conducting cell and colony counts, and 
running differentiation tests. 
Chapter 4: The traditional method of expanding MSCs is the static monolayer 
culture, which forms the basis of this chapter. MSCs were expanded under different 
culture conditions, and their changes in proliferation and differentiation capacity 
were recorded. The results of this chapter are used as a control to compare the 
findings from the suspension and pour-off cultures against this standard technique. 
Chapter 5: In this chapter, the proteome of MSCs expanded under the same 
conditions as in chapter 4 was analysed using high throughput differential proteomic 
techniques. This was of interest because researchers theorise that MSCs lose their 
stem cell character and slow down in proliferation when expanded too much on 
plastic. To verify this theory, the proteome of MSCs after passage 2 and 4 were 
compared. 
Chapter 6: The development and the implementation of a protocol for stirred 
suspension culture of MSCs is described in this chapter. This protocol was based on 
the culture conditions for static monolayer cultures, developed in chapter 4. 
However, the aim of this chapter was not only to develop but also to optimise the 
protocol to achieve the possibility of scale-up, automation and high stem cell quality. 
This required the usage of different medium additives which increased the cost, a 
problem every published study of MSCs in suspension cultures has reported. The 
results were compared with the findings from the static monolayer cultures in chapter 
4, and the conclusion for further improvement let to the usage of pour-off cultures, as 
mentioned in chapter 7. 
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Chapter 7: To address the problems arising from MSCs expansion in static and 
suspension cultures, and also to prove the assumption of suspension based 
proliferation, pour-off culture experiments were conducted. This chapter explains the 
methods, and presents the results achieved with this culture method. The aim was to 
be able to use the cheap culture medium and conditions of the static monolayer 
cultures, while being able to scale-up, automate and monitor the cultures in a similar 
way as it is possible with stirred suspension based bioreactors. The results were 
compared with the findings from both static and suspension derived MSCs. 
Chapter 8: The results and conclusions in this thesis are summarised here, allowing a 
direct comparison of the performance of the different culture systems. Finally, future 
research is suggested. 
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Chapter 2 
General Background and Review 
88 
2.1 Introduction 
The history of stem cell research started in 1963, when the first descriptions of the 
self-renewing activities of transplanted mouse bone marrow cells were documented 
by Ernest McCulloch and James Till (Becker et al., 1963). Further success was 
achieved when scientists at the beginning of the 1980's derived mouse embryonic 
stem cells from the inner cell mass (Martin, 1981). With this finding, research into 
animal and human stem cells began, and has been ongoing since this time. In the 
1980's and 1990's, improved methods for growing mammalian cells in vitro allowed 
for the intensification and deepening of the analysis of stem cells, which in 1998, led 
to the establishment of the world's first human embryonic stem cell line by James 
Thomson (Thomson et al., 1998). Thomson successfully removed cells from spare 
embryos at fertility clinics and cultured them in vitro. Since this discovery,' stem 
cells, with their regeneration potential and differentiation capacity, have become 
more and more attractive for many applications in tissue engineering, cellular 
therapies and drug screening, especially since research has shown that stem cells 
exist in most, if not all, tissues (Ortiz-Gonzalez et al., 2004), (Woodward et al., 
2005), (Mimeault et al., 2006) (Trounson, 2006). 
Implementation of stem cells for tissue engineering requires a technique that is able 
to cultivate large quantities of readily available stem cells or their differentiated cell 
types. Unlike most traditional biotechnological processes in which cells are 
cultivated to produce a certain product (e.g. protein or virus) this new technology 
aims to generate the cells themselves as the product. For haematopoietic stem cell 
transplantation, for example, the undifferentiated stem cells have to be expanded in 
cell cultures (Kwon et al., 2003), whereas for other applications (e.g. transplantation 
of skin) the production of a specific differentiated cell type with defined 
characteristics is required (Sun et al., 2005). While expanding undifferentiated stem 
cells, it is crucial to maintain their self-renewal and full differentiation capacity. For 
the production of specific differentiated cell types, on the other hand, it is important 
to carefully control the differentiation into a very specific lineage and eliminate all 
undesirable cell types that could arise during the differentiation process. In vitro 
differentiation of stem cells usually produces a mixed population of different cell 
lineages (Humphries et al., 1981). Both pose a challenge in the cultivation technique 
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of stem cells for clinical applications, making it necessary to clearly understand and 
determine the exact role of all parameters important for the control of the stem cell 
fate during the cultivation process. A further challenge for using stem cells in tissue 
engineering is the large number of cells required (about 7.S x 109 MSCs to help 
healing a 10 cm defect human femur). Stem cells are derived in small numbers form 
a donor, (e.g. only 0.01 - 0.001% of the nucleated bone marrow cells are 
mesenchymal stem cells) and have to be amplified before being further used for 
medical applications. Hence. a culture system for expanding stem cells in vitro needs 
to allow the control of the stem cell fate while producing large numbers of stem cells. 
The purpose of this study is to determine the potential of different culture techniques 
for the large scale expansion of one specific adult stem cell type. mesenchymal stem 
cells (MSCs). In this chapter, a review on stem cells and more specifically about 
MSCs is presented. The review will highlight the main achievements in 
mesenchymal stem cell research and focuses on the culture systems for MSCs and 
suggests where research is needed in order to better understand the control 
mechanisms of these cells. 
2.2 Definition and classification of stem cells 
A cell has to fulfil three criteria in order to be categorised as a stem cell. It must be 
an undifferentiated cell which, first, is capable of self-renewal by either symmetric or 
asymmetric division (Figure 2.1). second. is capable of multilineage differentiation 
and third. reconstitutes a given tissue in vivo (Potten and Lajtha, 1982) (Hall and 
Watt, 1989) (Weissman et al.. 2000). These properties make stem cells highly 
attractive for many applications in tissue engineering. cellular therapies and drug 
screening (Mimeault and Batra, 2006). However. the degree to which a stem cell 
differentiates through all the progenitor cell phases up to the fully differentiated cell 
is largely determined by the microenvironment in which the individual stem cell 
develops. Therefore. stem cell proliferation is very sensitive to various 
environmental stresses. and poses a challenge in their cultivation (Weissman et al .• 
2000). 
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(A) 
stem cell 
(8) 
stem cell 
stem cell 
stem cell 
stem cell 
specialised cell 
(e.g. red blood 
cell) 
Figure 2.1: A) Symmetric division of stem cells gives rise to two identical daughter 
cells, both fully functional stem cells. B) Asymmetric cell division of stem cells 
gives rise to one stem cell and one mature or specialised cell which has limited or no 
self renewal. (Modified from: 4. The Adult Stem Cell . In Stem Cell Information. 
Bethesda, MD: National Institutes of Health, U.S. Department of Health and Human 
Services, 2009 Available at http://stemcells.nih.gov/info/200Ireport/chapter4) 
Distinct stem cell types have been established from embryos and identified in the 
foetal tissues and umbilical cord blood, as well as in many adult mammalian tissues 
and organs (Ortiz-Gonzalez et al., 2004) (Rollini et al., 2004) (Trounson, 2006). 
Stem cells are classified according to their differentiation capability into totipotent, 
pluripotent and multipotent and, according to their differentiation stage, into 
embryonic and adult stem cells (Ulloa-Montoya et al., 2005). Totipotent stem cells 
can be found in early embryonic development up to the 8 cell stage. They give rise to 
all embryonic somatic tissues and germ cells including the extraembryonic tissue and 
thus are the only cells with the potential to develop into a complete individual (Yeom 
et al., 1996). Pluripotent stem cells can still differentiate into the three somatic germ 
layers that comprise an organism: mesoderm (muscle, bone, etc.), ectoderm (neurons, 
skin, etc.) and endoderm (hepatocytes, pancreatic beta cells, etc.), but are not able to 
form trophoblasts and therefore no longer have the capacity to develop into a 
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complete individual. Multipotent stem cells are the most developed stem cells with 
the capability to differentiate only into cells of the one tissue or germ layer from 
which they originated from (Ulloa-Montoya et 01.,2005). 
Embryonic stem cells (ESCs) are derived from the inner cell mass of the blastocysts. 
Their pluripotency was first identified by the formation of tumours consisting of 
different types of tissue, such as skin, hair and muscle, when embryonic stem cells 
were transplanted into post-natal animals (Wobus et 01., 1984) (Reubinoff et 01., 
2000). The presence of cells from all three germ layers in one tumour demonstrated 
their pluripotency. Furthermore, human ESCs have been differentiated into 
ectoderm, endoderm, and mesoderm cells in vitro (Yao et 01., 2005). More 
specifically, they express many cell markers that are common to pluripotent cells 
such as CD9, CD24, octamer-binding protein (Oct-4), Nanog, LIN28, Rex-} and 
Thy-! (Trounson, 2006) (Richards et 01., 2004) (Chambers, 2004). All ESCs have 
high levels of telomerase expression and activity for long-lasting periods in culture, 
giving them the ability to undergo unlimited self-renewal. Although they are able to 
generate large numbers of any cell type for transplantation into patients, and can 
proliferate indefinitely in culture, there are ethical considerations restricting the use 
of ESCs (Orkin and Morrison, 2002) (Pflegerl et 01., 2008) (Ohara, 2003) (Hug, 
2005). 
Adult stem cells are undifferentiated cells located in a differentiated adult tissue such 
as bone marrow, skin, liver, heart, brain, kidneys, eyes, gastrointestinal tract, 
pancreas, lungs, breast, ovaries, prostate and testis (Brittan et 01., 2002) (Tumbar et 
01., 2004) (Watts et 01., 2005) (Woodward et 01., 2005) (Guettier, 2005) (Heissig et 
aI., 2005) (Leri et 01., 2005) (Mimeault et al., 2006) (Seaberg et 01., 2004). Even 
though they differentiate into progenitor, precursor and mature cells of mUltiple 
lineages, they are not pluripotent. Adult stem cells contribute to ongoing tissue 
maintenance or repair (Bach et 01., 2000). In this situation, they are very few in 
number, but have a high proliferation potential, and the capacity to generate fully 
mature, tissue specific cell types. The exact numbers of stem cells are unknown and 
vary from tissue type to tissue type. Adult stem cells do not replicate indefinitely in 
culture, and their degree of self-renewal is more restricted compared to embryonic 
stem cells. Some concepts have been developed to explain the balance between 
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proliferation and differentiation (Fuchs et al., 2004) (Griffiths et aI., 2005) (Wilson et 
al., 2006). During stem cell self-renewal, the cells undergo symmetric division into 
two identical daughter cells both with full stem cell characteristics (Figure 2.1 A). In 
contrast, during differentiation the stem cells undergo asymmetric division into one 
daughter stem cell and one daughter cell which continues on a differentiation 
pathway (Figure 2.1 B). The differentiating daughter cell may give rise to other 
progenitor· cells and, ultimately, to more differentiated cells. These differentiated 
cells can constitute tissues or organs either where they originate or other distant 
tissues by performing cell migration. 
The three most used adult stem cells for tissue engineering and cellular therapies are 
neural stem cells, haematopoietic stem cells and mesenchymal stem cells. The most 
extensively of these cells are the haematopoietic stem cells (HSC) (Wilson et al., 
2006) (Fried and Johnson, 1968) (Weimann et al., 1974) (Spangrude et al., 1988). 
They give rise to all the blood cell types of both the myeloid and lymphoid. This 
includes monocytes and macrophages, neutrophils, basophils, eosinophils, T -cells, B-
cells, NK-cells, microglia, erythrocytes (red blood cells), megakaryocytes (e.g. 
platelets), and dentritic cells. Furthermore, when being transplanted, HSCs 
repopulate the haematopoietic system of a recipient with a removed or damaged 
system (Bhatia et al., 1997). Haematopoietic stem cells originate from the bone 
marrow. Another type of adult stem cells is neural stem cells (NSC). They have the 
ability to generate all the cells found in the adult central nervous system (e.g. 
neurons, astrocytes, oligodendrocytes) (Gage, 2000). They are present from birth, 
and now are believed to persist into adult life in the brain and spinal cord (Gage, 
2000). Mesenchymal stem cells (MSCs), which will be described in detail in section 
2.4, are also adult stem cells. Amongst other sources of origin, MSCs can also be 
isolated from the bone marrow, making the bone marrow home to two different adult 
stem cell types. 
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2.3 Bone marrow, primary location of Mesenchymal Stem Cells 
Bone marrow is a complex, well organised tissue filling the space between vascular 
sinuses and bone surfaces of the pores in cancellous bones. It is composed of two 
distinct but interdependent compartments: the haematopoietic system and the bone 
marrow stroma (Weiss, 1970). The haematopoietic system consists of developing 
haematopoietic cells, also called haematopoietic stem cells (HSCs). They can give 
rise to all blood cell types, and are retained in the bone marrow until they have 
matured and are released into the vascular system (Fliedner, 1998). This assures the 
continuous replenishment of all types of circulating haematopoietic cells. HSCs can 
be found within discrete cellular spaces termed 'niches' (Moore and Lemischka, 
2006). In these niches, the HSCs are in close contact with their microenvironment 
(Arai et ai. , 2005). At least three niches with specialised functions can be defined: 
the bony niche, the stromal niche and the adipocyte niche. Figure 2.2 shows the 
cellular composition of these three niches and their positions within the bone 
marrow. 
Blood 
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Figure 2.2: The three haematopoietic niches and their cellular components according 
to Dazzi et al., 2006. 
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Cells from the second compartment, the bone marrow stroma, generate and maintain 
the haematopoietic microenvironment of these three niches (Neiva et al., 2005). The 
bony niche is lined with osteoblasts and preosteoblasts, both of which are found 
close to the endosteal surface (Arai et al., 2004) (Calvi et al., 2003) (Zhang et al., 
2003). The stromal niche contains reticular cells, fibroblasts, endothelial cells and 
macrophages, and is found stretching into the medulla of the bone. Reticular cells are 
the dominant cells of the marrow stroma. They encase sinuses and branch into the 
surrounding haematopoietic space, where they form a spongework on which 
haematopoietic cells are arranged (Bianco et al., 1993). Reticular cells are considered 
"fibroblastic" in nature since they are defined by the expression of high levels of 
membrane-associated alkaline phosphatase activity, collagen types I and III and 
osteonectin. They originate from the primitive osteogenic periosteum of developing 
bones and co-migrate, along with ingrowing blood vessels, to the interior of 
developing bones, where they actively proliferate and provide the reservoir of 
immediate osteogenic precursors (proliferating pre-osteoblasts) for pre-natal 
osteogenesis (Krebsbach et al., 1999). It has been shown, that mature endothelial 
cells also play an important role in supporting haematopoiesis after radiation 
exposure as progenitors of the marrow stroma (Li et al., 2004) (Gaugler et al., 2001). 
The adipocyte niche is located in the non-haematopoietic space within the long bone, 
also known as "yellow marrow" (Dazzi et al., 2006). In post-natal human marrow, 
stromal cells demonstrate characteristics of pre-adipocytes (Bianco et af., 1988). It 
has been suggested that alkaline phosphatase (ALP) positive reticular cells and 
adipocytes are alternative phenotypes (Weiss, 1976). An inverse relationship 
between ALP-positive stromal cells and adipocytes can be demonstrated at any age 
or marrow site. The number of adipocytes increases in the bone marrow when there 
is a pathological or age related reduction in haematopoietic tissue or during skeletal 
development when there is space in excess of what is needed for haematopoiesis 
(Weiss, 1976). 
Investigations into the interactions between the haematopoietic and the stroma 
compartments have shown that a close relationship exists between osteogenesis and 
haematopoiesis (Taichman, 2005). Thus, haematopoietic cells influence the activity 
of the stromal compartment, and in return some cell types of the marrow stromal 
tissue (reticular cells, adipocytes, osteoblasts and macrophages) not only serve as a 
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mechanical support for differentiating haematopoietic cells, but also support 
haematopoiesis by regulating the survival, proliferation, migration, and 
differentiation of HSCs through several mechanisms (Taichman, 2005). This 
includes cell contact interactions or the production of growth factors, chemokines 
and extracellular matrix molecules. Several examples have been mentioned for these 
interactions. Reticular cells, for example, sort the differentiating haematopoietic cells 
into characteristic locations in their spongework (Weiss, 1976). Adipocytes can 
regulate haematopoiesis via secretion of leptin, which has been shown to correlate 
with white blood cell numbers (Wilson et al., 1997). Furthermore, the stromal 
osteoblasts express diverse soluble factors, such as granulocyte colony-stimulating 
factor (G-CSF), IL-6 and the Notch ligand jagged 1 that can influence the 
proliferation and differentiation of HSCs (Murphy et al., 2005). There is also 
evidence that cytokine production by mesenchymal stem cells (MSCs), osteoblasts 
and stromal cells can be influenced by 'cross-talk' between these cells and HSCs 
(Taichman et al., 1997) (Ahmed et al., 2001). In this matter, the work by Beachy et 
al. (2004) indicated that specific signals induced by the hedgehog (Hh) pathway and 
the Wnts pathway may be involved in the control of the bone marrow stem cell 
homing, migration and differentiation. 
As well as haematopoietic stem cells, the bone marrow is home to stem-like cells that 
are precursors of the stromal tissue. The majority, if not all, of the stromal cells 
derive from a common mesenchymal progenitor, referred to as the mesenchymal 
stem cell (MSC). Among the MSCs, there are primitive mesodermal progenitor cells 
(MPCs) or muitipotent adult progenitor cells (MAPCs). Together, they lead to the 
generation of different bone marrow and bloodstream cell lineages (Arai et al., 
2004). Thus far, the location and lineage commitment of MSCs in vivo are much less 
characterised than those of HSCs. The origin of mature osteoblasts and 
haematopoietic cells has been directly proven (Krebsbach et al., 1997) (Kuznetsov et 
al., 1997). However, the origin of the MSCs has only been surmised, in a 
perivascular region in the bone marrow tissue (Shi et al., 2003). As no specific 
antigens for MSCs have been described yet, it is not possible to determine the exact 
anatomical location within the bone marrow. 
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2.4 Mesenchymal Stem Cells 
Mesenchymal stem cells were first reported by Friedenstein et 01. (1968), who 
referred to them as colony-forming-units fibroblasts (CFU-f), according to their 
ability to adhere to tissue culture plastic, and grow into colonies when cultured in 
vitro (Friedenstein et al., 1968 and 1976) (Hung et 01., 2002). CFU-fs can develop, 
under appropriate experimental conditions, into a variety of fully differentiated 
connective tissues, such as cartilage, bone, adipose tissue, fibrous tissue, and 
myelosupportive stroma, both in vitro and in vivo (Friedenstein et 01., 1974) (Owen, 
1988) (Pittenger et 01., 1999), while retaining a high proliferation capacity 
(Friedenstein et 01., 1987). Based on such observations, researchers developed the 
concept that osteoblasts, chondrocytes, adipocytes and other connective tissue cells 
derive from a common ancestor, which was found to be a stromal stem cell persisting 
within the bone marrow of postnatal and adult organisms. It was then, that the name 
marrow stromal cell, or mesenchymal stem cell (MSC) was formed (Rickard et 01., 
1996) (Prockop, 1997) (Colter et 01., 2001). MSCs are harvested most commonly 
from bone marrow, where they represent about 0.01 - 0.001% of the nucleated cells, 
but they can also be found in other different tissues such as umbilical cord blood, 
synovial membrane of knee joints, adipose tissue and muscle. All these tissues 
contain MSC like cells with the ability to proliferate extensively in culture and to 
differentiate into multiple lineages under specific conditions in vitro (De Bari et 01., 
2001) (Chang et at., 2006) (Zuk et 01.,2001) (Nesti et 01.,2008) (see Figure 2.3). 
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Figure 2.3: Differentiation potential of adult mesenchymal stem cell. They can 
differentiate into multiple lineages such as osteocytes, chondrocytes, fibroblasts, 
adipocytes, astrocytes and myocytes (Grassel and Ahmed, 2007). 
The term mesenchymal stem cell can describe a vast variety of multi potent adult 
stem cells, since the only way to define MSCs is by their differentiation capacity. 
Although, the CFU-f assay has traditionally been used to obtain the numbers of bone 
marrow derived MSCs, this assay on its own does not directly detect differentiation 
or self-renewal potential. In order to determine these cell properties, time consuming 
differentiation assays have to be conducted, in which MSCs are cultured in the 
presence of specific growth factors or differentiation agents (Bosnakovski et ai. , 
2005). Kuznetsov et a/. (1997) found that, upon transplantation, bone marrow 
derived CFU-fs form bone and even support haematopoiesis. However, the CFU-fs 
were heterogeneous with respect to their osteogenic differentiation potential and their 
capacity to support haematopoiesis (Kuznetsov et ai., 1997). Using in vitro 
differentiation assays, a clonal study of human MSCs also revealed varying 
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differentiation potential of the MSC clones (Muraglia et al., 2000). All of these 
clones had osteogenic potential, whereas 60-80% had osteo- and chondrogenic 
potential, and only 33% displayed osteo-, chondro- and adipogenic potential 
altogether. Furthermore, Muraglia et al. (2000) showed that, upon static monolayer 
culture, MSCs gradually lose their adipo- and chondrogenic potential. These findings 
clarify that a single type of differentiation potential of MSCs is not a reliable method 
to describe them. 
There are remarkable differences not only at the differentiation capacity of MSCs 
into multiple lineages, but also the cell morphology and rates of proliferation. Bruder 
et al. (1997) evaluated the growth kinetics of MSCs by serial subculture over 15 
passages, which corresponded to 38 population doublings. During subculturing, the 
cells showed changes in morphology from thin spindle-shaped cells to broad and 
flattened cells. The proliferation potential and the final cell number after a fixed 
period in culture also decreased with time (Bruder et al., 1997). In a similar study, 
the growth kinetics of bulk and clonal MSCs were reported for up to five passages, 
corresponding to 24 population doublings for the bulk population and 19 - 23 
population doublings for the clones (Banfi et al., 2000). During subculturing, the cell 
doubling time increased in the bulk population and a loss of the osteogenic 
differentiation potential in vivo was observed. These results prove that MSCs, in 
contrast to ESCs, cannot proliferate indefinitely in culture. Their limited life-span in 
vitro is thought to be due to their lack of telomerase activity, which prevents 
shortening of the telomeres. Hanfi et al. (2002) showed that the telomere shortening 
in MSCs during in vitro expansion (50-100 bp/doubling) falls within the range of 
telomere shortening for telomerase-negative somatic cells, which only have a very 
limited life span. In addition they also found that the gene expression profile of late 
passage MSCs revealed a commitment towards the osteogenic lineage. 
Thus far, a definitive demonstration of both self-renewal and multilineage 
differentiation of a MSC at the single-cell level is missing, and the molecular 
mechanisms that control MSC self-renewal and differentiation are not fully 
understood. This is in part because of the heterogeneous MSC populations isolated 
from the bone marrow, which also vary among different laboratories (Baksh et al., 
2004). Therefore, investigations at the single cell level are necessary (Kemp et al., 
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2005). In order to analyse MSCs at this level, they have to be identified and isolated 
first. However, neither their differentiation capacity nor their morphology are 
parameters that allow a satisfying identification. The fibroblastic morphology in 
culture cannot be used to distinguish them from more differentiated cell phenotypes 
since both osteoblasts and fibroblasts are morphologically nearly indistinguishable 
(Ducy et 01., 2000). Hence, several molecular markers and certain antigens, in 
particular surface proteins, have been used as an attempt to characterise MSCs and 
distinguish them from more mature cells such as fibroblasts and osteoblasts (Ishii et 
01., 2005) (Haynesworth et al., 1992) (Bruder et 01., 1998) (Gronthos et 01., 2003) 
(Honczarenko et 01.,2006). 
Several research groups have employed proteomic studies on MSCs in order to 
characterised both changes in the intracellular pathways involved in differentiation 
processes and changes in the expression of protein surface markers in MSCs before 
and after the induction of differentiation (Baharvand et 01.,2007). Foster et 01. (2005) 
characterised changes in membrane protein markers of human MSCs undergoing 
osteoblast differentiation. Samples from the cells membrane were analysed using 
liquid chromatography coupled with tandem mass spectrometry (LCIMSIMS) in 
order to find surface markers that help to distinguish undifferentiated MSCs from 
early osteogenic progenitor cells. 463 unique proteins were identified, including all 
known markers of human MSCs. 83 identified proteins, such as alkaline 
phosphatase, increased in expression levels by at least twofold and 21 proteins, 
including fatty acid synthase, decreased upon osteoblast differentiation. Foster et 01. 
(2005) concluded that mass spectrometry-based proteomics can reveal novel markers 
of human MSCs. Another group (Zhang et 01., 2007) identified differently expressed 
proteins responsible for osteoblast differentiation in human MSCs by using two-
dimensional gel electrophoresis (2DE), MALDI-TOF-MS and peptide mass 
fingerprinting. Proteome maps were generated from undifferentiated human MSCs 
and from osteogenic induced MSCs. In total, 102 proteins with at least two-fold 
changes in expression were revealed with 2DE, whereof 52 could be successfully 
identified by MALDI-TOF-MS. An experiment using adipocytes, differentiated from 
human MSCs, for proteomic analysis with 2DE and MALDI-TOF-MS were 
conducted by Lee et 01. (2006). The MSCs were cultured as undifferentiated cells in 
static monolayer cultures for two passages before adipogenic differentiation was 
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induced. Cell samples from undifferentiated cells and adipogenic cells after different 
time length in adipogenic differentiation culture were used for the proteomic 
analysis. 32 protein spots were shown to have different expression levels. Among the 
up-regulated proteins, four were associated with adipogenesis. 
Although at present several markers are known to be expressed by human MSCs 
(e.g. CD13, CD4ge, CD73 (SH3 and SH4), COlO5 (SH2), Macl, POGF-R and Stro-
I), their antigenic phenotype is not unique, and hence no single marker has been 
found to be specific for MSCs (Con get and Minguell, 1999) (Barry and Murphy, 
2004). A combination of surface markers coexpressed on one single cell represents a 
promising strategy for distinct characterisation of MSCs (Kemp et al., 2005) 
(Schieker et 01., 2007). However, the expression of various markers, similar to the 
differentiation and proliferation potential, is variable between different cell 
populations, and also within a cell population, as a function of time in culture. 
2.S Therapeutic applications of Mesenchymal Stem Cells 
It is surprising that the lack of definition has not prevented the widespread use of the 
term mesenchymal stem cell, as well as the enthusiasm about their value for 
therapeutic applications (Colter et al., 2000). The wide differentiation potential of 
mesenchymal stem cells (MSCs) and their more differentiated progenitors allows 
them to be used for applications such as tissue engineering and gene therapy. The 
maintenance of their multipotential capacity after transplantation, which has been 
proven by Liechty et al. (2000), is the essential requirement for the usage in a huge 
variety of cell therapies. Liechty et al. (2000) transplanted human bone marrow 
derived mesenchymal stem cells in foetal sheep. The cells were first expanded in a 
static monolayer culture for one passage, and then stored in liquid nitrogen until they 
were injected into the peritoneal cavity of either 65 or 85 day old foetal sheep, which 
were in different development stages for haematopoiesis and immune response. The 
foetal lamb model was chosen because it is immunologically tolerant, and because 
human and sheep DNA and proteins are widely disparate, which allows the use of 
human-specific markers for the detection and characterisations of the transplanted 
human MSCs. The foetal sheep were killed at several time points after injection 
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(longest was 13 months), tissue and blood samples were collected and analysed for 
the presence of human cells by DNA isolation and immunohistochemistry. All 
analyses showed the presence of human MSCs in pre- and post-natal haematopoietic 
and lymphopoietic tissues like foetal liver, bone marrow, spleen and thymus as well 
as in nonlymphohaematopoietic sites like adipose tissue, lung, articular cartilage, 
pervascular areas of the central nervous system and cardiac and skeletal muscle. 
These results have caused great interest in developing and expanding populations of 
MSCs which are able to repopulate and repair damaged tissues. 
Disorders that might benefit from MSC based therapies include diabetes, heart 
failure, muscular disorders, arthritis, and vision disorders (Mimeault and Batra, 
2006). Several in vivo studies have been conducted to assess the therapeutic potential 
of MSCs for these disorders. For instance, Oh et al. (2004) examined the use of 
MSCs to treat pancreatic diseases. The cells were trans-differentiated in insulin 
producing cells in vitro before they were transplanted subcapsular into 
hyperglycemic mice. This resulted in a significant reduction of blood glucose levels 
which was maintained for up to 90 days post-transplantation. Thus, it also could be 
possible to develop cell therapies for human diabetic patients by using the human 
MSC derived p-cells. Nevertheless, additional in vivo work is needed to fully 
understand the migration and differentiation process of MSCs into p-cell-Iike 
progenitors. 
Another investigation indicated that the transplantation of mice bone marrow stem 
cells into the infracted heart of mice resulted in the differentiation of myocytes and 
the formation of coronary vessels, which improved cardiac function (Kajstura et al., 
2005). Hence, it appeared that MSCs could represent a more accessible source of 
stem cells for the treatment of cardiac disorders than cardiac stem cells. 
In further studies, MSCs were seeded onto ceramic scaffolds before being 
transplanted subcutaneously into mice in order to demonstrate their osteogenic 
differentiation capacity in vivo (Diao et al., 2009). Matsushima et al. (2009) also 
transplanted ceramic scaffolds loaded with human bone marrow derived MSCs into 
rats to determine the bone forming potential of the stem cells. In this study, the 
freshly harvested MSCs were expanded in static monolayer cultures for 2 passages 
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before being seeded either on hydroxyapatite ceramics or on J3-tricalcium phosphate 
ceramics. Both ceramics were then transplanted subcutaneously into nude rats and 
recovered after 8 weeks. Bone formation was measure by analysing the scaffolds 
using microcomputer tomography (micro CT) and automated picture analysing 
software. The results suggested that human MSCs cultured on ceramics could retain 
their osteogenic differentiation capacity even after ectopic implantation. 
In another transplantation experiment, MSCs were harvested from the bone marrow 
of rhesus monkeys, expanded and differentiated into neural lineage cells in vitro 
before being transplanted into the injured spinal cord of the rhesus monkeys (Oeng et 
al., 2006). 3 month after transplantation, the primates achieved nearly normal 
sensory responses and 1 0% of the transplanted MSCs showed the presence of neural 
cell markers. Deng et al. (2006) concluded, that the implantation of differentiated 
MSCs activated neurogenesis and functional recovery in the primate spinal cord 
injury model. 
Moreover, human MSCs from healthy donors were also used to reconstruct 
chemically burned rat corneal surfaces (Ma et al., 2006). The cells were first 
expanded in culture on human amniotic membrane in Oulbecco's modified Eagle's 
medium (OM EM) before being transplanted into rat corneas, 7 days after chemical 
burns. Ma et al. (2006) observed that transplantation of MSCs successfully 
reconstructed the damaged corneal surface, however, they concluded that the 
therapeutic effect may be due, in part, to an inhibition of inflammatory and 
angiogenic processes rather than the epithelial differentiation of MSCs. This opinion 
was also shared by Popp et al. (2009) who believed that mesenchymal stem cells are 
promising candidates for immunomodulation therapy. Popp et al. (2009) stated that 
MSCs suppress the immune response in a variety of in vitro and disease models and 
thus may be of benefit for patients suffering from autoimmune disorders or transplant 
rejection. The mechanism by which MSCs modulate the immune response has still to 
be investigated, but it most likely involves expression of local factors such as 
indoleamine 2,3-dioxygenase, inducible nitric oxide synthase, and others, as well as 
interactions with dendritic or antigen-presenting cells (Popp et al., 2009). 
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The clinical transplantation procedures of MSCs, which depend on patient state and 
diagnosis, generally involve the intravenous injection or subcutaneous administration 
of a specific number of stem cells directly into therapeutically targeted areas. 
However, transplantation is not the only way to use MSCs in cell therapy. The high 
plasticity and migratory potential of bone marrow derived MSCs, offer the 
possibility of injecting these stem cells into the circulation or mobilising them in vivo 
using signalling factors to regenerate the particular damaged tissue (Blau et 01., 2001; 
Orlic, 2005). These procedures are often applied when studying the MSC's repair 
potential ofinfracted myocardium (Vandervelde et al., 2005). 
Besides their use for tissue engineering, MSCs can also be used for gene therapy. 
Gene-based strategies involve modifications or replacement of a particular gene 
product in the stem cells before their transplantation into the patient. These therapies 
might be considered for the treatment of diverse genetic and incurable diseases such 
as bleeding disorders. For instance, it has been reported that bone marrow stem cells 
transfected with a gene for human coagulation factor IX (hFIX) secreted the 
biologically active hFIX form of this factor in in vitro experiments. When 
transduced stem cells were subcutaneously transplanted into immunocompromised 
mice, secretion of hFIX into the circulation could be proven (Krebsbach et 01., 
2003). 
Before MSCs can fulfil their expected role in cell therapies, the underlying 
mechanisms of the MSC biology, which are involved in self renewal and 
differentiation, have to be better understood. In addition, efforts have to be made to 
optimise the production of bone marrow derived MSCs for a variety of technological 
applications (Colter et 01.,2000). 
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2.6 Culture systems for Mesenchymal Stem Cells 
A variety of culture techniques for MSC cultivation has been described in the 
literature, and is described below. Although all of these techniques are suitable for in 
vitro expansion of MSCs, each has its own advantages and disadvantages. The 
problems of providing ideal culture conditions for MSCs are based in the lack of 
appropriate surface markers associated with identifying them, and the limited 
knowledge of their requirements to maintain the full differentiation and proliferation 
capacity. A proteomic study on MSCs by Wagner et al. (2006) pointed to the lack of 
common standard for cultivation protocols of MSCs in vitro. Wagner et al. (2006) 
compared the proteome of human MSCs, which were expanded in two different 
culture media. This work demonstrated the influence of different culture conditions 
on the proteome and cellular organisation of MSCs. Human bone marrow derived 
MSCs were either expanded in 58% Oulbecco's Modified Eagles Medium-Low 
Glucose and 40% MCOB 201 from Sigma, supplemented with 2% fetal calf serum, 
or in a commercially available Poietics Human Mesenchymal Stem Cell Medium 
(PT -3001) from Cambrex. After 6 passages, the MSCs were harvested, and the 
proteome was analysed by matrix assisted laser desorption I ionisation time of flight 
mass spectrometry (MALOI-TOF-MS). In total, 136 proteins were identified. 
Proteins involved in metabolism were more up regulated in the mixed culture 
medium, whereas proteins involved in development and differentiation were more up 
regulated in the commercially available medium. This study proves that culture 
conditions exert a prominent impact on the proteome of MSCs, and thus it is 
necessary to have a common standard for expanding MSCs in vitro when comparing 
results from different laboratories. This underpins why the application of MSCs is 
not yet routinely used for medical applications. 
2.6.1 Static monolayer cultures 
The general protocol for expanding bone marrow derived mesenchymal stem cells 
involves isolation of the mononuclear cells and seeding these cells on tissue culture 
plates, such as T-flasks in a medium containing foetal bovine serum (FBS). After the 
adherent cell fraction attaches to the plastic surface and forms a monolayer, the 
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complete medium is changed for the first time to remove all non-adherent cells. The 
adherent cells are allowed to proliferate until they reach about 90% confluency. At 
this point, they have to be lifted off the plastic surface by incubating them with 
trypsinlEDTA and re-plated into new culture plates to ensure further proliferation as 
a monolayer. The adherent cells, which consists mainly of MSCs are normally 
expanded for a limited number of passages, and then used for further applications or 
assays such as various differentiation assays (Ulloa-Montoya et al., 2005). 
Different strategies have been implemented to improve the isolation and in vitro 
expansion of MSCs, including optimisation of culture temperature, initial plating 
density and initial selection of a more purified and homogeneous MSC population 
based on cell surface markers or cell size (Stolzing and Scutt, 2006) (Colter et al., 
2000) (Gronthos et al., 2003). Extensive expansion of MSCs leads to in vitro aging, 
the accumulation of oxidative damage and, as a result of both, to reduced 
proliferation and differentiation capacity (Sugiura et al., 2004). Stolzing and Scutt 
(2006) have shown that a lower culture temperature of 32°C improved the 
differentiation potential of MSCs and reduced apoptosis by decreasing the effects of 
oxidative damage to the cells. Furthermore, Shui and Scutt (2001) demonstrated that 
mild heat shock (repeated exposure to 39 / 41°C) stimulated alkaline phosphatase 
activity in bone marrow derived MSCs and their differentiation into osteoprogenitor 
cells. Both studies hypothesise that the up-regulation of several heat shock proteins 
might be involved in the differentiation process of MSCs. Hence, a carefully 
controlled and regulated culture temperature is crucial for MSCs to keep their full 
differentiation and proliferation potential whilst being expanded in culture. 
The seeding cell density has been proven to influence the proliferation potential of 
MSCs in static cultures (Colter et al., 2000). Cells, initially plated at low densities 
(1.5 - 3 cellslcm2), grew more rapidly and expanded an average of 600 fold (about 
50 population doublings), whereas cells at higher densities (12 cells/cm2) grew more 
slowly and expanded only 3 - 5 times (about 15 population doublings) (Colter et al., 
2000). These findings were confirmed by another study examining initial seeding 
cell densities in a larger interval of 10 - 1000 cells/cm2 (Sekiya et al., 2002). They 
also showed that the lowest cell density produced the highest fold increase in cell 
number. In addition, changes in cell morphology were found with different cell 
26 
densities, and were correlated with varied differentiation potential. Low cell density 
cultures favoured the appearance of thin, spindle shaped MSCs (called RS-IA) that 
differentiated into adipocytes. Plating MSCs at higher cell densities promoted 
appearance of wider spindle-shaped cells that could be differentiated into cartilage 
(Sekiya et af., 2002). 
A purification of the initial MSCs population can also improve their proliferation in 
vitro. An initial selection of purified and homogeneous MSCs was achieved by cell 
sorting of human bone marrow mononuclear cells using the cell surface markers 
STRO-l and vascular cell adhesion molecule 1 (VCAM-l) (Gronthos et af., 2003). 
The purified MSC population expressed telomerase and could be expanded for over 
40 population doublings in a serum free media. They showed a 50% cloning 
efficiency for fibroblast colonies, and tri-lineage mesenchymal differentiation 
potential in vitro but heterogenous differentiation capacity in vivo. Simmons et af. 
(1991) first showed that the cell surface marker STRO-l identified a population of 
bone marrow cells that had the capacity to form fibroblast colonies, gave rise to cells 
with smooth muscle phenotype and had adipogenic and osteogenic differentiation 
potential. 
As mentioned at the beginning of the section 2.6.1, bone marrow derived MSCs are 
isolated by plating the mononuclear cells from bone marrow on tissue culture plates 
in medium containing FBS. However, slight variations in the composition of the 
serum are unavoidable, since FBS is obtained from different sources and at different 
times. These variations in FBS appear to have a major effect on MSC cultures, 
affecting the plating efficiency and subsequent expansion. In order to minimise the 
effects, different lots of FBS are mixed which each other, thus the differences in the 
serum composition are minimised. Nonetheless, the only way to avoid these effects 
completely is by using serum free media. Gronthos et af. (1994) was able to expand 
STRO-l+ and STRO-l+ VCAM-l+ MSC populations in serum free medium, and 
found that in these conditions dexamethasone and L-ascorbate were essential for 
colony formation, whereas epidermal growth factor (EGF) and platelet-derived 
growth factor (PDGF) supported the colony growth. 
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Another downside of the static monolayer culture technique, besides the use of serum 
in the culture medium, was observation that serial subculturing of the MSCs affected 
their proliferation capacity (Sun et 01.,2006) (Celebi and Elcin 2008). Both research 
groups conducted proteome analysis on subcultured MSCs to investigate these 
effects. Sun et 01. (2006) analysed the proteome of hMSCs using 20E and MALOI-
TOP-MS. They were interested in finding different regulated proteins during serial 
subculturing, which might be involved in proliferation and differentiation related 
processes. Indeed, several proteins associated with cell proliferation, cell cycle and 
apoptosis were shown to be differentially regulated, indicating that passage-specific 
protein regulation can playa role in the decrease of proliferation and osteogenic 
differentiation potential. Celebi and Elcin (2008) were also interested in the effect of 
serial subculturing on rat bone marrow derived MSCs. They expanded the MSCs in 
static monolayer cultures for up to 10 passages before extracting the proteins and 
separating them by 2DE. About 1000 protein. spots were detected, and of these 31 
proteins were successfully identified by MALOI-TOP-MS. Amongst them were 18 
differentially expressed proteins that were involved in cell proliferation and 
differentiation through different signaling pathways. 
The advantage of the static monolayer culture system and the reason why this 
method is commonly used for MSCs expansion, is the surface based growth of these 
cells. In static monolayer cultures, MSCs can easily adhere to the culture plastic 
surface and proliferate in relatively simple culture conditions. However, this 
simplicity also has its disadvantages. Although bone marrow derived MSCs were 
successfully expanded for several passages in static monolayer cultures, these culture 
systems have a poor reproducibility, lack of mixing (gradients for pH, dissolved 
oxygen, cytokines and metabolites) and do not allow online monitoring or control of 
the culture conditions (Ohgushi et aI., 1999). However, a better control of the culture 
condition can improve the expansion of MSCs, as mentioned above. Being able to 
amplify MSCs in large numbers is very important, since the donor derived cell 
samples only consist of a small number of MSCs (about 0.1 % or -40,000/ml), which 
cannot meet the expected demands for therapeutic applications (about 7.5 x 109 
MSC to help healing a 10 cm defect in a human femur). Therefore, a technique is 
required which is able to cultivate large quantities of stem cells in a controlled and 
well defined environment. 
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2.6.2 Stirred suspension cultures 
Bioreactors provide a controlled in vitro environment, allowing the study of stem cell 
proliferation and differentiation. The main advantage of the bioreactor is not only the 
production of larger quantity of cells and easier handling, its use also allows for the 
permanent monitoring and control of the physical and chemical environment, thus 
providing the cells with optimised culture conditions which are crucial for their 
cultivation. In a bioreactor, different culture parameters can be investigated (e.g. 02 
tension, cytokine concentration, medium exchange rates, glucose concentration, etc) 
that may influence the viability, proliferation and differentiation of MSCs (Ulloa-
Montoya et 01., 2005) (Baksh et 01., 2003). For example, reduction in glucose 
concentrations led to decreased apoptosis, an increased rate of MSC proliferation and 
increased the number and size of fibroblastic colonies in the CFU-f assay (Stolzing et 
01., 2006). Low oxygen concentrations in vitro can also increase proliferation rates 
and enhance differentiation along the different mesenchymal lineages (Das et 01., 
2009). The observation that more mature cells may be less sensitive to changes in 
their oxygen environment than their immediate precursors (Cipolleschi et 01., 1993) 
suggests that the definition of an "optimal" oxygen tension may depend not only on 
the kind of stem cells used but also on the developmental potential ofthe cells being 
stimulated. 
A variety of bioreactors for cell cultivation already exists and can be easily adapted 
for large scale MSC cultivation. However, first, it has to be proven that MSCs can 
proliferate in suspension, in order to be amplified in suspension based bioreactors. 
Cells with similar properties to mesenchymal stem cells can be isolated from the 
circulation (Zvaifler et 01., 2000) and thus may be able to survive and proliferate in 
suspension. Furthermore, studies have shown that MSCs do not necessarily need 
adherence to a surface to grow and proliferate (Baksh et 01., 2003). Therefore, an 
alternative and more attractive method for their cultivation can be the stirred 
suspension culture. Promising results on the growth ofhaematopoietic (Kwon et 01., 
2003), neural (Sen et 01., 2002), and embryonic (Fok et 01., 2005) stem and 
progenitor cells in stirred suspension cultures have been obtained. These protocols 
may be used to develop and improve the cultivation of MSCs in stirred suspension 
cultures. Baksh et 01. (2003) and Chen et 01. (2006) have proven that marrow derived 
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st~omal cells (detected as CFU-f) can also be expanded in stirred suspension cultures. 
In both studies MSCs were grown in culture medium supplemented with stem cell 
factor (SCF) and interleukin 3 (lL-3) and showed osteogenic differentiation potential. 
As mentioned in section 2.3, there is a close interaction of all bone marrow cells in 
vivo either by cell - cell contact or by secretion of cytokines and other signalling 
molecules. These complex influences on MSC development make it very difficult to 
find the optimum culture condition and require time intensive investigations of these 
interactions. One possibility to create a culture condition, which offers a similar 
microenvironment to MSCs in stirred suspension cultures than the niche of MSCs in 
the bone marrow, is to culture whole bone marrow cells. So far, however, the 
suspension culture systems do not mimic the complex three-dimensional 
microenvironment of adult bone marrow. According to Zandstra and Nagy (2001), it 
is likely that these "adult" microenvironments are highly damped in their ability to 
initiate extensive stem cell self-renewal. They argue that, although many studies have 
shown that lineage commitment and mature cell function are stabilised by cell - cell 
and cell - extracellular matrix interactions, stem cell self-renewal may be more 
efficient in the absence of these signals. In fact, direct evidence of feedback-induced 
differentiation has been shown in embryonic stem cells (Klug et al., 1996). 
Furthermore, the effect of mature cell populations or their products is well 
documented on haematopoietic stem cell differentiation (Cashman et al., 1999). 
In addition to the physicochemical parameters, it is clear that the protein 
microenvironment also has significant effects on stem cell development. Stem cell 
properties are the result of expression of a specific subset of genes. Changes in their 
expression will determine development from the stem cell state into functional cell 
lineages. Although there is still much to learn about the genes involved in such 
changes and how they are regulated, it is clear that stem cells interact with many 
molecules in their extracellular environment via transmembrane receptor complexes 
to maintain their viability, and to change their differentiated state. A key feature of 
any stem cell culture system is the combination of cytokines it delivers to the 
microenvironment of the cells, and how the concentrations of these cytokines and 
their associated receptors are maintained over time. All publicised experiments with 
MSCs in suspension cultures used quite expensive additives of cytokines for their 
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culture medium (Baksh et al., 2003) (Chen et al., 2006), which will raise a financial 
problem for the scale-up to large scale production of these cells. The dynamic nature 
of cytokine supplementation also needs to be taken into account, as the number of 
ligand-receptor complexes depends on 1) the number of unoccupied receptors 
available and 2) the ligand concentration, which both change with time 
(Lauffenburger et al., 1987). In stem cell cultures, not only does the dynamic 
requirement of cytokines effect the MSCs development, but the production of 
cytokine and growth factors by the cells themselves are likely to effect the outcome 
of these cultures as well, as observed in other stem cell cultures e.g. on 
haematopoietic stem cells (Zandstra et al., 1997 and 1999). Ideally, when critical 
numbers of particular cells are generated, the culture system may no longer require 
exogenous growth factors to maintain optimised MSCs expansion. 
Summarising, the advantages of stirred suspension cultures over static monolayer 
cultures are promising. Not only can higher MSC numbers be obtained from stirred 
suspension cultures, but, more importantly, a suspension based proliferation is 
necessary for the application of bioreactors as culture vessels. Bioreactors allow 
control of the culture environment, and thereby enable the investigation of how 
different parameters effect the MSC proliferation and differentiation. The downside 
of stirred suspension cultures is the fact that expensive growth factors have to be 
added to the culture medium in order to achieve increase in MSC number. These 
growth factors will increase the production costs for MSCs at a large scale, and 
thereby may restrict the usage of these cells for medical applications. Furthermore, 
by stirring the culture medium, shear forces are exerted on the MSCs, and these shear 
forces can damage or kill the cells. 
A compromise between stirred suspension culture and surface adherent culture 
system are solid or macroporous microcarriers. Solid microcarriers are made of 
cross-linked dextran, cellulose or polystyrene and support cell growth on their 
external surface, whereas macroporous microcarriers, typically made of gelatin, 
collagen or other soft material with high oxygen diffusion characteristics, have open 
pores to provide larger growth surface area (Bancel and Hu, 1996). MSCs are 
allowed to adhere to the microcarriers, which are then put into a stirred suspension 
culture to amplify the cells. The suspension culture with microcarriers is maintained 
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in a similar way than the suspension cultures of MSCs. Regular medium change 
provides the MSCs with enough nutrients, and stirring will keep the microcarriers in 
suspension (Schop et 01., 2008). The advantages of this culture system are the 
combination of adherent growth of MSCs on the surface of the microcarriers with a 
large scale expansion, considering the large number of microcarriers which can be 
suspended in the culture medium (Weber et 01 .• 2007). However. this system also 
combines the disadvantages of static monolayer cultures and stirred suspension 
cultures. Although the MSC expansion is supported by adherence to the surface of 
the microcarriers. the extensive mixing in the stirred suspension culture might still 
disturb the formation of a normal microenvironment which would be formed by 
those cells when grown on a stationary surface. In addition, any surface bound 
system has the disadvantage that trypsin treatment is necessary to detach the cells 
(Weber et 01.,2007). Hence, by using microcarriers in stirred suspension cultures to 
expand MSCs, both shear stress and chemical stress will be exerted to the celJs. 
2.6.3 Further culture systems 
Single pass perfusion (SPP) is an alternative way to expand mesenchymal stem cells 
as monolayer cultures without the shear stress caused by any stirring system. In SPP 
cultures, cells are seeded into a chamber in which the culture medium is continuously 
replaced by fresh medium at a slow, controlled rate without disturbance or removal 
of cells. This allows a controlled exchange of nutrients and metabolic by-products 
and an optimal maintenance of the microenvironment. The beneficial effect of 
medium perfusion has been demonstrated on the improved productivity and viability 
of bone marrow cultures (Schwartz et 01., 1991), and also on the metabolic activity 
and growth factor production rates of marrow stromal cells (Caldwell et 01., 1991). 
The usage of the SPP technology led to the development of an automated perfused 
bioreactor system for the clinical-scale expansion of human primary cells (Lundell et 
01.. 1999). Bone marrow mononuclear cells cultured in a perfused bioreactor go 
through a major change in the composition of cell populations, resulting in a mixed 
lineage cell product, termed Tissue Repair Cells (TRCs), that has been used for 
patient-specific haematopoietic reconstitution (Pecora et 01.,200) (Stiff et 01.,2000). 
TRCs are a mixed cell population containing cells of haematopoietic, mesenchymal, 
and endothelial lineages. 
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Another culture method, named "pour-off culture", can be used to show that MSCs 
proliferate in suspension. It was applied by three different research groups to obtain 
bone marrow derived MSCs with high proliferation potential and full differentiation 
ability (Oreffo et al., 1996) (Zhang et al., 2009) (Baksh et al., 2007). Pour-off 
cultures were first described by Oreffo et al. (1996) who used this culture system to 
examine the non-adherent bone marrow stromal fraction from human bone marrow 
samples. Pour-off cultures can be seen as a combination between static monolayer 
cultures and suspension cultures. Oreffo et al. (1996) cultured whole bone marrow 
cells in a cell culture dish for 24 hours before transferring the non-adherent cells into 
a new dish. Thus, only the non-adherent cells were kept in the cultures, whereas the 
adherent cells were used to analyse the colony forming potential of the non-adherent 
cells at the time point of re-plating. Zhang et al. (2009) applied the pour-off culture 
technique to establish the presence of non-adherent MSCs in adult bone marrow. 
They expanded bone marrow derived MSCs in pour-off cultures by seeding 1 x 10' 
whole bone marrow cells in a culture plastic dish and re-plating the non-adherent 
cells every 24 hours. An increase in MSCs number of 2.3 fold was achieved with this 
technique after only 4 days compared to the initial cell seeding density. The 
expanded MSCs were then used for transplantation to establish their migration and 
differentiation potential in vivo. Zhang et al. (2009) concluded that the adult bone 
marrow harbours pluripotent. non-adherent MSCs which can migrate in vivo to any 
organ of the body through the circulation and, in the appropriate microenvironment, 
can adhere, proliferate and differentiate into specialised cells of the target tissue, and 
thus function in tissue regeneration. Baksh et al. (2007) also used this culture system 
to characterise suspension-derived MSCs for therapeutic strategies requiring 
systemic infusion. They found that the bone marrow contains a CD4ge1ow 
subpopulation of MSCs, which are present in the non-adherent cell fraction and 
which are able to proliferate in suspension while maintaining a single and round 
morphology. However, Baksh et al. (2007) reported that the remaining adherent cells 
of the pour-off cultures did not form fibroblastic colonies when the non-adherent cell 
fraction was removed after 24 hours. Therefore, they concluded that the adherent 
cells were either a mature cell type which is not able to proliferate and form colonies, 
or they require some stimulation from the non-adherent cell types to initiate their cell 
cycle. 
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Pour-off cultures combine the advantages of the static monolayer cultures and the 
stirred suspension cultures but avoid the disadvantages of both. In other words, using 
. pour-off cultures to expand MSCs from bone marrow cells, allows the cells from the 
adherent fraction of the bone marrow to adhere to a plastic ·surface whilst the non-
adherent cells can stay and proliferate in suspension. Furthermore, this culture 
technique does not require the use of trypsin or of an agitation method, and therefore 
minimises the stress exerted on the cells. Thus, a more MSC friendly culture 
environment is created which supports the amplification of MSCs in vitro. 
However, the disadvantages of the pour-off technique are the extremely work 
intensive handling of the cultures and the fact that no medium is changed during the 
whole culture period. Both will limit the potential for a large scale MSC expansion in 
pour-off cultures. In order to use the pour-off culture method to amplify large 
numbers of MSCs the automation of this technique including a regular medium 
change is necessary. 
2.7 Conclusions 
In this chapter, the wide field of stem cell research was briefly introduced by 
presenting a general background to the definition and classification of all stem cells 
with focus on one particular cell type, the mesenchymal stem cells (MSCs). Different 
in vitro expansion methods for MSCs are investigated in this thesis, and therefore the 
in vivo niches and several in vitro culture methods for these cells are described. The 
potential usage of MSCs in therapeutic applications such as tissue engineering and 
gene therapy is mentioned to explain the widespread interest in MSC research. By 
describing the complexity of the in vivo microenvironment of MSCs and the lack of 
definition for these cells, difficulties with the culture methods resulting from it are 
provided. 
Despite the reported achievements in successfully expanding MSCs in suspension 
cultures, there are still many obstacles to overcome before MSCs can be used for 
regenerative medicine on a wide spread base. For instance, the addition of cytokines 
to the culture medium in MSC suspension cultures, which was reported by all 
research groups, will pose an enormous cost factor and thus, the use of these cells 
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will be less appealing. Therefore, the optimisation of the culture conditions is still of 
great importance. A voiding the addition of growth factors is just one way to optimise 
the cultivation method. The aim of this study is to find a cheap and practical way to 
produce large numbers ofMSCs by expanding them in large scale cultures. Based on 
the literature available, the following chapters will introduce three methods for MSC 
culture techniques. The results obtained from these techniques will be investigated 
and compared to each other and to the literature in detail. Table 2.1 summarises the 
advantages and disadvantage of these culture methods for MSC expansion as 
described in the literature. 
Table 2.1: Summary of the advantages and disadvantages for in vitro MSC expansion 
in static monolayer cultures, suspension cultures or pour-ofT cultures as described in 
this chapter. 
Culture method advantage disadvantage 
• well established • lack of mixing 
static monolayer cultures • similar conditions to • no online monitoring I 
natural niche control 
• easy handling • poor reproducibility 
• large expansion rates 
suspension cultures • possibility for online • need of growth factors 
control • shear forces 
• easy scale-up 
• suspension based 
• extremely work proliferation intensive pour-off cultures • supporting adherent 
• no medium change cells 
• no online control 
• large expansion rates 
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Chapter 3 
General Materials and Methods 
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3.1. Introduction 
In this chapter, the general materials and commonly used methods for the 
experiments throughout all chapters are described and explained. The source of the 
cells and their extraction methods are detailed. Assays and techniques to quantify cell 
number, cell viability and colony forming behaviour are described, and different 
ways to measure cell differentiation are explained. However, materials and specific 
cell culture methods relating to individual culture techniques are described in the 
relevant chapter dealing with the particular technique. 
3.2. Reagents and consumables 
Unless stated otherwise, all general chemicals were purchased from Sigma-Aldrich 
(Poole, Dorset U.K.), tissue culture media, foetal calf serum and phosphate buffered 
saline were purchased from Lonza (Wokingham, U.K.), cytokines from PeproTech 
EC Ltd (London, U.K.), and plasticware from Nunc (Nottingham, U.K.) or Greiner 
Bio One (Gloucester, U.K.). 
3.3 Culture medium 
Two different standard media, Dulbecco's Modified Eagles Medium (DMEM) and 
MyeloCult® medium, were used to cultivate bone marrow derived rat MSCs in vitro. 
High glucose (4500 mg/l) DMEM with non-essential amino acids consists of 2 mM 
Glutamax, 2 mM penicillin / streptomycin (PS) and 10% foetal calf serum (FCS). 
MyeloCult® medium consists of Alpha Minimum Essential Medium (a-MEM) 
without L-glutamine, supplemented with 12.5% horse serum, 12.5% FCS, 2 mM 
Glutamax, 2 mM penicillin / streptomycin, 0.16 mM i-Inositol, 0.016 mM folic acid 
and 0.1 mM 2-mercaptoethanol. Both media were further modified in several 
experiments as determined in chapter 4,6 and 7 (section 4.2, 6.2 and 7.2). 
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3.4 Isolation of rat bone marrow cells (Scutt et aI., 2003) 
The rat bone marrow cells (BMCs) were obtained from male Wister rats (200 -
250g) from the Field Laboratories at the University of Sheffield. The rats were killed 
by cervical dislocation and sprayed with 70% Industrial Methylated Spirit (JMS) to 
kill fungal spores etc, before the dissection. The back legs were removed cleanly at 
the hip joint, transported to the cell lab and all soft tissue were removed from the 
bones under sterile conditions. The growth plates were removed from both the femur 
and the tibia. Using a bone cutter, the tibia at the tibial/fibula junction and the femur 
a little below the hip joint were cut. The cut bones were placed cut side down, on 
inserts in 1.5 ml Eppendorf tubes and were spun at 2000 rpm (900 g) for 1 minute. 
The inserts help to ensure that the bone marrow is deposited in the bottom of the 
Eppendorf tube. The bones and inserts were removed and the marrow was 
resuspended in I ml culture medium which was then made up to 10 ml per bone in 
culture medium, forcing the cells through a 1000 III pipette tip to break down the big 
cell clusters. Figure 3.1 illustrates the workflow beginning with the Wistar rats, then 
showing the removed femurs and tibias and finally the flushed out bone marrow 
cells. 
(A) 
¢ 
Figure 3.1: Key stages in the isolation of rat bone marrow cells. (A) 200 - 250 g 
Wistar rats were used to obtain (B) the femurs and tibias, from which in turn (C) the 
bone marrow cells were collected. 
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3.5 Cell count and cell viability 
The determination of the overall health of a cell culture requires measurements of 
both the total cell concentration, and the ratio of viable and dead cells, i.e. the 
viability. This data is essential to monitor the cells and find the optimum culture 
conditions. Three methods were used to determine the cell viability in the samples 
taken from all the cultures and they are discussed in tum below. 
3.5.1 Haemocytometer 
MSCs in solution have a diameter of about 20 J.1m, therefore they are big enough to 
be analysed with a light microscope and a haemocytometer using the trypan blue 
exclusion method (Guo et a/., 2002). When cells die, their membranes become 
permeable allowing for the uptake of the trypan blue dye. As a result, the dead or 
non-viable ~ells appear to be blue under a light microscope. Counting both stained 
and unstained cells allows the investigator to determine the viability of a cell culture. 
In this studie, 100 J.11 of a sample, taken from a cell culture, was mixed with 100 J.1.1 of 
trypan blue (Sigma 93590) to stain the dead cells. The solution was incubated for 5 
minutes at room temperature before 10 J.1.1 of the stained cell solution were transferred 
onto a haemocytometer. The stained and unstained cells in the large middle square 
(consisting of 25 small squares) of the counting grid were counted with an inverted 
light microscope from Novex Kolland (K - Range) using a 100 x magnification. The 
volume between coverslip and middle square equals 0.9 mm3• Therefore multiplying 
the counted cell number with 2 x 104 will result in the total cell concentration 
[cells/mIl of the sample taken from the culture before it was diluted with trypan blue. 
For example, if the analysis of a 100 J.11 sample taken from a 12 ml cell solution 
resulted in 30 counted cells, the total cell concentration in the 12 ml cell solution was 
6 x lOS cells/mt. The total cell number in the 12 ml solution was then 7.2 x 106 cells. 
30 (cells counted) x 2 (dilution factor with trypan blue) x 104 (volume correction) 
= 6 x lOs cells/ml in culture. 
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6 x lOs (cells/ml in solution) x 12 (ml solution) 
= 7.2 x 106 (total number of cells) 
3.5.2 ViCell™ XR Cell Viability Analyser 
A similar way to count cells and measure their viability is to use the video imaging 
system ViCell™ XR Cell Viability Analyser (Beckman Coulter®). It automates the 
trypan blue dye staining protocol by taking pictures from stained cell samples which 
are automatically recognised and counted by the ViCell™ XR software. The 
software also determines which cells have or have not absorbed the trypan blue 
according to the gray scale of the cells in the pictures. Cells absorbing the trypan 
blue dye appear darker, hence have lower gray scale values. 
Before the first use, general information about the cell type (e.g. minimum and 
maximum cell size) had to be added into the database of the ViCell™ XR software. 
Then, 0.5 ml of the cell sample was pi petted into a sample cup provided with the 
ViCell™ system. The cup was placed into the ViCell™ analyser and the sample ID 
was entered into the computer. For each sample, 3 replicates were prepared. Mixing 
the cells with the trypan blue staining solution and sample loading into the counting 
chamber were done automatically by the machine. Results included information 
about the total cell count, the viability and the average cell size. 
3.5.3 Guava Personal Cell Analysis (peA) System 
Viability tests based on the principle of flow cytometry were carried out on the 
Guava Personal Flow Cytometer (Guava Technologies, Hayward, CA) using the 
Viacount software package. All cells to be analysed were stained with the 
ViaCount™ reagent, which consist of a combination of two fluorescent nucleic acid 
dyes. These dyes stain viable and non-viable cells differently according to the 
permeability of the cell membranes. The nuclear dye stains only nucleated cells, 
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while the viability dye stains dying cells. Both dyes are detected at different 
wavelength thus enabling measurement of both live and dead. Debris is excluded 
from results based on negative staining with the nuclear dye. 
Prior to the analysis, the cell samples were prepared by washing in 200 III phosphate 
buffered saline (PBS) and disrupting any cell clumps using a 200 III pipette tip. A 50 
III aliquot of the cell sample was diluted 1:6 with the Guava ViaCount™ reagent and 
incubated for 5 minutes at room temperature. Then the samples were loaded into the 
Guava Personal Flow Cytometer, the dilution factor was entered into the computer 
and total cell concentration as well as the percent viability were measured with the 
Guava ViaCount™ software package. 
3.6 Fibroblastic colony forming uni~ (CFU-t) assay 
This assay is based on a technique reported by Friedenstein et 01. (1974). It measures 
the colony forming ability of single cells by allowing them to adhere to a plastic 
surface and proliferate to form fibroblastic colonies. From all bone marrow cells, 
only MSCs are known to have this fibroblastic colony forming ability. Therefore the 
CFU-f assay is the traditional method used to determine MSC numbers in BMC 
suspensions. Furthermore, by checking the size of a colony as well as the shape and 
size of the cells, which are forming the colony, it's possible to qualitatively describe 
the stem cell character of the MSCs. 
All CFU-f cultures were conducted in triplicate with either 0.3 ml freshly harvested 
BMCs or about 4 x 103 MSCs in 56 cm2 cell culture dishes. They were incubated in 
10 ml DMEM or MyeloCult® medium at 37°C in an atmosphere with 7.5% CO2• 
The first medium change was after 5 days and thereafter it was changed twice 
weekly for up to 14 days. The cultures were then stopped by washing with Phosphate 
Buffered Saline (PBS) and fixing with 70% Industrial Methylated Spirit (IMS). After 
fixing, the plates were washed 3 times in tap water. 
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3.6.1 Colony staining and imaging 
Fixed colonies were stained for 30 minutes with borate buffer at a pH 8.8 containing 
1 % 1,9-Dimethyl-Methylene Blue (Sigma 341088). The plates were then washed in 
tap water until no more dye was eluted and allowed to air-dry overnight. To count 
the colonies, the dishes were photographed using a Pixera Professional digital 
camera at a resolution of 800/600 pixels. Due to the uneven surface of the individual 
colonies, the image analysis software 'Gene Tools' (Syngene, Cambs.) could 
recognize larger colonies as several distinct colonies. To prevent this, differences 
between neighbouring pixels were eliminated and isolated pixels, whose values differ 
from those of their surroundings, were removed. This may lead to data loss in not 
well or unstained areas of the CFU-fplates. The pictures were then converted into an 
8-bit greyscale TIFF image using Adobe Photoshop. Gene Tools image analysis 
software was applied to obtain the number of colonies per dish and the mean colony 
size. Only colonies of 20 to 10000 pixels and having an intensity of 20 grey levels 
above the background were recognised (Dobson et 01., 1999). Figure 3.2 shows the 
workflow of the colony analysing process. First a picture was taken from a stained 
CFU-f culture, which was then converted into 8-bit greyscale TIFF image. This grey 
image was used with the Gene Tools image analysis software to obtain the colony 
number on the plate. 
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(A) (8) 
(C) (0) 
Figure 3.2: (A) A methylene blue stained CFU-f culture dish. (8) The same culture 
dish as in A but converted into an 8-bit greyscale TIFF image. (C) and (D) Screen 
shots of the Gene Tools image analysis software, showing how the colony numbers 
on the plate were obtained. 
However, the counted colony number does not equal the number of CFU-fs in a 
sample taken from the suspension or monolayer culture, because the samples were 
diluted in order to start every CFU-f culture always with 4 x 103 cells. To acquire the 
total number of the CFU-fs in a suspension or monolayer culture, at the time point 
the sample was taken, the counted colony number had to be mUltiplied by the 
dilution factor and a factor correcting the relation between sample and culture size. 
For example, if I ml sample was taken from a 40 ml suspension culture and diluted 3 
times, in order to start the CFU-f assay with 4 x 103 cells, the counted colony number 
(let' s say 120 colonies per dish) has to be multiplied with 3 x 40. 
120 (colonies) x 3 (dilution factor) x 40 (culture size) 
= 14,400 CFU-f (in the suspension culture) 
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3.7 Differentiation assays 
To demonstrate the differentiation potential of the cultured MSC populations, the 
cells of interest were differentiated into osteoblasts and adipocytes by culturing them 
in standard osteogenic and adipogenic medium as detailed below (Maniatopoulos et 
al., 1988) (Janderova et al., 2003). 
3.7.1 Osteogenic differentiation 
Osteogenic differentiation was demonstrated by staining three different markers 
present in osteoblasts but not MSCs. Alkaline phosphatase was stained with 
naphthol phosphate and fast red, calcium was stained with alizarin red and collagen 
was stained with Sirius red (Drury et al., 1967). 
Osteogenic cultures were conducted in triplicate in 56 cm2 cell culture dishes. They 
were started with either 0.3 ml freshly harvested BMCs or about 4 x 103 MSCs taken 
from a suspension culture (chapter 6.2) or a monolayer culture (chapter 4.2) and 
incubated in 10 ml DMEM or MyeloCult® medium for approximately 4 to 5 days. 
At the first medium change the culture medium was replaced by 10 ml osteogenic 
medium consisting of standard DMEM with the addition of 10.8 M dexamethasone 
and 50 J!glml 2-ascorbate-phosphate (Maniatopoulos et al., 1988). For MSCs 
cultured using the pour - off method (chapter 7), cells were differentiated by adding 
osteogenic medium directly into the culture dish after the pour off. After incubating 
for 14 days with media change twice a week, the cultures were washed with PBS and 
fixed with 70% IMS. After fixing, the plates were washed 3 times in tap water and 
were ready for staining. 
3.7.1.1 Alkaline phosphatase assay 
The enzyme alkaline phosphatase can hydrolyse organic phosphate under alkaline 
conditions and this phosphate can then combine with free calcium ions to form 
insoluble calcium phosphate; The presence of the enzyme alone can already be 
considered as a marker for osteoblasts. However, monocytes, embryonal stem cells 
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and gut epithelial cells are also known to express this enzyme (Heinemann et al., 
2000) (O'Connor et al., 2008) (Vaishnava and Hooper, 2007). To confirm the 
differentiation into an osteoblast, the presence of calcium and collagen in the 
osteogenic cell has to be shown as well. The alkaline phosphatase assay measures the 
breakdown of the substrate naphthol phosphate AS-BI under alkaline conditions to 
insoluble naphthol. This can be stained by the dye fast red to produce a red colour. 
Fixed and washed colonies were used for alkaline phosphatase staining. A solution of 
20 mM Tris, pH 8.5, containing 50 Jlg/ml naphthol phosphate AS-BI (Sigma N212S)o 
and 1 mg/ml Fast Red TR Salt hemi(zinc chloride) (Sigma F8764) was freshly 
prepared and added to the cultures. Even though the staining takes place within 
hours, the plates were incubated overnight at room temperature before the solution 
was removed, the plates were washed with tap water and photographed as soon as 
they were dry. All colonies producing alkaline phosphatase appeared red. Gene Tools 
image analysis software was applied to count them as described in section 3.6.1. 
After the pictures were taken, the colonies were destained with 0.2 M sodium 
hydroxide in 70% IMS to be ready for the calcium staining assay. 
3.7.1.2 Calcium staining assay 
Alizarin Red is widely used to determine the presence of calcium deposition in 
osteogenic cells by forming an Alizarin Red S-calcium complex. However, it also 
can interfere with magnesium, manganese, barium, strontium, and iron but these 
elements usually do not occur in sufficient concentration (Drury et al., 1967). 
To stain the osteogenic cells for calcium, 1 mg/ml Alizarin Red S (Sigma ASS33) 
was dissolved in distilled water and the pH was adjusted to pH 5.5 with ammonium 
hydroxide. Cells were incubated in this solution overnight at room temperature. The 
next day, the stain was removed; the plates were washed and photographed before 
they were destained in 5% perchloric acid to be ready for the collagen staining assay. 
The pictures were analysed using the Gene Tools image analysis software (section 
3.6.1) to count any dark red stained colonies which have produced calcium. 
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3.7.1.3 Collagen staining assay 
Sirius Red stain was used to show any collagen fonnation in the differentiated cells. 
1 mg/ml Sirius Red, also known as Direct Red 80 (Sigma 43665), was added to 
saturated picric acid. The osteogenic cells were incubated overnight in the Sirius Red 
stain, before they were washed. Photographs were taken from the plates. The 
colonies with cells containing collagen appeared red, and were counted using the 
Gene Tools image analysis software (section 3.6.1). Subsequently, cells were 
destained with 0.2 M sodium hydroxide/methanol (50:50). 
3.7.2 Adipogenic differentiation 
Adipogenic differentiation was demonstrated by staining the lipid vesicles with Oil 
Red O. The lipids were stained by Oil Red a because the solubility of the dye in the 
lipoid substances is greater than the solubility of it in the hydroalcoholic dye 
solvents. To avoid the staining of non-adipogenic cells, Oil Red 0 has to be 
dissolved in isopropanol. 
An Oil Red a stock was prepared by dissolving 0.7g Oil Red a (Sigma 0-0625) in 
200 ml 100% Isopropanol, stirring it slowly overnight and filtering it with a 0.2 J.1m 
filter. The stock solution was kept at 4°C for up to half a year. To obtain an Oil Red 
a working solution, 6 parts of the Oil Red 0 stock were mixed with 4 parts distilled 
water. This mixture had to be kept for 20 minutes at room temperature and filtered 
again with a 0.2 J.1m filter before it was ready to use. 
Adipogenic cultures were conducted in triplicate in 56 cm2 cell culture dishes. They 
were started with either 0.3 ml freshly harvested BMCs or about lOx 103 MSCs 
taken from a suspension culture (chapter 6.2) or a monolayer culture (chapter 4.2) 
and incubated in 10 ml DMEM or MyeloCult® medium for 8 days. At the first 
medium change the culture medium was replaced by 10 ml adipogenic medium 
consisting of standard DMEM with the addition of 10-6 M dexamethasone, 10 J.1g/ml 
Insulin, 500 mM isobutyl-methylxanthine and 0.2 mM indomethacin. For MSCs 
cultured using the pour - off method (chapter 7), cells were differentiated by adding 
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adipogenic medium directly into the culture dish after the pour ofT. After incubating 
for at least 3 weeks with media change twice a week, the cultures were confluent and 
fixed in 4% Paraformaldehyde. To fix the cells, they were washed in PBS, about 5 
ml Paraformaldehyde was added to the dish and incubated at least for 1 hour up to 
overnight at room temperature. After all the Paraformaldehyde was removed, the 
cells were washed in 60% isopropanol and 5ml of the Oil Red 0 stain (working 
solution) was added when the dishes were dried. The cultures were stained for 1 hour 
at room temperature, and the stain was washed ofT under running water before 
pictures were taken of the differentiated cells with a digital camera. Adipocytes were 
identified on the basis of lipid droplets, which had formed within the cells, stained 
red with the Oil Red 0 stain. 
3.8 Data handling 
Three biological replicates of all suspension culture and pour - off experiments were 
performed. In addition, each result of cell or CFU-f analyses was calculated as a 
mean +/- standard deviation (S.D.) of triplicate counts (technical replicates). The data 
in the figures are presented as mean +/- standard deviation of the biological replica. 
However, if biological replica were not available (e.g. due to contamination 
problems), data are presented as a mean +/- standard deviation of the technical 
replica. Significance between 2 treament groups was as seed by using an unpaired 
Student's T test, whereas the significance between more than 2 treatment groups was 
assessed by using analysis of variance (ANOVA). Differences are considered 
significant at a probability of <0.05. 
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Chapter 4 
Growth of Mesenchymal Stem Cells in 
Static Culture Systems 
48 
4.1 Introduction 
Friedenstein et al. (1968) discovered that bone marrow contains a cell type capable 
of self renewal and ditTerentiation into osteoblasts. These cells could be expanded in 
vitro by allowing them to adhere to a plastic surface, where they would grow as a 
monolayer covered with culture medium. Nowadays these cells are referred to as 
mesenchymal stem cells (MSCs). Static monolayer cultures in plastic flasks (T-
flasks), specially treated to increase the adherence of cells, are still the standard 
method used to expand MSCs in vitro and are the subject of this chapter. 
The most widely used culture medium for MSCs in static cultures is DMEM with 
10% serum (Bruder et al., 1997) (Guo et al., 2001) (Mok et al., 2003). However, to 
compare the results from the experiments in suspension and pour-otT cultures (see 
chapters 6 and 7) with the results from the standard experiments in this chapter, the 
same culture medium from the suspension and pour-otT cultures, MyeloCult® 
medium with various additives, was also used for the monolayer cultures. The results 
from this chapter were taken as a control to determine which system worked best, the 
traditional monolayer culture method, the stirred suspension culture method or the 
"pour-off' culture method. Furthermore, testing new media constituents in a well 
studied and well defined culture system also enables the etTect of these compounds 
on the proliferation and ditTerentiation behaviour ofMSCs to be investigated. 
One of the medium additives was Pluronic F -68, which is known to bind to the cell 
membrane and thereby strengthen it (Zhang et al., 1992). Since it was mainly used in 
stirred suspension cultures, more details about PluronicF -68 will be given in section 
6.1. In order to determine a potential side etTect of Pluronic F-68 on the membrane 
proteins of MSCs, the infra red spectra from cells in static cultures containing 
Pluronic F-68 were compared to the infra red spectra from cells in static cultures 
without Pluronic F-68 using Fourier Transform Infrared Spectroscopy (FTIR). A 
change in the membrane protein quantity can have an effect on the infra red spectrum 
of the cells, which can be measured by FTIR (Cricenti et al., 2003). FTIR identifies 
types of chemical bonds in molecules which absorb infrared light by the production 
of an infrared absorption spectrum. Absorption of infrared radiation by a typical 
organic molecule results in the excitation of vibrational, rotational and bending 
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modes. The absorption will be detected as a symmetric interferogram and translated 
into a spectrum by fourier transformation. Although FTIR is not a method to detect 
changes of specific membrane proteins, it is a simple and fast analysis technique 
which can confirm the presence or absence of organic compounds in a sample. 
Furthermore it has been shown that it is possible to obtain a FTIR spectrum of 
MSCs, and use this information to identify the differentiation state of individual 
human mesenchymal stem cells (Kraffi et al., 2007) 
Another fast and easy way to detect an effect of Pluronic F -68 on the membrane 
proteins of MSCs grown in static cultures is the measurement of their electrophoretic 
mobility (EPM). Cells in solution have a surface charge, which is either negative or 
positive and a diffusion layer, which electrically screens the surface charge (Dukhin 
and Semenikhin, 1970). If an electric field is applied both surface charge and 
diffusion layer exert opposite directed electrostatic forces on the cell (Dukhin and 
Semenikhin, 1970). Since the force of the surface charge is stronger, the cell moves 
in the direction of this force, resulting in what is called electrophoretic mobility. So 
far several general experiments to determine the EPM of some types of mammalian 
tissue cells as well as tumour cells have been conducted (Simon-Reuss et af. 1964) 
(Vassar, 1963), and it was found that the electrophoretic properties of cells were 
mainly caused by ionogenic groups present at the cell peripheries. More 
interestingly, it has been shown that EPM can be used to discriminate between MSCs 
and cells with similar surface antigens (Lee et al., 2006). Lee et al. (2006) stated that 
although cell electrophoresis cannot determine the specific surface protein, it can 
reflect the net surface charge density of the cell membrane. A modification of the 
functional groups of peripheral membrane proteins can change this net surface 
charge which then can be measured. 
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4.2 Materials and methods 
The general methods for cell culture have already been given previously in chapter 3. 
In this chapter methods are described for the culturing and expansion of rat bone 
marrow derived mesenchymal stem cells specifically in static culture systems. Two 
different basic culture media were applied, Dulbecco's Modified Eagle Medium 
(DMEM) and MyeloCult® medium, and both were supplemented with various 
additives such as Pluronic F-68, dexamethasone, Interleukin-3 (IL-3) and Stem Cell 
Factor (SCF). Furthermore, the use of additional analysing techniques such as FTIR 
and EMP are also described. 
4.2.1 Expansion of Mesenchymal Stem Cells in static culture 
Mesenchymal stem cells were derived from rat bone marrow as described in chapter 
3 (section 3.4). 10 ml of freshly harvested bone marrow cells (BMCs) were 
suspended in 10 ml culture medium and seeded into a T75 flask, having a final 
density of about 1 x 106 cells/ml. Cell culture medium was either normal DMEM, 
DMEM with 0.05% Pluronic, DMEM with 10-8 M dexamethasone, normal 
MyeloCult® medium, MyeloCult® medium with 10-8 M dexamethasone or 
MyeloCult® medium with 10-8 M dexamethasone, 2 nglml IL-3 and 10 nglml SCF. 
The cells were incubated at 37°C in an atmosphere of 7.5% C02. The first medium 
change was after 5 days and thereafter it was changed twice weekly until -90% 
confluence was reached. Then the cells were passaged and again expanded until 
-90% confluence. To detach the adherent cells, the medium was removed and the 
flask was washed with phosphate buffered saline (PBS) before 3 ml of 0.25% trypsin 
/ 1 mM EDTA solution was added. The culture was incubated for 5 minutes at 37°C. 
The detachment of the cells was carefully monitored by phase microscopy using an 
inverted microscope (Novex Kolland). The sides of the flask were tapped to help 
loosen the cells. To stop the incubation, 9 ml of culture medium, containing 10% 
foetal calf serum (FCS), were added and a 100 III sample was taken to determine the 
cell number in the suspension using a haemocytometer. The detached cells then were 
transferred into new sterile T75-flasks, which were seeded each with 1 x 106 cells. A 
smaller sample of the cells was used to start fibroblastic colony forming unit (CFU-t) 
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and differentiation assays as described in chapter 3 (section 3.6 and 3.7). However, 
differentiation assays started with cells from passage level 3 and 4 were seeded at a 
higher cell density than described in section 3.8. Instead of 4 x 103 MSCs per dish, 
about 8 x 104 cells were used. To calculate the fold increase in total cell number, the 
counted cells were compared to the number of adherent cells in the bone marrow 
sample used to start the first culture. This number was determined by using 0.3 ml 
from the bone marrow cells to start a CFU-f assay and count the formed colonies (see 
section 3.5.1 and 3.6.1 for haemocytometer and CFU-f assay). Figure 4.1 shows the 
schematic diagram of the workflow. 
For example, the CFU-f assay, started with 0.3 ml bone marrow cells, had 250 
colonies and 75 cells were counted with the haemocytometer in the 100 Jll sample 
taken when passaging the cells. 
The initial number of colony forming cells in 10 ml bone marrow was 8 x 103 cells. 
250 (colonies) I 0.3 (volume to start CFU assay) x 10 (volume to start static culture) 
= 8 x 103 MSCs (initial MSCs number in static culture) 
The number of MSCs when the culture was passaged was 13.5 x 106 cells. 
75 (cells counted) x 2 (dilution factor with trypan blue) x 104 (volume correction) 
= 1.5 x 106 cells/ml detached MSCs . . 
1.5 X 106 (cells/ml detached MSCs) x 9 (ml suspension) 
= 13.5 x 106 (total number ofMSCs) 
The fold increase in this case was 1.6 x 103 
13.5 x 106 (MSC number when cells were harvested) I 8 x 103 (initial MSC number) 
= 1.6 x 103 
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Figure 4.1: Diagram of the workflow for static monolayer cultures of MSCs. 
4.2.2 Fourier Transform Infrared Spectroscopy (FTIR) 
The MSCs used for FTIR analysis were expanded in cell culture flasks as monolayer 
cultures for 2 passages using DMEM as control and DMEM with 0.05% Pluronic as 
a test condition. When cultures were 90% confluent after the second passage, cells 
were trypsinised, centrifuged at 1200 rpm for 5 minutes to remove the trypsin 
solution and resuspended in 1 ml normal DMEM. 100 Jil of this cell solution was 
made up to 1 ml with DMEM before placed on a calcium fluoride (CaF2) glass 
window. The MSCs on the CaF2 window were then placed in a cell culture dish, 
transferred to an incubator and cultured overnight at 37°C and 7.5% C02, to allow 
the cells to attach to the glass surface. Care was taken that the MSCs did not dry out. 
Just before the FTIR analysis the CaF2 window was taken out of the incubator, 
washed with phosphate buffered saline (PBS) and transferred to the FTIR 
S3 
spectrometer. FTIR measurements were performed on a Perkin Elmer Spectrum One 
Fourier transformation infrared spectrometer. For liquid samples in transmission 
mode, the cells were monitored using a liquid infrared flow cell (Sigma-Aldrich) 
with CaF2 windows. A total of 100 scans with a resolution of 4 cm- I and wave 
number range from 4000 to 950 cm- l were collected for the samples in transmission 
mode using the flow cell. The spectra of PBS were used as a background and the 
baseline shift of the spectra was corrected using the Spectrum One software (Perkin-
Elmer). Micro-FTIR spectra images were also collected on a Perkin Elmer Spotlight 
FT-IR Imaging System over the 4000-700 cm- l wave number range, taking eight (8) 
scans per pixel at a resolution of 4 cm- l and a beam diameter of 6.25 Ilm. 
4.2.3 Electrophoretic mobility of Mesenchymal Stem Cells 
The electrophoretic mobility is only a very small movement, which can be detected 
with Phase Amplitude Light Scattering (PALS) (Tschamuter, 2001) using for 
example the zetaPALS instrument (Brookhaven Instruments Corporation). The 
zetaP ALS determines zeta potential and electrophoretic mobility measuring small 
phase shifts in the scattered light that arise due to the movement of particles in an 
applied electric field. The measured phase change is proportional to the change in the 
position of the particles. Although this machine is more commonly used to determine 
the zeta potential of small colloidal samples (Najafi et al., 2007), it also should be 
able to be applied to larger objects such as MSCs (Zhang et al., 2009). 
MSCs used for zetaPALS analysis were cultured in cell culture flasks as a monolayer 
for either 2 or 4 passages using DMEM as control and DMEM with 0.05% Pluronic 
as test condition. When the cultures were 90% confluence after the second passage, 
cells from one T75 - flask were harvested using trypsinlEDTA, centrifuged at 1200 
rpm for 5 minutes to remove the trypsin solution, washed 2 times in PBS and split 
into 4 aliquots before finally being resuspended in 1 ml of running buffer (IOmM, 
30mM, 60mM and IOOmM of either PBS or potassium chloride). The cell 
concentration in each aliquot should be around 5· x lOs cells. A 10 III aliquot of 
MSCs resuspended in 0.1 M PBS and in 0.1 M potassium chloride (KCl) was taken 
out to analyse the cell viability using the trypan blue staining method to make sure 
that the cells do not break apart in the buffer conditions the zetaPALS analysis. The 
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experiment was carried out at a frequency of 2.0 Hz and a voltage of 2.5 V. Each 
sample was analysed 10 times to get a mean value for the electrophoretic mobility. 
4.3 Results and discussion 
The following results demonstrate the expansion capacity of MSCs in static cell 
cultures. The total cell number of each monolayer culture was monitored over a 
period of 28 days (5 passages) by analysing the cell samples with the methods 
described in section 3.5 when the cultures were passaged. To detennine the stem cell 
character of the expanded MSCs, cell samples were taken at each passage and 
analysed using CFU-f and differentiation assays. The CFU-f assay was applied to 
measure the number of colony fonning cells at each passage level of the monolayer 
cultures. In Figures 4.3 and in Figure 4.4 plates from the CFU-f assays with cells 
expanded in DMEM and MyeloCult®, respectively, are shown as an example for all 
conducted assays in this thesis. The infonnation obtained from the CFU-f and the 
differentiation assays for this chapter is summarised in Table 4.3 in the conclusion 
section of this chapter. The differentiation assay was used only in a qualitatively way 
to show the presents of MSCs with the ability to differentiate into osteoblasts or 
adipocytes. The reason, that the quantity of these cells was not counted, was the 
difficulty in harvesting a sufficient number of MSCs with these abilities. This was 
less of a problem for the static culture method than it was for the suspension culture 
(chapter 6) and pour - off culture method (chapter 7). The effect of different basic 
culture media (DMEM and MyeioCult® medium) as well as different medium 
additives (pluronic, dexamethasone, interleukin-3 (IL-3) and stem cell factor (SCF» 
on the proliferation capacity and the differentiation potential of MSCs in monolayer 
cultures was assessed. A possible effect of Pluronic F-68 on the cell membrane was 
analysed with FTIR spectroscopy and measurements of the electrophoretic mobility 
of MSCs were made. 
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4.3.1 DMEM versus MyeloCult® medium in static monolayer cultures 
A commonly used and cheap (about £30 I litre) culture medium for MSC expansion 
in vitro is DMEM containing 10% foetal calf serum, glutamine and penicillin I 
streptomycin (Bruder et al., 1997). MyeloCult® medium compared to DMEM is 
considerably more expensive (about £70 I litre), contains more serum (25%), more 
amino acids and vitamins (L-ascorbic acid, O(+)biotin and O-pantothenic acid). For 
expansion of MSCs MyeloCult® is used as culture medium in stirred suspension 
cultures (Chen et al., 2006) (Baksh et al., 2003). The experiments in this thesis 
conducted in static cultures with DMEM and MyeloCult® medium allowed for a 
comparison of the effect of these two media on the growth behaviour of MSCs and 
enabled an assessment of a possible beneficial influence of MyeloCult® medium in a 
well established culture system. 
MSCs expanded in MyeloCult® medium grew faster than comparable cultures of 
MSCs kept in normal OM EM. In order to passage both set of cultures at the same 
time, and thus take cell samples to count the total cell number in both cultures at the 
same time points, the MyeloCult® cultures were seeded at a slightly lower starting 
cell density after every passage (about 0.7 x 106 cellslml) and passaged after 100% 
confluence. The fold increase in total cell number after 9 days, at the first passage, in 
both cultures was about the same, 0.9 x 103 fold in OMEM and 1.0 x 103 fold in 
MyeloCult® medium (Figure 4.2). However at the end of the experiment, after 29 
days (5 passages) the fold increase in the MyeloCult® cultures was clearly higher, 
3.9 x lOS fold, compared to 0.2 x lOS fold (p = 0.001) in OMEM cultures. That 
means, for the OM EM cultures, starting with a bone marrow sample which contained 
for example 3400 plastic adherent cells. the final total cell number would be about 
0.07 x 109 cells, whereas in the MyeloCult® cultures, the final total cell number 
would be about 1.3 x 109 cells, if started with the same bone marrow sample. 
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Figure 4.2: Increase in total cell number verses time. Cells were derived from rat 
bone marrow and expanded in static cultures with either DMEM or MyeloCult® 
medium. Results for the DMEM culture are mean +/- S.D. from 3 different cultures 
whereas results for MyeloCult® cultures are mean +/- S.D. from 3 cell counts from 
just I culture due to contamination problems. *p < 0.01; **p < 0.05, DMEM 
compared with MyeloCult® 
Despite this massive increase in total cell number for both cultures, and the 
significant (p = 0.00 I) beneficial effect of the MyeloCult® medium on the cell 
proliferation, the more interesting question was if all these cells still retained their 
full differentiation potential. Therefore, cells amplified in DMEM and MyeloCult® 
medium were used for osteogenic, adipogenic and colony forming (CFU-f) assays. 
The colony forming behaviour is an indicator of the stem cell character of plastic 
adherent MSCs. As displayed in the Figures 4.3 and 4.4 cells expanded in static 
cultures with DMEM for as long as 2 passages formed recognisable colonies during 
the CFU-f assays. The colonies were rather small and did not stain very well. MSCs 
passaged more than twice formed even smaller colonies, which were barely visible 
on the plates. In contrast, the stained cells in the CFU-f assays started with MSCs 
derived from MyeloCult® monolayer cultures stained stronger and were easier to 
identify (Figure 4.4). Due to cell growth, a monolayer rather than single colonies 
were formed in the dishes from the passage levelland 2, but after 3 passages single 
colonies were recognisable. However, using the colony detection software with the 
parameters mentioned in chapter 3.6.1, colonies were detected on all plates. 
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Figure 4.3: Methylene blue stained CFU-f dishes started with MSCs from monolayer 
cultures with DMEM, after one passage (A), two passages (B), three passages (C) 
and four passages (D). 
(8 ) 
(D) 
Figure 4.4: Methylene blue stained CFU-f cultures started with MSCs from 
monolayer cultures with MyeloCult® medium, after one passage (A), two passages 
(B), three passages (C) and four passages (D). 
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The number of colony forming cells in the monolayer cultures with DMEM 
increased 4.6 fold after 9 days (Figure 4.5). That means, the static cell culture which 
was started with 3,400 CFU-fs grew to about 15,600 CFU-fs after 9 days. The 
increase in CFU-f number of the static culture with MyeloCult® medium for the 
same time was similar at 4.5 fold. Over time, the number ofCFU-fs in both cultures 
continuously decreased, resulting in a final 2 fold increase since the initial starting 
culture for DMEM, and a 2.3 fold increase since the initial starting culture for 
MyeloCult® medium after 23 days (Figure 4.5). This is only a very small increase in 
colony forming cells compared to the development of the total cell number, and 
means that the final CFU-f number would be about 6800 cells in the DMEM cultures 
and about 7800 cells in the MyeloCult® cultures. More interestingly, the highest 
increase in CFU-fs was not at the end of the culture period but after 9 days (the first 
passage). The pictures taken from the CFU-f assays of MSCs expanded in DMEM 
cultures further suggest, that MSCs harvested from later passages lost their colony 
forming ability (Figure 4.3). Although the development of the CFU-f number in 
DMEM and MyeloCult® cultures was the same, an obvious difference was the 
colony size. While the colonies derived from the DMEM experiment were barely 
recognisable, the colonies from the MyeloCult® cultures stained very strongly, and 
even formed a confluent monolayer in the background of the plates which were 
started with MSCs from the first two passage levels (Figure 4.4). This indicates that 
the proliferation capacity of the cells forming a colony must be higher in cells 
derived from MyeloCult® cultures compared to cells derived from DMEM cultures. 
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Figure 4.5: Development of CFU-f verses time. Cells were derived from rat bone 
marrow and expanded in static cultures with either DMEM or MyeloCult® medium. 
Results for both cultures are mean +/- S.D. from 3 different CFU-f cultures. *p < 
0.0 I; **p < 0.05, DMEM compared with MyeloCult® 
The CFU-f assay however is only an indicator of the stem cell character of MSCs. To 
confirm the real differentiation capacity, cell aliquots from both static cultures were 
taken after every passage and grown in either osteogenic or adipogenic 
differentiation medium for 14 days. The formation of osteoblasts was shown by 
staining the cells for alkaline phosphatase, calcium and collagen. Although the CFU-
f number decreased over time, MSCs with osteogenic differentiation capacity were 
found throughout all the passages for both types of monolayer cultures. Figures 4.6 
and 4.7 show one example plate used for the osteogenic differentiation assay of 
MSCs harvested from the DMEM and the MyeloCult® monolayer culture, 
respectively, after 23 days. The colonies on the plate were stained with 
naphtholphosphate and fast red for alkaline phosphatase (picture A), with alizarin red 
for calcium (picture B) and with sirius red for collagen (picture C). All three of these 
osteogenic markers were present. The plates from the osteogenic differentiation 
assay of cells derived from DMEM and MyeloCult® cultures seemed to be very 
similar in colony density and staining intensity, which could be evidence for a 
similar osteogenic differentiation potential for MSCs expanded in both types of 
medium. The adipogenic differentiation of MSCs harvested from any monolayer 
culture failed , indicating that this differentiation ability got lost during the in vitro 
expansion. 
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Figure 4.6: Differentiation assay of MSCs harvested from monolayer cultures with 
DMEM after 4 passages. The plate was stained for alkaline phosphatase (A), calcium 
(B) and coHagen (C). 
Figure 4.7: Differentiation assay of MSCs harvested from monolayer cultures with 
standard MyeloCult® medium after 4 passages. The plate was stained for alkaline 
phosphatase (A), calcium (B) and collagen (C). 
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Summarising the results observed for monolayer expansion of MSCs in DMEM and 
MyeloCult® medium, it is obvious that the proliferation capacity of MSCs in 
MyeloCult® medium after 23 days was higher than in DMEM (p = 0.001) but this 
increased proliferation did not result in a significantly (p = 0.137) higher CFU-f 
number or better osteogenic differentiation potential compared to the CFU-f number 
and the differentiation potential of DMEM derived MSCs. For both media 
conditions. the increase in CFU-f number was small compared to the increase in total 
cell number and adipogenic differentiation could not be seen at any time. A possible 
explanation was found by Sekiya et al. (2002) saying that a MSC monolayer culture 
comprises of different progenitor cell types. which have different proliferation and 
differentiation capacities. Therefore. the tested culture conditions (i.e. MyeloCuIt® 
medium) could have supported the expansion of early osteogenic precursor cells with 
limited differentiation and colony fonning capacity rather than supported the growth 
of fully undifferentiated mesenchymal stem cells. These finding support the theory, 
that MSCs lose their stem cell character when cultured for a long period in static 
monolayer cultures (Sun et al .• 2006). 
4.3.2 Effect of interleukin-3 and stem cell factor on Mesenchymal Stem Cell 
expansion in monolayer cultures 
The cytokines Interleukin-3 (lL-3) and stem cell factor (SCF) act as growth factors 
for MSCs and improve their proliferation capacity (Wang et al., 1990) (Yamada et 
al., 2000). This benefit was of interest for the stirred suspension culture experiment 
(chapter 6) and the studies using the pour-off technique (chapter 7) and since in both 
culture systems MyeloCult® was the main culture medium, the effect of IL-3 and 
SCF was detennined in static monolayer cultures with MyeloCult® only. A more 
detailed introduction on IL-3 and SCF will be given in chapter 6 section 1. The 
results from the studies in this chapter were used to investigate how important the 
support from the growth factors was for the proliferation capacity, using a less 
stressful culture method. 
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MSCs grown in MyeloCult® medium with IL-3 and SCF achieved an increase of2.3 
x 103 fold after 9 days whereas the control in MyeloCult® medium increased by 1.0 
x 103 fold. After the final passage at day 29, the increase in cell number of the culture 
with growth factors was 6.1 x 105 fold compared to the control with 3.9 x 105 fold 
(Figure 4.8). This result indicates that the addition of IL-3 and SCF could enhance 
the growth rate of MSCs in static cultures over a period of 29 days (p = 0.001), but at 
some time points in between the period of the experiment, the control culture had 
higher increase rates, e.g. after 13 days (10.1 x 103 fold for control and 6.9 x 103 fold 
for the culture with growth factors) (Figure 4.8). 
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Figure 4.8: Increase in cell number verses time. Cells were derived from rat bone 
marrow and expanded in static cultures with either MyeloCult® or MyeloCult® with 
2 nglml IL-3 and 10 nglml SCF as culture medium. Results for both cultures are 
mean +/- S.D. from 3 cell counts from only I culture each, due to contamination 
problems. *p < 0.01, MyeloCult® compared with MyeloCult® + IL-3 + SCF 
The effect of IL-3 and SCF in MyeloCult® medium on the colony forming ability 
was determined with the CFU-f assay. Only the plate with MSCs from the first 
passage displayed single colonies, the other plates seemed to have a monolayer of 
cells. Nevertheless, colonies were detected in all plates using the colony detection 
software detailed in section 3.6.1. The development of the colony number over time 
is presented in Figure 4.9. An increase of 4.1 fold was achieved after 9 days and a 4.6 
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fold increase after 13 days. After 23 days, the total increase in CFU-f compared to 
the initial CFU-f number was only 2.2 fold (Figure 4.9). 
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Figure 4.9: Development of CFU-f over time. Cells were derived from rat from bone 
and expanded in static cultures with either MyeloCult® medium only or with 
MyeloCult® medium containing dexamethasone, IL-3 and SCF. Results for the three 
conditions are mean +/- S.D. from 3 different CFU-f cultures. No significant 
differences between the CFU-f numbers in either culture. 
MSCs harvested from monolayer cultures with MyeloCult® medium containing IL-3 
and SCF were able to differentiate into osteoblasts and could be stained for alkaline 
phosphatase, calcium and collagen, respectively. Adipogenic differentiation of these 
cells could not be achieved. 
Although, the addition of the growth factors was supposed to have a beneficial 
impact on the proliferation rate of MSCs (Baksh et al., 2003), neither the overall total 
cell number (p = 0.80) nor the overall number of colony forming cells (p = 0.87) was 
significantly increased in static cultures with IL-3 and SCF (Figures 4.8 and 4.9). 
Furthermore, the differentiation potential of these cells was unchanged, as no 
adipogenic differentiation was detected. Considering the higher costs caused by use 
of the cytokines (about £200 / litre culture medium), the benefits in static culture 
systems are negligible. 
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4.3.3 Effect of dexamethasone on Mesenchymal Stem Cell expansion in 
monolayer cultures 
The effect of dexamethasone on the proliferation and differentiation of MSCs in 
static cultures was determined in both DMEM and MyeloCult® medium. 
Dexamethasone is a glucocorticoid, which can effect the proliferation and the 
differentiation behaviour of MSCs (Song et al., 2009) The results from the 
experiment in MyeloCuIt® medium will be used later as a control for the stirred 
suspension cultures in MyeloCult® medium with dexamethasone (chapter 6). The 
outcome from the experiments in DMEM were compared with those in MyeloCult® 
medium to see if a potential positive effect of dexamethasone is medium independent 
and consequently to test whether dexamethasone should be used as a standard 
medium additive. 
The increase in total cell number in the DMEM cultures with dexamethasone was 1.2 
x 103 fold after 9 days, compared to 0.9 x 103 fold in the controls in DMEM without 
dexamethasone and a final increase of 9.2 x 103 fold in the dexamethasone cultures 
after 23 days compared to an increase of 11.8 x 103 fold in the controls (Figure 4.10). 
The numbers obtained from the MyeloCult® cultures with dexamethasone were 
similar, 1.7 x 103 fold increase after 9 days compared to 1.0 x 103 fold in the controls 
in MyeloCult® without dexamethasone and 3.7 x 105 fold increase at the end of the 
experiment compared to 3.9 x lOS fold of the controls (Figure 4.11). 
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Figure 4.) 0: Increase in total cell number verses time. Cells were derived from rat 
bone marrow and expanded in static cultures with either DMEM only or DMEM 
with 10-8 M dexamethasone. Results are mean +/- S.D. from 3 different cultures. No 
significant differences between the cell numbers in either culture. 
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Figure 4. 11: Increase in total cell number verses time. Cells were derived from rat 
bone marrow and expanded in static cultures with either MyeloCult® or MyeloCult® 
with 0.05% pluronic as culture medium. Results for all cu ltures are mean +/- S.D. 
from 3 different cultures. No significant differences between the cell numbers in 
either culture. 
The CFU-f assay from MSCs expanded in monolayer culture with DMEM 
containing ) 0-8 M dexamethasone showed numerous colonies on the plates from 
passage I and 2, some of them were easy to recognise. The plates of the CFU-f assay 
started with MSCs from passage 3 and 4 on the other hand seemed to have only very 
few and very small colonies, which were not visible on the picture. MSCs harvested 
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from monolayer cultures with MyeloCult® medium containing 10-8 M 
dexamethasone produced recognisable colonies in the CFU-f assay after the first 
passage_ However, the CFU-f culture plates from later passages did not display 
colonies. Nevertheless, colonies were detected using the colony detection software 
detailed in chapter 3.6.1. The development of the CFU-f number in monolayer 
cultures with DMEM and 10-8 M dexamethasone resulted in a 4.6 fold increase after 
9 days and still a 3.5 fold increase after 13 days. Yet, after 23 days, the colony 
number dramatic decreased to 0.1 fold of the initial number of colonies (Figure 
4.12). The CFU-f numbers in the monolayer culture with MyeloCult® medium 
containing 10-8 M dexamethasone at the different passage levels is presented in 
Figure 4.13. After 9 days, an increase in CFU-f number of 3.8 fold was achieved, 
compared to the initial colony number of the monolayer culture at day I. The 
maximum of 4.4 fold increase was reached after 13 days. Towards the end of the 
monolayer culture period, the CFU-f number slightly decreased again to an overall 
increase of2.3 fold after 23 days (Figure 4.13). 
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Figure 4.12: Development of CFU-f verses time. Cells were derived from rat bone 
marrow and expanded in static cultures with either DMEM or DMEM and 
dexamethasone. Results for both cultures are mean +/- S.D. from 3 different CFU-f 
cultures. *p < 0.01 , DMEM compared with DMEM + Dexamethasone 
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Figure 4.13: Development of CFU-f verses time. Cells were derived from rat bone 
marrow and expanded in static cultures with either MyeloCult® medium only or 
MyeloCult® containing 0.05% pluronic. Results for all cultures are mean +/- S.D. 
from 3 different CFU-f cultures. **p < 0.05, MyeloCult® compared with 
MyeloCult® + Dexamethasone 
In both media types, DMEM and MyeloCult®, the addition of dexamethasone did 
not effect the proliferation or colony formation potential of the MSCs in static 
monolayer cultures. The increase in total cell number was about the same for the 
static cultures with DMEM (p = 0.83) and MyeloCult® medium (p = 0.92) 
containing dexamethasone compared to the respective control (Figures 4.10 and 
4.11). This is also true for the development of the CFU-f number in these static 
cultures. The MSCs harvested from static cultures in MyeloCult® medium with 
dexamethasone seemed to fonn less obvious colonies, but rather a monolayer of cells 
compared to the cells of the control in MyeloCult® only. Counting the colonies of 
both CFU-f assays revealed the same increase in colony fonning cells at the end of 
the culture period, a 2.3 fold increase in both the MyeloCult® dexamethasone culture 
and the control (p = 0.641). The two CFU-f assays started with MSCs expanded in 
DMEM containing dexamethasone and DMEM only looked similar in regard to 
colony formation and staining intensity, but the CFU-f count showed that the colony 
fonning cells in the static culture with dexamethasone decreased faster (0.1 fold of 
the initial cell number) than in the control (2 fold of the initial cell number) at the end 
of the culture period (p = 0.012). 
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Differentiation into osteoblasts could be shown for cells growing in both culture 
media DMEM with dexamethasone and MyeloCult® medium containing 
dexamethasone (Table 4.3). The adipogenic differentiation assay, in contrast, did not 
generate any adipocytes. 
Summing up, the addition of dexamethasone to static cultures of bone marrow 
derived rat MSCs in either DMEM or MyeloCult® medium did not increase the 
proliferation behaviour of these cells. Although dexamethasone is known to play an 
important role in the osteogenic differentiation of MSCs (Song et 01., 2009) as well 
as in the adipogenic differentiation (Jing et 01., 2009) and furthermore has an effect 
on the apoptosis and proliferation behaviour of MSCs in vitro (Song et 01., 2009) 
(Akavia et 01., 2006), no adipogenic differentiation was observed in this study. 
4.3.4 Effect of Pluronic F -68 on Mesenchymal Stem Cell expansion in monolayer 
cultures 
Pluronic F-68 was mainly used in stirred suspension cultures (chapter 6) with 
MyeloCult® as culture medium. Since the results from the monolayer cultures were 
a control for the findings in suspension cultures, Pluronic F-68 was only tested in 
monolayer cultures with MyeloCult® medium. Pluronic F-68 is known to strengthen 
the cell membrane (Zhang et 01. 1992) thereby protecting the cells from shear stress, 
which is a beneficial effect for cells in stirred suspension cultures. In order to 
determine any other positive or negative effect of pluronic on MSCs, the 
proliferation and differentiation behaviour of these cells was recorded in a culture 
system where no shear stress was exerted on the cells. 
Comparing the static monolayer cultures of MSCs grown in MyeloCult® medium 
with or without Pluronic F-68, it is clear that the cell proliferation at the end of the 
culture time in the pluronic culture is slower (p = 0.001). 0.8 x 103 fold increase after 
9 days, and a final increase of 0.1 x 105 fold after 29 days in pluronic cultures 
compared to 0.9 x 103 fold at day 9 and 3.9 x lOs fold at day 29 in the control (Figure 
4.14). 
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Figure 4.14: Increase in total cell number verses time. Cells were derived from rat 
bone marrow and expanded in static cultures with either MyeloCu1t® or MyeloCult® 
with 0.05% Pluronic as culture medium. Results for all cultures are mean +/- S.D. 
from 3 different cultures. *p < 0.01, MyeloCult® compared with MyeloCult® + 
Pluronic F-68 
The colonies formed by MSCs harvested from static cultures in MyeloCult® with 
0.05% pluronic stained only very faintly however, on the CFU-f plates with MSCs 
from the first passage colonies were recognisable. On the plates with cells from the 
second passage no colonies, but a monolayer was found, and on plates with cells 
from third passage no cells were visible at all. This observation was confirmed by the 
CFU-f count conducted with the colony detection software (chapter 3.6.1), showing 
that the number of colonies decreased with increasing passage number. At the first 
passage, the CFU-f number increased by 4.3 fold compared to the initial CFU-f 
number in the monolayer culture, but at the end of the monolayer culture after 18 
days, the number of CFU-f decreased to 0.1 fold of the initial value (Figure 4.15). 
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Figure 4.15: Development of CFU-f verses time. Cells were derived from rat bone 
marrow and expanded in static cultures with either MyeloCult® medium only or 
MyeloCult® containing 0.05% pluronic. Results for all three cultures are mean +/-
S.D. from 3 different CFU-f cultures. *p < 0.01, MyeloCult® compared with 
MyeloCult® + Pluronic F-68 
Regardless of the dramatic drop in CFU-f number, MSCs taken from static cultures 
in MyeloCult® medium with pluronic at passage 2 differentiated into osteoblasts. 
Adipogenic differentiation was not observed. The proliferation data in this study 
showed a slow increase of total cell number over time in the static monolayer culture 
containing pluronic (Figure 4.14), but comparing these numbers with the fold 
increase achieved in the control cultures it is obvious that the proliferation rate was 
significantly reduced (p = 0.001) (Figure 4.14). The effect ofpluronic on the co lony 
fonning ability of MSCs in static culture is even more dramatic (Figure 4.15). 
Although the proliferation and colony forming ability of MSCs in vitro was effected 
negatively by pluronic, the results from the differentiation assay suggest that the 
differentiation capacity remained unchanged as MSCs harvested after the third 
passage had already experienced a decrease in CFU-f number, but still fonned 
osteoblasts in the osteogenic differentiation assay. With these experiments, it could 
be shown that pluronic affected the proliferation and colony fonning potential of 
MSCs, but not their differentiation capacity. Pluronic did not kill or destroy the cells, 
it merely slowed down their growth rate. A possible reason for the effect on the 
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proliferation capacity can be the fact that pluronic attaches to the cell membrane, and 
thereby may replace the same functional groups which are essential for the cell 
proliferation. To find some evidence for this theory, FTIR analysis on MSCs was 
conducted and their electrophoretic mobility was measured. Results and discussion 
are presented in the following section. 
4.3.5 FfIR spectroscopy on Mesenchymal Stem Cells 
The propose of the FTIR analysis of MSCs was to determine a possible effect of 
pluronic on the cell membrane proteins, and to test how useful different bench scale 
FTIR spectrometers were for analysing MSCs in general. Much of the FTIR analysis 
on biological material was completed using synchrotron radiation (Jamin et al., 
1998) (Holman et al., 2002). The results presented here demonstrate that an IR 
absorption spectrum can be obtained from MSCs (Figure 4.16), and that several 
specific peaks, typical for any biological sample, can be identified in this spectrum 
(Table 4.1). Using the FTIR spectrometer (Perkin Elmer Spotlight FTIR Imaging 
System) which has a built in microscope and digital camera, spectral measurements 
of single cells, or specific regions of the MSC could be taken. Figure 4.17 -A is such 
a picture, with three in vitro expanded MSC attached to the calcium fluoride (CaF2) 
window. Scanning the whole area of this picture during the FTIR analysis resulted in 
the infrared (IR) picture of these cells (Figure 4.17-8). The blue background of the 
picture means that there was very little absorption of IR light, while the red area 
indicates the highest absorption of IR light. The spectrum in Figure 4.17 -C is the 
spectrum from the red area of the IR picture. Although it looks similar to the 
spectrum from the green area of the IR picture (Figure 4.17-D), there were slight 
differences in the p=o stretching of P02- (peak 5 and 6 in Table 4.1) and in the 
symmetric stretching of carboxylic acid groups c-o of coo- (peak 3 in Table 4.1). 
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Figure 4.16: FTIR absorption spectrum of bone marrow derived rat MSCs in 
phosphate buffered saline. The cells were expanded for 2 passages as monolayer 
cultures with DMEM as culture medium before being analysed. 
Table 4.1: Explanation of the peaks in the FTIR spectrum obtained from MSCs in 
Figure 4.24. Band assignments according to : Naumann et 01. (199 \), Jiang et 01. 
(2004). Vee et 01. (2004) and Dittrich et 01. (2005) 
peak number description 
typical wave number 
(em-I) 
peak \ 
N-H bending of amides associated with 
1584 
proteins (amide II) 
peak 2 
asymmetric deformation of CH3 /CH2 of 
1468 
proteins 
peak 3 
symmetric stretching of carboxylic acid 
1400 
groups (C-O of COO- groups) 
peak 4 Amide III components of proteins 1310-1240 
peak 5 P=O asymmetric stretching of P02- 1250-1220 
peak 6 P=O symmetric stretching of P02- 1088-1084 
at 1690 cm-I different amide I band components 1695 
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Figure 4.17: Picture of MSCs attached to the CaF2 window of the FTIR spectrometer. 
The picture was taken with the digital camera connected to the microscope of the 
spectrometer. (A) IR picture of the same cells as in picture A. The picture was 
generated after scanning the area of the picture A. (B) FTIR absorption spectrum of a 
MSC. This spectrum originated from the red area of the IR picture. (C) FTIR 
absorption spectrum of the same MSC as in picture C. This spectrum originated from 
the green area of the IR picture. (D) 
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In addition to the absorption spectra, the IR pictures themselves can be a valuable 
source of information. As can be seen in Figure 4.18, different IR pictures can be 
taken from the same cell sample. Taking an IR picture at the wavelength where 
amides absorb the IR light (1695 cm- I, 1548 cm-I and 1310-1240 em-I) revealed the 
regions with the most proteins (red areas in the Figure 4.18-B). Repeating the same 
process but at the wavelength where either OH-bonds (-3500 cm-I) or 
polysaccharides (1200-900 em-I) absorb the LR light highlighted regions in the 
pictures where either alcohols or polysaccharides were located (red areas in the 
Figure 4.18 C and D). 
(A) .: 
• 
.. 
Figure 4.18: Picture ofMSCs attached to the CaF2 window of the FTIR spectrometer. 
The picture was taken with the digital camera connected to the microscope of the 
spectrometer. (A) IR picture of the same cells as in picture A. This picture was 
generated after scanning the area of the picture A and disflaying only the absorption 
of IR light caused from the amides (1695 cm-I, 1548 cm- and 1310-1240 cm-I). (B) 
IR picture of the same cells as in picture A. This picture was generated by displaying 
only the absorption of IR light caused from OH bonds in alcohol, etc (-3500 cm-I). 
(C) IR picture of the same cells as in picture A. This picture was generated by 
displaying only the absorption of IR light caused from the polysaccharides (1200-900 
em-I). (D) 
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These results show that IR images of single MSCs and spectra of different cell 
compartments could be obtained using the Perkin Elmer Spotlight FTIR Imaging 
System in conjunction with a microscope and a digital camera (Figure 4.17). This 
method also enabled different regions in the IR picture, showing areas with high 
levels of proteins, polysaccharides and alcohols / sugars to be highlighted (Figure 
4.18). Applying this technique, a bench size FTIR spectrometer can be used to 
analyse IR pictures of single MSCs, and compare them to each other to obtain 
information about differences in their composition. 
Although the pictures are a nice visual feature to illustrate that FTIR is a useful tool 
to analyse MSCs, the spectra obtained from the spectrometer Perkin Elmer Spotlight 
FT-IR Imaging System were not sensitive enough to reveal any differences in the cell 
membrane (protein region of the IR spectrum) of MSCs expanded in culture medium 
with or without Pluronic F-68 (results not shown). To find these differences another 
spectrometer (Perkin-Elmer Spectrum One Fourier transformation spectrophotometer 
(Perkin-Elmer, UK) was used. It was unable to take pictures of the cells, but the 
signal/noise ratio was higher and thus the analysis resulted in more sensitive 
spectra. Two spectra from these analyses are displayed in Figure 4.19. The brown 
spectrum (A) is from MSCs expanded in DMEM containing pluronic, the black 
spectrum (B) is from cells expanded in DMEM only. At three different wavelength 
(1360 cm-I , 1170 cm-I and 980 cm-I), peaks were present in the brown spectrum (A) 
but not in the black spectrum (B). These peaks were in the Amide III region of the IR 
spectrum and in the region where vibration of carbohydrates (C-O-C, C-O) absorb 
the IR light, and are highlighted with red circles (Figure 4.19). 
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Figure 4.19: Normalised FTIR absorption spectra of rat bone marrow derived MSCs 
in phosphate buffered saline. The MSCs causing the brown spectrum (A) were 
expanded for 2 passages as monolayer cultures with standard DMEM as culture 
medium. The cells responsible for the black spectrum (B) were cultured the same 
way but in DMEM + 0.05% pluronic. The differences in the two spectra are 
highlighted with red circles. 
The difference in the Amide III peak (1360 cm'l) was associated with proteins, as 
was the difference in the vibration of carbohydrates (C-O-C, C-O) (1170 cm,I). 
These differences associated with proteins would fit with the theory of a change in 
functional groups in the MSC membrane. Furthermore, the observed change in 
proteins could have appeared anywhere in the cell as FTIR does not measure only the 
surface of the cells but the cell as a whole. The spectrum does not give any 
information about where in the MSC this has occurred. In general, FTIR is a fast and 
easy method to analyse differences in the DNA and protein ratio of different cell 
populations, and can also be used to reveal high and low levels in proteins, DNA or 
alcohol/sugars of different cells. FTfR has been used on mammalian cells to track 
chemical changes in the cells, to distinguish between cancerous and noncancerous 
cells (Mourant et al., 2002) to map the distribution of functional groups within a cell 
(Jamin et ai., 1998) or to observe different growth stages (Mourant et ai., 2003). 
With MSCs, FTIR was used to identify the differentiation state of single cells (Krafft 
et al., 2007). However, to obtain more detailed information about the effect of 
Pluronic F-68 on the membrane proteins of MSCs, more specific techniques have to 
be applied, e.g. proteomic methods. 
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4.3.6 Electrophoretic mobility of Mesenchymal Stem Cells 
In this experiment, the measurement of the electrophoretic mobility (EPM) should 
reveal if pluronic changes the surface charge of MSCs by attaching to the cell 
membrane. Showing the incorporation of pluronic into the cell membrane would 
strengthen the theory that pluronic slows down the proliferation rate of MSCs in in 
vitro cultures by replacing functional groups in the cell periphery. Brooks and 
Seaman (1973a, d) demonstrated that the electrokinetic potential of red blood cells 
changed when suspended in solutions containing several polymers of various 
molecular weights, including dextran and Pluronic F-68. Through the use of 
radioactive dextran and a combination of theoretical and experimental calculations of 
the zeta potential, they demonstrated that this change is the result of adsorption of 
these polymers onto the cell membrane. 
The zetaPALS experiments on MSCs were conducted in static cultures with DMEM 
only and DMEM with 0.05% pluronic as culture medium. Two different running 
buffers were tested to resuspend the harvested MSCs, phosphate buffered saline 
(PBS) and Potassium chloride (KCt). PBS was used as standard buffer for all MSCs 
handling in this thesis, whereas KCl was used as running buffer for zetaPALS studies 
on E.coli (Eboigbodin et al., 2006). In order to decide if both buffers were suitable, a 
simple viability test using trypan blue staining was conducted. MSCs resuspended in 
0.1 M PBS had a viability of 90.6% after 20 minutes in the buffer solution, whereas 
MSCs after the same time in 0.1 M KCl only had a viability of 23.1 %. The outcome 
can be seen in Figure 4.20. Figure 4.20-A shows a sample of MSCs resuspended in 
0.1 M PBS. The cells in this picture appear healthy. Figure 4.20-B shows the same 
cells stained with trypan blue. Most of the cells did not take up the dye, which means 
they were not damaged or dead. The MSCs resuspended in KCI appeared to be 
damaged (Figure 4.20-C). This was confirmed by the staining in Figure 4.20-D. Most 
of the cells were blue, and therefore either dead or damaged. 
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Figure 4.20: 40 x magnifications of MSCs resuspended in 01. M PBS after being 
harvest from a static culture. (A) The same cells as in A but stained with trypan blue. 
(B) 40 x magnifications of MSCs resuspended in 01. M KCI after harvesting from 
the same static culture as the MSCs in picture A. (C) The same cells than in C but 
stained with trypan blue. (D) 
Since the electrophoretic mobility of cells is affected by a variety of chemical and 
physical factors (Simon-Reuss, 1964), all MSCs were resuspended in the same 
running buffer. The viability experiment conducted showed that PBS, even at the 
lowest ionic strength used for the measurement, did not damage the MSCs, and 
therefore is a suitable buffer (Figure 4.20). Potassium chloride was tested as well, but 
the results revealed that KCl caused massive damage to the cells (Figure 4.20). 
Although Simon-Reuss (1964) found that viability and nonviability had no 
significant difference on electrophoretic mobility, the MSCs resuspended in KCI 
burst into small fragments, and are therefore not likely to be measuring the EPM of 
whole cells. Hence PBS was chosen as running buffer for all measurements. MSCs 
from the same sample were split into 4 aliquots and analysed at different molarities 
(\ 0 mM, 30 mM, 66 mM and 100 mM). All cells exhibited negative mobility values, 
implying that the surface of these cells had a net negative charge. The results are 
presented in Table 4.2, indicating an increasing EPM with a decreasing molarity. 
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These finding are not surprising, since there are less free ions available to form the 
diffuse layer around the cell in a buffer with low ionic strength. The diffuse layer 
however, decreases the EPM. To see if the electrophoretic mobility ofMSCs changes 
when they are kept in culture medium containing pluronic, the values for the EPM at 
all molarity levels were compared with the control, but no significant difference was 
found (p = 0.383). Thus, there was no evidence that pluronic alters the functional 
groups in the cell membrane when attached to it. 
Table 4.2: Mean EPM values at different running buffer concentrations. The MSCs 
used for this experiment were expanded for 2 passages in two different medium 
conditions, DMEM only and DMEM + 0.05% pluronic. 
condition PBS concentration mean mobility Std. error (mM) (J.1m/s) I (V/cm) ~m/s) I (V/cm) 
DMEM 10 -3.10 0.04 
DMEM 30 -2.30 0.05 
DMEM 66 -1.93 0.07 
DMEM 100 -1.91 0.06 
pluronic 10 -3.11 0.09 
~luronic 30 -3.01 0.10 
~luronic 66 -2.01 0.08 
pluronic 100 -1.95 0.10 
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4.4 Conclusions 
In this chapter hone marrow derived rat MSCs were expanded in static monolayer 
cultures using different culture media. The static culture system is the most widely 
accepted standard method to expand MSCs in vitro (Ulloa-Montoya el 01., 2005). 
Thus, the results from the experiments conducted in this chapter were used to test the 
effect of various medium compounds on the proliferation and differentiation capacity 
of the expanded MSCs. In addition, the results will be used later on as a control for 
the experiments with MSCs in suspension cultures (chapter 6) and the so-called 
pour-off cultures (chapter 7) in order to compare the efficiency of these methods. 
Furthermore, MSCs expanded in monolayer cultures were analysed using FTIR 
spectroscopy and zetaPALS measurement in order to study a possible effect of 
pluronic on the cell membrane. 
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Table 4.3: Summarised infonnation from the pictures of the CFU-fand differentiation assays conducted in the experiments mention in this chapter. 
Medium initial cell Time Colony formation Osteogenic differentiation Adipogenic I density [days] differentiation 
DMEM 1 x lOb cells/ml 9 small medium -
DMEM 1 x 106 cells/ml 13 small medium 
-
DMEM 1 x 106 cells/ml 18 barely visible medium 
-
DMEM 1 x 106 cells/ml 23 barely visible small . -
MyeloCult 0.7 x lOb 9 confluent small 
cells/ml -
MyeloCult 0.7x 10
6 
13 confluent small 
cells/ml -
MyeloCult 0.7x 10
6 
18 small confluent 
cells/ml -
MyeloCult 0.7 x 10
6 
23 medium confluent 
cells/ml -
MyeloCult + IL-3 + 0.7 x 10° 9 confluent + small + medium SCF cells/ml medium -
MyeloCult + IL-3 + 0.7 x 106 13 confluent small + medium SCF cells/ml -
MyeloCult + IL-3 + 0.7x 106 18 confluent small + medium SCF cells/ml -
MyeloCult + IL-3 + 0.7 x 106 23 confluent small + medium SCF cells/ml -
DMEM+Dex 1 x lOb cells/ml 9 small medium + big 
-
DMEM+Dex 1 x 106 cells/ml 13 small medium +big 
-
DMEM+ Dex 1 x 106 cells/ml 18 not visible small 
-
DMEM+Dex 1 x 106 cells/ml 23 not visible small 
-
-_._-
--- - - - -------
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MyeloCult + Dex 0.7 x 10
6 
9 small confluent 
cells/ml -
MyeloCult + Dex 0.7 x 10
6 
13 confluent confluent 
cells/ml -
MyeloCult + Dex 0.7 x 10
6 
18 confluent confluent 
cells/ml -
MyeloCult + Dex 0.7 x 10
6 
23 confluent confluent 
cells/ml -
MueloCult + 0.7 x lOb 9 small medium pluronic cells/ml -
MueloCult + 0.7x 106 13 confluent medium pluronic cells/ml -
MueloCult + 0.7 x 106 18 not visible pluronic cells/ml - -
MueloCult + 0.7 x 106 23 not visible pluronic cell s/m I - -
-- ~~---
--- - -- -
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The studies in this chapter have confinned that it is possible to expand MSCs in 
static monolayer cultures with all tested media conditions and achieve high increases 
in the total cell number after 29 days (5 passages). However, there was a large 
discrepancy between the increase in total cell number and the increase in colony 
fonning cells. 
The highest increase in CFU-f number was found after one or two passages as 
summarised in Table 4.4. Thereafter, the increase reduced to a lower level than at the 
beginning. This was true for all medium conditions. A possible reason could be the 
treatment with trypsin when passaging the MSCs. This treatment is known to stress 
the cells (Sun et 01., 2006), and could reduce their colony fonning capacity as well as 
their differentiation potential. 
Table 4.4: Summary of the results for the fold increase in CFU-f achieved by the 
different static culture methods. Since there are no significant differences between 
the medium conditions, cultures with DMEM are at least the cheapest to perfonn. 
Media type Static cultures max Costs (£) I fold increase increase in CFU-f (folq} 
DMEM 4.6 1.3 
DMEM+ Dex 4.6 1.3 
MyeloCult® 4.6 3.0 
MyeloCult® + Dex 4.4 3.2 
MyeloCult® + pluronic 4.3 3.3 
MyeloCult® + IL-3 + SCF 4.7 11.S 
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The addition of dexamethasone, IL-3 and SCF did not have any significant positive 
effect on the proliferation or differentiation behaviour of colony forming MSCs. If 
any of these additives provided an advantage, it was not evident in static culture 
systems. Maybe in more stressful environments like a stirred suspension culture the 
benefits of these additives will result in increased proliferation and survival rates. 
0.05% Pluronic F-68 in the culture medium was sufficient to decrease the 
proliferation rate and the colony forming ability of MSCs in monolayer cultures. 
However, using FTIR spectrometry and zetaPALS analysis no evidence could be 
found that this effect was caused by pluronic changing functional groups in the cell 
membrane. In addition, pluronic did not seem to change the osteogenic 
differentiation capacity of the cells. 
MSCs taken from all static cultures at any time point differentiated into osteoblasts 
when incubated in osteogenic medium. Furthermore, clearly visible colonies were 
formed in all osteogenic differentiation assays, as long as the assays were started 
with a sufficient number of MSCs. This indicates that at least some MSCs kept their 
full osteogenic differentiation and colony forming capacity. 
In contrast to the osteogenic differentiation, no adipocytes were found in any 
adipogenic differentiation assay started with MSCs from any monolayer culture. This 
implies that the MSCs expanded in any of the static cultures did not have their full 
differentiation potential. Together with the results from the CFU-f assay, this is 
evidence that the static culture system is not the best way for in vitro expansion of 
MSCs. 
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Chapter 5 
Proteomic Analysis of Mesenchymal Stem 
Cells' 
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5.1 Introduction 
In chapter 4, studies on the in vitro expansion of Mesenchymal Stem Cells (MSCs) in 
static monolayer cultures were described, and the results were presented. With this 
culture system, an increase in MSC number with osteogenic differentiation potential 
was achieved after a culture period of two weeks. The data indicated that a MSC 
population with the capacity to form colonies on culture plastic and to differentiate 
into osteoblasts can be expanded in adherent culture systems. However, a 
discrepancy between the increase in total cell number and in colony forming cells, 
led to the hypothesis that this culture method exerted chemical stress on the MSCs, 
and thus restricted their proliferation potential and their full differentiation capacity 
as indicated by a reduced capacity of colony formation, and the inability to 
differentiate into adipocytes. The chemical stress might be caused by using trypsin 
when subculturing the cells. To analyse the biological changes within stressed MSCs, 
and understand the reason for the loss of their proliferation and differentiation 
capacities, analysis of the global proteomic response using an isobaric labelling 
technique called iTRAQTM were conducted on rat bone marrow (BM) MSCs 
expanded in static monolayer cultures for either 2 passages or 4 passages. 
As highlighted in chapter 2, several groups have worked on the proteomic analysis of 
MSCs, and built up a comprehensive understanding of the MSC proteome in addition 
to the sequenced genome. Such information can be used to discover biomarkers and 
identify the normal proteomic pattern, in comparison to changes in activated or 
suppressed pathways, which occur during proliferation, differentiation, or other 
experimental conditions (Wagner et 01., 2006). Thus far, the majority of MSC 
proteomic research has primarily used 2-dimensional gel electrophoresis (2DE), 
which visualises parts of the cell proteome of MSCs, and then identifies single 
proteins from the gels by various forms of mass spectrometry (MS). Of special 
interest are the changes of the MSCs proteome caused by differentiation, especially 
osteogenic and adipogenic differentiation, by various cytokines and by in vitro aging .. 
Foster et al. (2005), Salasznyk et af. (2005) and Zhang et al. (2007) identified 
differently expressed proteins responsible for osteoblast differentiation in human 
mesenchymal stem cells (hMSCs) using 2DE and Matrix Assisted Laser Desorption I 
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Ionization - Time Of Flight (MALDI-TOF) mass spectrometry. Lee et al. (2006) 
analysed the proteome of adipocytes differentiated from hMSCs applying the same 
techniques and found 4 proteins with different expression levels, which were 
associated with adipogenesis. Wang et al. (2004) and Kratchmarova et al. (2005) 
studied the mechanism of divergent growth factor effects in hMSCs using 2DE and 
liquid chromatography - tandem mass spectrometry (LC-MSIMS). More interesting 
proteomic research related to the project described in this chapter was conducted by 
Sun et al. (2006) and Celebi and Elcin (2008) both using 20E and MALOI-TOF-MS. 
Sun et al. (2006) analysed the pr:oteome of hMSCs during serial subculture and 
osteogenic differentiation and showed that the proliferation and osteogenic capacity 
of these cells decrease during serial subculturing. Several proteins associated with 
cell proliferation, cell cycle, morphological changes, and apoptosis were shown to be 
differentially regulated during serial subculture. Moreover, further proteins were 
identified, which were differentially regulated during osteogenic differentiation, 
indicating that differentially regulated passage-specific proteins may play a role in 
the decrease of osteogenic differentiation potential under serial subculturing. Celebi 
and Elcin (2008) aimed to generate proteome maps of undifferentiated rat BM-
MSCs, and to identify differentially regulated proteins during serial subcultures. 
They extracted proteins from Wistar rat BM-MSCs, and detected about 1000 proteins 
of which 31 proteins were successfully identified and 18 were differentially 
expressed. Some of these proteins were associated with proliferation and 
differentiation capacity such as N-myc downstream regulated protein, adenylate 
kinase isoenzyme 1 and T -complex protein 1 alpha subunit. 
Although the majority of MSC proteomic research has primarily used 20E, this 
technique has a major limitation since not all proteins can be visualised in this way. 
Alternative non-gel-based quantitative MS approaches in proteome research are 
available. One technique is referred to as isobaric tag for relative and absolute 
quantitation (iTRAQ), which permits more accurate quantification and improved 
sequence coverage of proteins (Wiese et al., 2007). Furthermore, it allows the direct 
comparison of entire protein networks and the uncovering of critical differences that 
are capable of changing the fates of MSCs. iTRAQ technology is based on labelling 
peptides after enzymatic digestion of the proteins. iTRAQ labels (tags) are designed 
to form a covalent link with primary amines found at the lysine side chain and on the 
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N-terminus of tryptic peptides generated from protein digests (Ross et al., 2004). The 
iTRAQ workflow is shown in Figure 5.1. Different labelled samples are combined, 
fractionated by nano liquid chromatography (nanoLC) and analysed by tandem mass 
spectrometry (MSIMS). Due to the isobaric mass design of the iTRAQ reagents, 
differentially labelled peptides appear as single peaks in MS scans, thus reducing the 
probability of peak overlapping. When iTRAQ-tagged peptides are subjected to 
MSIMS analysis, the fragmentation of the tags attached to the peptides liberates a 
low molecular mass, isotope-encoded reporter ion that is unique for each group of 
tags. Relative quantification requires integrating the area under the MS peak for each 
reporter ion and calculating the different ratios of reporter ion peak areas. These 
ratios correspond to the ratios of peptide concentrations in the tested experimental 
conditions and the proteins from which they originate. Database searching of the 
fragmentation data from the peptides results in the identification of the labelled 
peptides and the corresponding proteins. Because there are up to eight different 
iTRAQ reagents available, comparative analysis of a set of 2 - 8 samples is possible 
within one single MS run. Several research groups have used the iTRAQ technique 
to analyse and compare the proteome of different mammalian cells (Unwin et al., 
2005) (Xu et al., 2009), including human MSCs (Seshi, 2006). 
One of the major hurdles that have to be overcome in large-scale proteomic studies 
in general is the reduction of sample complexity. As yet, there is no single method 
that allows identification of all proteins present in a sample. Furthermore, differences 
in culture methodologies applied in different laboratories are likely to induce 
variations in protein expression (Wagner et al., 2006). Thus, the different protein 
separation techniques, proteome analysis methods, and culture conditions, of various 
individual research groups, result in the generation of a variety of proteome data sets 
that are difficult to compare directly. Nevertheless, the information obtained through 
different methods should prove to be complementary, and provide a better 
understanding of the biological system. In this chapter, the proteomic differences in 
bone marrow derived rat BM MSCs from different passage levels were analysed in 
order to determine their influence on the proliferation and differentiation capacity of 
these cells. The protocol for culturing MSCs in static monolayer pour-off cultures 
was the same as that described in chapter 4. 
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5.2 Materials and methods 
The methods for analysing the proteome of MSCs, which were expanded in static 
monolayer cultures, are described. The analysis was conducted with an electrospray 
ionisation quadrupole time-of-flight tandem mass spectrometer (ESI-qQ-TOF-
MS/MS) using an iTRAQ based proteomic workflow. 
5.2.1 Mesenchymal Stem Cell static culture 
MSCs were derived from rat bone marrow as described in chapter 3.4. 10 ml of 
freshly harvested BMCs were suspended in 10 ml culture medium and seeded into a 
T75 flask, having a final density of about 1 x 106 cellslml. Cell culture medium was 
normal DMEM. The cells were incubated at 37°C in an atmosphere of 7.5% CO2• 
The first medium change was after 5 days and thereafter twice weekly until -90% 
confluence was reached. Then the cells were passaged and again expanded until 
-90% confluence. To detach the adherent cells, the medium was removed and the 
flasks were washed with phosphate buffered saline (PBS) before 3 ml of 0.25% 
trypsin/I mM EDT A solution was added. The culture was incubated for 5 minutes at 
37°C. To stop the incubation, 9 ml of culture medium, containing 10% FCS, were 
added and a sample was taken to determine the cell number in the solution using a 
haemocytometer. The lifted cells then were split 1:2 and transferred into new sterile 
T75-flasks. At passage 2 and 4 cells from 3 confluent flasks were combined and 
centrifuged (Scientific Laboratory Supplies Sigma 4K15) at 300g for 5 minutes to 
pellet the cells. To remove all traces of medium, cells were washed with 3 ml 
Dulbecco's Phosphate Buffered Saline (PBS) (Cambrex Bio Science Ltd 
Wokingham). 
5.2.2 Protein extraction 
Cells were re-suspended in 300 JlI PBS by dissociating the pellet with a 200 JlI 
pipette, forcing the cells into and out of the tip in a controlled manner. To break the 
cells open, they were sonicated for 10 - 15 seconds using the So~ifier 450 (Branson). 
Proteins were recovered by centrifugation at 21,000g for 30 minutes at 4°C (Heraeus 
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Model Multifuge 3S-R, Germany). The total protein concentration in the supernatant 
was quantified using the Bradford test (OD595) (BioRad) according to the 
manufacturer's instructions. Two times 100 J.lg of protein (biological replicates) from 
both conditions (cells harvested at passage 2 and at passage 4) were precipitated in 
4°C cold acetone by mixing one volume of protein solution corresponding to 100 J.lg 
of protein with six volumes of acetone, incubating at -20°C for 4 hours and decanting 
the acetone. 
5.2.3 Protein reduction, cysteine blocking and protein digestion 
The following two steps mentioned in section 5.2.3 and 5.2.4 were carried out using 
the iTRAQTM 4 plex kit from Applied Biosystems. 
To reduce the proteins, 20 J.l1 dissolution buffer, IJ.l1 denaturant and 2 J.ll reducing 
reagent were added to each sample before they were incubated for 1 hour at 60°C. 
After spinning the samples down (2,000g for 2-3 seconds), 1 J.l1 cysteine blocking 
reagent was added and they were incubated at room temperature for another 10 
minutes. Finally 10 J.ll trypsin solution (containing 25 J.lg trypsin and 222 J.lg calcium 
chloride) was mixed into each sample which were then incubated at 37°C overnight. 
5.2.4 Labelling the protein digests with the iTRAQ ™ reagents 
Each iTRAQTM reagent (114 - 117) was dissolved in 70 J.l1 ethanol, transferred to the 
sample tubes c~ntaining the cell digests and incubated at room temperature for 1 
hour. The two biological replica samples from passage 2 were labelled with reagents 
114 and 115 and the samples from passage 4 were labelled with the reagent 116 and 
117. Afterwards, the labelled samples were combined and vacuum concentrated prior 
to fractionation using strong cation exchange. 
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5.2.5 Strong cation exchange (SeX) fractionation 
Separation was performed on a BioLC HPLC column (Dionex, Surrey, U.K.) using a 
Polysulfoethyl A column (PolyLC, Columbia, MD) 5 flm of 100 mm length x 2.1 
mm Ld. and 200 A pore size. Buffer A consisted of 10 mM KH2P04 and 25% 
acetonitrile at pH 3.0, filter sterilised and buffer B consisted of 10mM KH2P04, 25% 
acetonitrile, and 500 mM KCI at pH 3.0, filter sterilised. The 60 minute gradient 
consisted of 100% buffer A for 5 minutes, 5 to 30% buffer B for 40 minutes, 31 to 
100% buffer B for 5 minutes, 100% buffer B for 5 minutes, and finally 100% buffer 
A for 5 minutes. A flow rate of 0.2 ml/minute was maintained with an injection 
volume of 200 fll. A UV detector (UVD 170U) and Chromeleon Software v6.50 
(DionexILC Packings, The Netherlands), was used to monitor the chromatogram as 
fractions were collected every minute using a Foxy Jr. Fraction Collector (Dionex). 
Fractions were dried in a vacuum centrifuge and stored at -20°C prior to mass 
spectrometric analysis. 
5.2.6 Mass spectrometry 
Mass spectrometry (MS) was performed using a QStar XL Hybrid ESI Quadrupole 
time-of-flight tandem mass spectrometer, ESI-qQ-TOF-MSIMS (Applied 
Biosystems, Framingham, MA; MDS-Sciex, Concord, Ontario, Canada) coupled 
with an online capillary liquid chromatography system (Famos, Switchos and 
Ultimate from DionexILC Packings, Amsterdam, The Netherlands). 60 JlI of 3% 
acetonitrile and 0.1 % formic acid (Switchos buffer) was used to resuspend the dried 
samples ready for the MS. 10 - 15 JlI (depending on the peptide concentration as 
seen in the peak intensity of the SCX chromatogram) were injected to the nano-LC-
ESI-MSIMS system for each analysis. Initial separation took place on a PepMap C-
18 RP capillary column (LC Packings) with a constant flow rate of 0.3 Jll/min. LC 
buffers A and B were made up as 3% acetonitrile, 0.1 % formic acid and 97% 
acetonitrile, 0.1 % formic acid, respectively. The gradient was started as 97% buffer 
A and 3% buffer B for 3 minutes, followed by 3 to 25% buffer B for 120 minutes, 
90% buffer B for 7 minutes and finally 97% buffer A for 7 minutes. Data acquisition 
in the mass spectrometer was set to the positive ion mode, with a selected mass range 
of350-1800 mlz. Tandem mass spectrometry was performed on peptides with +2, +3 
charge states across a scan range of 65-2000 m1z. 
5.2.7 Protein identification 
Protein Pilot software v.2.0 (Applied Biosystems, MDS-Sciex) was used for protein 
quantification and identification. Identifications were made on the 8th July 2008, 
using NCB I and swiss prot protein database. Search parameters were set at a mass 
tolerance suitable for QST AR instruments and Peptides with above 80% confidence 
were used for identification and quantification (Figure 5.1). The Panther (Protein 
ANalysis THrough Evolutionary Relationships) classification system was used to 
assign molecular function and biological process for the set of proteins identified 
(and relatively quantified). The functional relationship of differentially expressed 
proteins was further investigated using MetaCore™ (GeneGo Inc.) software. 
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Figure 5.1: Diagram to show the sample preparation and the proteomic workflow for 
iTRAQ based analysis of mesenchymal stem cells. 
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S.3 Results and Discussion 
The results are presented and discussed in three parts. Firstly, the biological 
phenotype i.e. growth and colony forming behaviour, as well as the morphology of 
mesenchymal stem cells at the different passage levels is described. Secondly, the 
differentially regulated proteins are identified, characterised and compared to other 
proteomic studies of bone marrow MSCs. Finally, only proteins which have been 
identified for the first time as proteins of interest, in terms of MSC biology are 
described in detail. 
S.3.1 Morphology and proliferation rate of Mesenchymal Stem Cells 
MSCs were expanded in static monolayer cultures as mentioned in paragraph 5.2.1. 
They were always plated at the same density (- 1 x 106 cells / flask) and subcultured 
at similar confluence levels. The proliferation rate of MSCs during the 4 passage 
period decreased only slightly. The time to reach confluence varied for the different 
passage levels (Figure 5.2). The p-value for significant differences between the times 
to reach confluence from passage 2 and 4 is p = 0.024. More interestingly, after an 
initial increase, the colony forming potential decreased over the same time period. 
Figure 5.3 displays the number of colonies formed when 4 x 103 MSCs were plated 
into cell culture dishes and grown as CFU-f culture after each passage. At passage 2, 
11,900 colony forming cells were present, whereas at passage 4 only 5,000 CFU-fs 
could be found. The p-value for significant differences between these numbers is p = 
0.047. 
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Figure 5.2: Proliferation rate of rat bone marrow derived MSCs, in terms of reaching 
confluence level during subcultures. Cells were expanded in static cultures with 
standard DMEM. Plating density was about I x 106 cells per T -75 flask. Data are 
presented as mean +/- S.D. from 3 different cultures. **p < 0.05, confluence time at 
each passage level compared with confluence time at passage number 2. 
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Figure 5.3: Development of CFU-f verses passage number. Cells were derived from 
rat bone marrow and expanded in static cultures with DMEM. Data are presented as 
mean +/-S.D. from 3 different CFU-f assays. **p < 0.05, colony number at each 
passage level compared with colony number at passage number 2. 
Furthermore, the average size of the colonies also decreased after serial subculturing. 
MSCs expanded in static cultures for as long as 2 passages formed small but 
recognisable colonies during the CFU-f assay. The colonies formed by MSCs 
passaged more than twice were barely visible on the plates (Figure 5.4). In addition, 
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the morphology of the single MSC in the monolayer cultures changed over time as 
well, and some phenotypic differences were observed between primary and 
subcultured cells. As it can be seen in Figure 5.5, the shapes of the adherent rat bone 
marrow cells in the primary culture (passage 0 cells) were heterogeneous, consisting 
of both fibroblastic cells and polygonal cells (Figure 5.5A). The majority of the cells 
demonstrated spindle morphology in ongoing subcultures. At passage level 2, they 
spread and demonstrated typical elongated fibroblastic phenotype (Figure 5.58). 
Figures 5.5C and 5.5D show a representative confluent culture after 3 and 4 
passages, respectively. In both cultures, the accumulation of the extracellular matrix 
can be observed as the cells became wider. 
(A) (8) 
Figure 5.4: Methylene blue stained CFU-f cultures started with MSCs which were 
expanded in standard monolayer cultures. Visible colony formation with MSCs after 
passage level 2 (A) and no visible colonies after 4 passages (8). 
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Figure 5.5: Methylene blue stained MSC static cultures. Confluent primary culture of 
rat bone marrow derived cell, passage 0 (A). Thin spindle shaped like MSCs after 
passage 2 (B). Bigger and wider MSCs at passage 3 (C) and passage 4 (D). 
5.3.2 Mass spectrometry analysis 
The proteins extracted from MSCs harvested after passage 2 and passage 4 were 
identified and relatively quantified using the iTRAQ technique (see material and 
methods in this chapter). A complete list of all identified proteins can be found in 
Appendix A. In order to calculate the different expression levels of the proteins at 
passage 2 and passage 4, the 10gIO ratio of the peptides labelled from both replicas at 
passage 2 (115:114) were compared to the loglO ratios of the peptides labelled from 
passage 4 and passage 2 (116: 114) and (117: 114), using the equation 5.1. 
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(115114) (115:114) 
log + log ----
(116:114) (117:114) 
( 
Fold change = 10 
) 
2 5.1 
Proteins were considered up-regulated for a fold change rate of a minimum of 1.5 or 
bigger and down-regulated for a rate of maximum of 0.5 or smaller. In total, 381 
proteins were identified and of these 105 were differently expressed with 48 proteins 
up-regulated and 57 down-regulated. In a study conducted by Seshi (2006), the 
iTRAQ technique was applied to identify differently expressed proteins in normal . 
and leukemic bone marrow stromal cells. In this study 900 proteins were identified in 
total, and 73 of these were differentially expressed in the leukemic cells. Comparing 
both iTRAQ results with other liquid chromatography / tandem mass spectrometry 
based studies of MSCs, similar numbers of identified and regulated proteins 
(between 104 and 113 proteins) were identified (Foster et 01.,2005) (Kratchmarova 
et 01., 2005). However, most of the studies analysing the MSC proteome used 2 
dimensional gel electrophoresis (2DE) and matrix assisted laser desorption / 
ionisation time of flight mass spectrometry (MALDI-TOF-MS). Applying these 
techniques between 1000 and 1700 protein spots were separated in 2DE gels and 
between 12 and 63 proteins were identified with MALDI-TOF-MS (Sun et 01.,2006) 
(Wagner et 01., 2006). Celebi and Elcin (2008) also investigated the effect of 
subculturing on the proliferation potential of bone marrow derived rat MSCs. They 
detected 1000 proteins spots on 2DE gels of which only 31 proteins were identified 
with MALDI-TOF-MS. Compared to the findings by Celebi and Elcin (2008), the 
iTRAQ approach in this study allowed identification of a higher percentage of the 
proteins in the samples and a greater number of differentially expressed proteins. 
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5.3.3 Functional categories and identification of regulated proteins 
In total, 79 of the regulated proteins in this study could be classified into nine 
functional categories (cell structure and cytoskeleton, ion transport, protein synthesis 
and degradation, metabolic enzymes, translation and transcription, signalling 
pathways, cell adhesion, cell cycle and proliferation, and stress response) (Tables 5.1 
and S.2). The largest group of regulated proteins were the cell structure and 
cytoskeleton proteins (25%), followed by the metabolic enzymes (20%) and the 
proteins involved in protein synthesis and degradation (14%). Figure 5.6 shows the 
percentage of all categorised proteins. These numbers, however, changed when either 
only the up-regulated or only the down-regulated proteins were considered. Amongst 
the up-regulated proteins, 26% were involved in protein synthesis and degradation, 
whereas for the down-regulated proteins the largest group were the cell structure and 
cytoskeleton proteins (27%). Furthermore, all identified cell cycle proteins were 
down-regulated, whereas all identified proteins engaged in cell adhesion were up-
regulated (Figures 5.7 and 5.8). 30 of these 79 classified proteins were found in 
earlier proteomic studies of bone marrow derived MSCs (Wagner et al., 2006) 
(Zhang et al., 2007) (Sun et al., 2006). Hence, 49 proteins being regulated in MSCs 
during subculturing are mentioned in this study for the first time. A list of all 
regulated and classified proteins with the corresponding reference of previous studies 
(if applicable} can be found in Table 5.1. 
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o Cell Structure, cytoskeleton 
• Ion transport 
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o Metabolic enzymes 
• Translation, Transcriptation 
4% 0 Signaling pathways 
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• Stress response 
Figure 5,6: Functional categories of all identified and regulated proteins. The 
majority belong to cell structure and cytoskeleton, protein synthesis and degradation, 
and metabolic enzymes. 
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Figure 5,7: Functional categories of up-
regulated proteins. The largest group 
consists of protein synthesis and degradation. 
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Figure 5.8: Functional categories of 
down-regulated proteins. The largest 
group consists of cell structure and 
cytoskeleton proteins. 
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Table 5.1: Differentially expressed proteins (up-regulated) in rat bone marrow MSCs identified by Protein Pilot software v.2.0 (Applied Biosystems, 
MDS-Sciex) and NCB I I swiss prot protein database. Proteins were categorised using PANTHER software. The references mention the study in 
which the proteins were described before. A blank entry means indicates a novel protein found in MSCs. 
Accession Protein identity fold Category References 
i no. change 
I gil71681130 A TP synthase, H+ transporting 5.35 Ion transport Sun et al. 2006 
! gil63101555 Sec61 alpha 1 subunit (S. cerevisiae) 4.72 Cell Structure 
-
. gil728810 ADP/ATP translocase 2 (ANT 2) 4.45 Ion transport -
gil83300587 A TP synthase subunit alpha 3.57 Metabolic enzymes Foster et al. 2005 
gil92373398 Y box protein 1 3.36 Translation, Transcriptation -
Sun et at. 2006; 
gil9845234 annexinA2 3.09 Cell Structure Nengshend et al. 2006; Zhang et at. 2007; 
Wang et at. 2004 
gil85541036 Myosin-Id (Myosin heavy chain myr 4) 3.05 Cell Structure Mareddy et al. 2009 
gil62512124 Ribophorin II (RPN-II) 2.84 Protein sythesis 
-
gil57012987 PRAI family protein 3 2.73 Protein sythesis 
-
gil157823041 integrin, alpha 11 2.73 Cell adhesion Foster et at. 2005 
gil68565369 Isocitrate dehydrogenase (NAD(+)-specific ICDH) 2.71 Metabolic enzymes Wagner et at. 2006 
gil 145566928 Polymerase I and transcript release factor (cav-p60) 2.65 Translation, Transcriptation -
Sun et at. 2006; 
gil6981052 heat shock 10 kDa protein 1 2.55 Protein sythesis Wagner et at. 2006; Mareddy et al. 2009; 
Nengsheng et at. 2006 
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gil55824765 Serpinhl protein 2.55 Protein sythesis 
-
gil149015978 fibronectin I, isoform CRA a 2.51 Cell adhesion 
-
gil763181 annexin VI 2.47 Signaling pathways Kratchmarova et al. 2005 
gi158865778 dolichyl-di-phosphooligosaccharide-protein 2.44 Cell Structure 
-glycotransferase 
gil48675371 complement component 1 2.39 Stress response 
-
gil33086478 Abl-205 2.24 Metabolic enzymes 
-
gil6822247 Nogo-A protein 2.24 Metabolic enzymes 
-
gil50403574 60S ribosomal protein L 1 0 1.94 Protein sythesis 
-
gil8393206 cysteine and glycine-rich protein 1 1.89 Cell Structure 
-
gil157823877 cytoskeleton-associated protein 4 1.89 Cell Structure 
-
gil3914232 Transmembrane emp24 domain-containing protein 2 1.89 Signaling pathways 
-
gi155977470 Tubulin alpha-IA chain (Alpha-tubulin I) 1.83 Cell Structure Kratchmarova et al. 2005; Wagner et al. 2006 
gil77993298 signal sequence receptor, alpha 1.81 Protein sythesis 
-
gil154816168 heat shock 70kDa protein 9A 1.79 Stress response 
-
gil38454246 ribosomal protein L3 1.75 Protein sythesis Wagner et al. 2006 
gil157820787 NADH dehydrogenase (ubiquinone) 1 1.73 Metabolic enzymes 
-
gil57858 ribosomal protein S24 1.72 Protein sythesis 
-
gil42476 I 81 malate dehydrogenase, mitochondrial 1.71 Metabolic enzymes Wang et al. 2004 
gil44888251 Phosphatidylinositol-binding c1athrin assembly protein 1.68 Translation, Transcriptation -
gil78214352 cysteine and glycine-rich protein 2 1.68 Cell Structure 
-
gil71795613 ribosomal protein, large P2 1.61 Protein sythesis Wagner et al. 2006 
gil56971262 Hnrpa 1 protein 1.61 Translation, Transcriptation -
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Table 5.2: Differentially expressed proteins (down-regulated) in rat bone marrow MSCs identified by Protein Pilot software v.2.0 (Applied 
Biosystems, MDS-Sciex) and NCBI I swiss prot protein database. Proteins were categorised using PANTHER software. The references mention the 
study in which the proteins were described before. A blank entry means indicates a novel protein found in MSCs. 
Accession Protein identity fold Category References 
no. change 
gil77404363 nucleosome assembly protein I-like I 0.12 Cell cycle, proliferation 
-
gil6981326 S 1 00 calcium-binding protein A4 0.21 Stress response 
-
i gil839361 0 karyopherin (import in) beta 1 0.29 Signaling pathways 
-
gi1157786926 actin related protein 2/3 complex, subunit 3 0.32 Cell Structure 
-
gil81884568 Macrophage-capping protein (CAP-G) 0.32 Cell Structure 
-
gil14549433 calcium binding protein NEF A 0.33 Ion transport 
-
gil157819651 chaperonin subunit 7 (eta) 0.33 Cell Structure Zhang et a1. 2007 
gil157786744 dihydropyrimidinase-like 2 0.34 Metabolic enzymes Zhang et a1. 2008 
gil69 1 1221 CArG-binding factor A 0.36 Translation, Transcriptation -
gil55562869 Tumor protein, translationally-controlled 1 0.38 Cell cycle, proliferation Wagner et al. 2006 i 
gil56585024 Phosphoglycerate kinase 1 0.41 Metabolic enzymes Ye et a1. 2006 
gil70912366 ARP3 actin-related protein 3 homolog 0.41 Cell Structure Kratchmarova et al. 2005 
gi151316981 ADP-ribosylation factor 1 0.44 Signaling pathways 
-
gil52783577 Dynein light chain 1 0.44 Cell Structure 
-
gil54036318 S100 calcium-binding protein All (Calgizzarin) 0.45 Cell cycle, proliferation 
-
gi16093729 Procollagen-Iysine,2-oxoglutarate 5-dioxygenase 1 0.45 Metabolic enzymes 
-(LH1) 
gil407164 heat shock protein 70 0.46 Stress response Wagner et a1. 2006 I 
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gi174355722 Capping protein (actin filament) muscle Z-line, alpha 2 0.46 Cell Structure Sun et al. 2006 
gil38382858 Protein disulfide isomerase associated 3 0.47 Protein sythesis Sun et al. 2006; Wagner et al. 2006 
gil59709467 CAP, adenylate cyclase-associated protein 1 0.48 Signaling pathways -
gil2498032 Myosin regulatory light chain 2 0.48 Cell Structure Mareddy et al. 2009 
gil149030883 glutathione synthetase, isoform CRA 0.49 Metabolic enzymes Wagner et al. 2006 
gil14903497 1 rCG426 12, isoform eRA b 0.49 Cell Structure -
gil6978505 annexinA5 0.50 Metabolic enzymes Wagner et al. 2006 
gil40254781 GDP dissociation inhibitor 2 0.50 Signaling pathways Wagner et al. 2006 
gil399660 aldehyde reductase 0.51 Signaling pathways Zhang et al. 2007 
gil81889864 Tubulin alpha-4A chain 0.52 Cell Structure Kratchmarova et al. 2005; Wagner et al. 2006 
gil149029682 rCG42490, isoform CRA f 0.53 Cell Structure 
-
gil149036910 actin related protein 2/3 complex. subunit 4 0.54 Cell Structure 
-
gil157818179 eukaryotic translation elongation factor 1 beta 2 0.55 Translation, Sun et at. 2006 Transcriptation 
gil157819753 reticulocalbin 1 0.56 Signaling pathways 
-
gil6981712 tyrosine 3-monooxygenase 0.56 Cell cycle, proliferation 
-
gil48675845 IMP cyclohydrolase 0.56 Metabolic enzymes Wagner et al. 2006 
gil6831527 Dimethylarginine dimethylarninohydrolase 1 (DDAH- 0.56 Cell cycle, proliferation I) -
gil71051777 Heat shock protein 8 0.57 Stress response Wagner et at. 2006 
gil158631214 arginyl-tRNA synthetase 0.57 Translation, Transcriptation -
gil6978501 annexinAI 0.57 Metabolic enzymes Sun et at. 2006 
gil56404680 Protein DJ-I (Parkinson disease protein 7 homolog) 0.59 Translation 
-
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gil62201921 Prothymosin alpha 0.59 Metabolic enzymes 
-
gi191771192 Asparagine synthetase [glutamine-hydrolyzing] 0.59 Protein sythesis 
-
gil33086658 Ccl-6 0.59 Metabolic enzymes 
-
gil 149033299 rCG52516 0.59 Protein sythesis 
-
gil47605935 Transforming protein RhoA precursor 0.59 Cell Structure 
-
giI1490117~~ reticulocalbin 2 0.60 Signaling pathways -,-
-------
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MetaCore TM was used to put the classified proteins in relation to each other by 
assigning groups of them to the same regulatory and metabolic networks. According 
to the MetaCore TM software (GeneGo Inc.), 27 networks were identified in which at 
least two or more proteins were present. The relation of the proteins to each other in 
these networks was calculated using Dijkstra's algorithm (Dijkstra, 1959). 
Furthermore, each of these networks was associated with a Z-score which ranks the 
networks according to their saturation with the proteins initially identified. A high Z-
score indicates that the network is highly saturated with identified proteins. The 
formula for the Z-score is listed in equation 5.2. 
R 
r-n 
Z-score = ( R r R r' n - 1 ) 
17 - . 1-- . 1-- ,-~ N N V-I 
Where : 
N - total number of nodes in MetaCore database 
R - number of the network's objects corresponding to the genes and proteins in your list 
n - total number of nodes in each small network generated from your list 
r - number of nodes with data in each small network generated from your list 
Equation 5.2: Z-score used by MetaCore TM to rank the networks of identified 
proteins. 
33 of the categorised proteins could be found in these 27 networks, but only 4 
proteins, grouped in 2 pairs, with direct interactions were identified. The tumour 
protein, translationally-controlled 1 (TPT I) regulated the eukaryotic translation 
elongation factor 1 beta 2 (eEFl B), and the heterogeneous nuclear ribonucleoprotein 
Al (hnRP AI) influenced the prothymosin alpha (PTMA). 
The translationally-controlled tumour protein 1 (TPTI) is believed to be important 
for cell growth and cell division as it was found considerably up-regulated in cells 
entering the cell cycle. This conclusion was based on the results from three different 
studies. Gachet et af. (\999) found that overexpression of TPT \ in mammalian cells 
caused slow growth and a delay in cell cycle progression, a knockdown of TPT 1 in 
Caenorhabditis elegans resulted in a slow-growth phenotype (Kamath et al., 2003), 
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and Li et 01. (2001) demonstrated that TPTI can prevent cell death by inhibiting 
caspase-3-like activity and concluded that the down-regulation of TPTI was 
associated with massive cell death. Thus, an antiapoptotic function of TPTI in 
human cells has been recognised. Furthermore, Koziol et al. (2007) suggested that 
TPTI represents a global regulator of pluripotency, and that it might have a general 
role in establishing an embryonic pattern of gene expression because it controlls the 
transcription of oct4 and nanog. Baharvand et 01. (2007) also detected decreasd 
TPTI levels in differentiating mouse embryonic stem cells. In MSCs, TPTI was 
reported for the first time by Wagner et 01. (2006). however no details on the 
involvement in the regulation of the cells was given. 
Eukaryotic translation elongation factor I beta 2 (eEFIB) is predominantly located in 
the endoplasmic reticulum (ER) (Sanders et 01., 1996). As part of the eEF-lp~5 
complex, it catalyses the exchange of guanosine diphosphate (GDP) for guanosine 
triphosphate (GTP) on eEF-la (Iwasaki et 01., 1976). eEF-la is the protein that is 
responsible for the binding and transportation of aminoacyl-tRNA to the ribosome. 
Modification of the subunit eEFIB, could affect the formation rate of the eEF-la-
GTP-aminoacyl-tRNA complex. and thereby alter the cellular protein sythesis 
(Janssen et al., 1988). eEFIB contains a casein kinase II activity. This kinase 
phosphorylates eEFIB at a specific serine residue and thus influences negatively the 
nucleotide exchange activity. which in tum has consequences for the regulation of 
translation (Walter et al., 1984). Sun et al. (2006) found eEFIB down-regulated in 
bone marrow derived MSCs after serial subculturing (3 - 5 passages). They 
concluded that the down-regulation of passage specific proteins are the reason for 
their observed decreased in proliferation capacity. 
In this study, TPTI and eEFIB were both down-regulated in MSCs passaged 4 times 
compared to MSCs passaged only twice. With MetaCore™, a possible direct 
interaction of TPTI and eEFIB was found (Figure 5.9). Furthermore, eEFIB and 
eEFIA are directly connected in this network, indicating that this network may be 
part of the translation regulation. The observed slight decrease in proliferation of in 
vitro expanded MSCs, and the even more obvious reduction in colony size and in 
colony forming capacity supports the theory that TPTI and eEFIB regulate the cell 
proliferation in MSCs. A list of all networks calculated by MetaCore TM and the 
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legend for the diagrams in Figures 5.9 and 5.10 are attached in the Appendix Band 
Appendix C. 
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Figure 5.9: Regulatory network calculated by MetaCore™ in which TPTl, eEFIB 
and eEFl A are in direct interaction. A legend can be found in Appendix C. 
In this study, 18 out of the 33 interacting proteins were found expressed in MSCs for 
the first time. The following paragraphs describe some of these newly discovered 
proteins. Amongst them were heterogenous nuclear ribonucleoprotein Al (hnRP AI) 
and prothymosin alpha (PTMA), which were connected by a direct interaction, 
according to MetaCore™. 
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Heterogenous nuclear ribonucleoprotein Al (hnRP AI) plays an important role in the 
mRNA metabolism by binding RNA at its N terminus (Dreyfuss et al., 2002) (Krecic 
et al., 1999). The C-terminal domain also contributes to RNA binding and 
additionally includes an amino acid sequence, that is involved in hnRPAI nuclear 
import and export (Michael et al., 1995) (Weighardt et al., 1995). At steady state, 
hnRPAl is predominantly nuclear, but it can shuttle rapidly between the nucleus and 
the cytoplasm, which is thought to playa role in cell proliferation, cell survival, and 
differentiation. Two transport receptors of the karyopherin family, Tml and Tm2b, 
mediate the hnRPAI nuclear import (Pinol-Roma et al., 1992). Another hnRPAI 
interacting protein is the E2a-Pbxl oncoprotein, which prevents differentiation and 
maintains continued cell division. Following inactivation of E2a-Pbxl, hnRP A 1 was 
up to 10 fold down-regulated (Skyes et al., 2003). In addition, the gene encoding 
testosterone-IS-alphahydroxylase (Cyp2AS) was identified as a target of hnRPAl 
(Raffalli-Mathieu et ai., 2002). By binding to Cyp2AS-RNA, hnRPAl can prolong 
the Cyp2AS-RNA half-life (Glisovic et al., 2003). 
Prothymosin alpha (PTMA) is a small, highly acidic nuclear protein, which is highly 
conserved and expressed in a wide variety of cells, tissues, and organisms (Haritios 
et al., 1984). This suggests that PTMA is required for an essential function in the 
cell. Numerous studies have indicated that PTMA may be involved in cell growth, 
and the expression of its gene is generally correlated with cellular proliferation 
(Haritios et al., 1984). Ihis relationship has been supported by the direct correlation 
of both PTMA-mRNA and protein levels with levels of proliferation (Eschenfeldt et 
al., 1989), and the finding that PIMA was phosphorylated in stimulated proliferating 
cells (Barcia et aI., 1992). Additionally, overexpression of PIMA has been shown to 
accelerate proliferation, and to slow down differentiation in HL-60 promyelocyte 
(Rodriguez et al., 1998). Moreover, the transcription of the PIMA gene is regulated 
by the c-myc gene, a key player in the control of proliferation (Eilers et al., 1991). 
Barbini et al. (2006) concluded that high levels of PTMA need to be present in the 
nucleus for proliferation, whereas programmed cell death requires low levels of 
PIMA outside of the nucleus. Jiang et al. (2003) found that PTMA negatively 
regulated caspase-9 activation by inhibiting apoptosome formation. 
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In this study, hnRPA 1 was up-regulated, and PTMA was down-regulated although 
both directly interact with each other (Figure 5.10). The fact that both are related to 
cell proliferation in several other studies leads to the conclusion that they may be 
also involved in MSC proliferation 
~ 
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Figure 5.10: Regulatory network calculated by MetaCore™ in which hnRPA! and 
PTMA are in direct interaction. A legend can be found in Appendix C. 
Another newly described protein present in the same network as hnRP A 1 and PTMA 
is Y box protein! (YB1) (Figure 5.10), which was up-regulated in subcultured 
MSCs. YB 1 appears to playa critical role in cell proliferation, DNA replication, and 
drug resistance. It is involved in promoting cell proliferation through the 
transcriptional regulation of various relevant genes, including proliferating cell 
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nuclear antigen, p53 protein, epidermal growth factor receptor, DNA topoisomerase 
lIa, thymidine kinase, and DNA polymerase a.S (Wolffe et al., 1994) (Okamoto et 
al., 2000). Furthermore, it activates the transcription of the human multidrug 
resistance 1 gene. (Ohga et al., 1998). The biological roles of YBI include 
modification of chromatin, translational masking of mRNA, participation in the 
redox signalling pathway, RNA chaperoning, and stress response regulation 
(Swamynathan et al., 1998). Hence, YBI appears to be related to both mRNA 
turnover and translational control. 
Further proteins described for the first time are adenyl ate cyclase-associated protein I 
(CAP), dynein light chain I (DLCI), cysteine and glycine rich protein2 (CRP2), 
asparagine synthetase (ASNS), ADP-ribosylation factort (ARF1) and Sec61. 
Adenylate cyclase-associated proteinl was down regulated in this study. It is part of 
the cyclic AMP pathway, and binds to G-actin, thus inhibiting actin polymerisation 
(Freeman et al., 1995). A CAP homologue of Drosophila has been reported to be 
involved in developmental morphogenesis, probably through its effect on the actin 
cytoskeleton (Benlali et al., 2000). Moreover, CAP has been associated with the 
aggressive behaviour of pancreatic cancer cells (Yamazaki et al., 2009) and 
Moriyama et al. (2002) found that CAP effectively recycles actin and cofilin, thereby 
allowing a rapid turnover of actin filaments, which is an essential driving force 
behind cell motility. 
Dynein light chain I (DLC1), also down-regulated in this study, is a component of the 
cytoplasmic dyne in motor complex (Hirokawa et al., 1998). This complex is 
involved in cytoplasmic organelle transport, mitosis, nuclear migration (Holzbaur et 
al., 1994) (Vaisber et al., 1993) and promotes normal differentiation of proliferating 
germ cells (Dorsett et al., 2009). Dorsett et al. demonstrated that the dynein motor 
complex inhibited proliferative cell fate, in part through regulation of METT-IO, a 
conserved putative methyltransferase and thus, dynein can act as an anti-proliferative 
factor. In addition to being an essential part of the dynein motor function, DLCI 
interacts with a number of proteins such as nitric oxide synthase, Pakl, KIBRA and 
Cip-interacting zinc finger protein 1 (Cizl), and thereby may regulate numerous 
biological processes (Rayala et al., 2006) (Hollander et al., 2006). The up-regulation 
of DLCI and its interaction with Pakl, KIBRA and Cizl is closely related to 
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stimulated cell growth and regulation of the cell cycle in estrogen receptor positive 
breast cancer cells. In this context, Rayala et 01. (2005) discovered that the down-
regulation of DLCI compromised the transactivation function of the estrogen 
receptor. 
Cysteine and glycine rich protein2 (CRP2) is involved in regulatory processes 
important for cell development and cellular differentiation. In this study, it was found 
to be up-regulated. CRP2 was shown to be a potent smooth muscle differentiation 
cofactor triggering the conversion of pluripotent fibroblasts into smooth muscle cells 
when overexpressed together with serum response factor (SRF) and GAT A proteins 
(Chang et 01., 2003). Moreover, a recent report demonstrated that CRP2 can 
effectively switch on smooth muscle gene activity in adult cardiac myocytes (Chang 
et 01., 2007), suggesting that CRP2 has essential functions in controlling smooth 
muscle gene activity. Additionally, it was shown that the expression of CRP2 is 
down-regulated with cellular dedifferentiation induced by oncogenic transformation, 
injury, or wound healing (Weiskirchen et 01.,2001). 
Asparagine synthetase (ASNS) was down-regulated in this study, and is classified as 
a metabolic enzyme. It catalyses the A TP-depended conversion of aspartic acid to 
asparagines, and thus its transcription is regulated by the availability of the amino 
acids aspartic acid and asparagines (Gong et 01., 1991). Bone marrow mesenchymal 
stem cells were shown to express high levels of ASNS in vivo, leading to high 
concentrations of asparagine in the bone marrow microenvironment and 
subsequently protecting the surrounding cell of these niches from the lethal action of 
asparaginase (Iwamoto et 01.,2007). 
ADP-ribosylation factorl (ARFI) is localised in the Golgi apparatus, and has a 
central role in intra-Golgi transport. It is active during mitosis, and involved in the 
mitotic fragmentation of the Golgi (Xiang et 01., 2007). Furthermore, ARF 1 interacts 
with the API, AP3, AP4 and the GAI-3 adaptors of the Golgi (D'Souza et at., 2006) 
(Robinson et 01., 2004), as well as the lipid-modifying enzymes phospholipase D and 
phosphatidylinositol-specific (PI)4 kinases (Godi et 01., 1999). Through these 
interactions, ARFI facilitate recruitment of the cytoplasmic coat protein (CDPl) to 
the Golgi membranes, and of the c1athrin polymers to the Golgi and endosomal 
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compartments. Thus, ARFI might act as a master regulator of coated vesicle 
fonnation. Through its regulation of the Golgi, ARFI plays an important role in post-
translational protein modification and trafficking. 
Sec61 is an endoplasmic reticulum (ER) membrane protein translocator. It consists 
of 3 major subunits, and fonns a protein-conducting channel through the ER 
membrane, allowing the translocation of polypeptides into the ER lumen (Rapoport 
et al., 1996). Furthennore, Sec61 is involved in the destruction of newly synthesised 
major histocompatibility complex (MHC) class I molecules by dislocating MHC 
class I molecules from the endoplasmic reticulum to the cytosol and delivering them 
to the proteasome. This process appears to be a reversal of the reaction by which 
Sec61 translocates polypeptides into the ER lumen (Wiertz et al., 1996). An 
additional interaction of Sec61 with a protein complex was discovered by Stockton et 
al. (2003). They used nanospray tandem mass spectrometry to show that this 
complex was composed of protein disulfide isomerase (PDI), calcium binding 
protein 1 (CABPIIP5), 72 kDa endoplasmic reticulum protein (ERp72), and BiP 
(heat shock protein A5IHSPA5), and occlude the cytosolic face of Sec61. 
5.4 Conclusions 
In this chapter, the effect of serial subculturing on the proteome of rat bone marrow 
derived MSCs was detennined. MSCs were expanded for up to 4 passages in static 
monolayer cultures. During this time, a small decrease in proliferation rate and a 
more obvious decline in colony fonning potential and colony size were observed. 
The proteome of MSCs from passage 2 was compared to that of MSCs from passage 
4 using iTRAQ. 381 proteins were identified, of which 48 proteins were up-regulated 
and 57 were found to be down-regulated at passage 4. 79 of the regulated proteins 
were classified into nine functional categories (cell structure and cytoskeleton, ion 
transport, proteins synthesis and degradation, metabolic enzymes, translation and 
transcription, signalling pathways, cell adhesion, cell cycle and proliferation, and 
stress response) and 49 of these proteins were described in this study for the first 
time in MSCs. Compared to a study by Celebi and Elcin (2008), in which they also 
analysed the proteome of sub-cultured bone marrow derived rat MSCs using 2DE 
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and MALDI-TOF-MS, the iTRAQ approach identified about 10 times more proteins. 
However, this study did not match any of the ,identified proteins by Celebi and Elcin 
(2008). Furthermore, they classified the majority of their proteins as ion-transport 
(22%), metabolic (17%) and signalling pathway (17%) proteins, whereas the 
majority of identified proteins in this study were classified as cell structure (25%), 
metabolic (20%) and proteins synthesis I degradation (14%) proteins. Despite these 
differences, both studies found that proteins involved in cell proliferation were 
down-regulated (TPTl, PTMA, OLCl in this study and Adenylate kinase 
isoenzyme I, SG2NA in Celebi and Elcin study) and proteins involved in 
differentiation were up-regulated (YB I, hnRP A I, CRP2 in this study and 
Mineralocorticoid receptor, NORG 1 in Celebi and Elcin study) 
18 of the 49 newly described proteins in this study could be assigned into different 
regulatory and metabolic networks such as proliferation, differentiation, 
transcription, translation or translational modification. Most of the proteins related to 
cell proliferation such as tumour protein, translationally-controlled I (TPTI), 
prothymosin alpha (PTMA) and dyne in light chainl (OLCl) were down-regulated. 
The proteins Y box protein 1 (YB 1), heterogenous nuclear ribonucleoprotein Al 
(hnRP A l) and cysteine and glycine rich protein2 (CRP2) were up-regulated. They 
were identified as regulation factors between proliferation and differentiation, 
depending on their intracellular concentration and location. Taking all these 
observations together (the down-regulation of proliferation related proteins and the 
up-regulation of differentiation related proteins) it can be hypothesized that serial 
subculturing may stimulate the differentiation of MSCs into early progenitor cells, 
and thus reduce their proliferation and colony forming capacity. However, to confirm 
this argument, further studies will be needed. 
This experiment was an important addition to the thesis, because it highlights the 
problem arising from the use of static monolayer cultures for large scale MSC 
expansion. Furthermore, it was shown that iTRAQ is a useful tool to investigate the 
proteome of MSCs, and generated results which can be used to complement previous 
proteomic studies on MSCs. In addition, newly described proteins were presented 
which regulate MSC proliferation and differentiation. These findings may help to 
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gain a better understanding of the processes controlling the proliferation and 
differentiation of MSCs. 
liS 
Chapter 6 
. Mesenchymal Stem Cells in Stirred 
Suspension Cultures 
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6.1 Introduction 
The results in chapter 4 showed that mesenchymal stem cells (MSCs) can be 
expanded in vitro using static monolayer cultures. However, these static culture 
systems are limited in their effectiveness in generating cell mass due to poor 
reproducibility, lack of sufficient mixing (leading to gradients for pH, dissolved 
, oxygen, cytokines and metabolites) and limited productivity for a given surface area 
(Ohgushi et 01., 1999). Furthennore, the static culture method also seems to interfere 
with the ability of the expanded MSCs to keep their colony fonning capacity and 
their full differentiation potential, as demonstrated in chapter 4. Therefore, there is 
limited scope in using large scale static culture systems. Monolayer cultures are 
attractive for MSC expansion, since they offer the cells a surface to which they can 
adhere and then proliferate but studies have shown that MSCs do not necessarily 
need attachment to grow and proliferate (Zandstra et 01., 1994). Hence suspension 
cultures may be an attractive alternative for in vitro MSCs expansion (Baksh et at., 
2003). They can generate large numbers of cells and enable easy scale-up, sample 
collection and process monitoring (Ulloa-Montoya et 01., 2005). In addition, no 
trypsin treatment is required in the expansion process. The chemical stress caused by 
the trypsin treatment was believed to be a possible reason for the gradual loss of 
colony fonning and differentiation potential ofMSCs in static cultures (chapter 4). 
So far, two different ways have been described to culture MSCs in suspension, (1) in 
a roller bottle (Chen et 01.,2006) and (2) in a stirred suspension culture (Baksh et 01., 
2003). The preferred culture medium in both cases was MyeloCult® medium, which 
has a relatively high serum concentration (25%), compared to the culture medium 
normally used for MSCs expansion (DMEM or a.-MEM, both with 10% serum). The 
addition of serum to any suspension culture medium has been shown to produce 
better growth in agitated and aerated cultures, in a dose dependent fashion (Toogood 
et 01., 1980). However, ideally the addition of serum should be avoided, since animal 
products are unwanted in the treatment of cells for reimplantation into humans. 
Furthennore, in both cases, the culture medium was supplemented with various 
cytokines such as human interleukin-3 (hIL-3), stem cell factor (SCF) or human 
platelet-derived growth factor (rhPDGF-BB). All these growth factors had a positive 
effect on the proliferation rate ofMSCs in suspension cultures (Baksh et 01.,2003). 
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Interleukin-3 (lL-3) is one of the major haematopoietic cytokines that regulates the 
survival of haematopoietic cells of various lineages by binding to the interleukin-3 
receptor (or CD123). CD123 consists of an a-subunit, a transmembrane molecule 
that specifically binds the ligand, and a ~-subunit, a cytoplasmic domain for 
intracellular signalling (Bazan, 1990). Binding of IL-3 to its receptor initiates rapid 
tyrosine phosphorylation of Janus kinases (JAKs) and of signal transducer and 
activator of transcription (STAT) proteins, as well as activation of the 
phosphatidylinositol-3 kinase (PI-3K)/Akt and Ras/RafIMAPK kinase 
(MEK)/mitogen-activated protein kinase (MAPK) pathways (Guthridge et al., 1998, 
DeGroot et al., 1998, Scott et al., 1999 and Woodcock et al., 1999). The JAKISTAT 
pathway is used for transmitting extracellular signals through transmembrane 
receptors directly to promoters of target genes in the nucleus of activated cells. IL-3 
receptor binding leads to activation of the receptor-associated JAK2 and JAKI 
kinases which further downstream leads in tum to the dimerization of STATI and 
STAT5. Once the STA Ts dimerize, they trans locate to the nucleus and bind to 
specific enhancer sequences in the promoters of activated genes (Guthridge et al., 
1998 and Woodcock et al., 1999). The MAPK pathways include the extracellular 
signal regulated kinase (ERK), c-Jun amino-terminal kinase (JNK), and p38 
signalling cascades (Guthridge et al., 1998 and Woodcock et al., 1999). These 
pathways are vital mediators of a number of cellular responses, including growth, 
proliferation, and survival. JNK phosphorylates the c-Jun transcription factor, 
whereas the p38 MAPKs activate the A TF transcription factor. The ERK pathway is 
involved in preventing apoptosis by up-regulating expression of the genes encoding 
bcl-2 and bcl-x in response to these cytokines (Kinoshita et al., 1995). In addition to 
activating survival genes, the ERK pathway prevents apoptosis by inhibiting the pro-
apoptotic factor BAD (Scheid et al., 1999). The PI3-K pathway regulates multiple 
cellular processes such as proliferation, growth, cell size, apoptosis, and cytoskeletal 
rearrangement (Cantley, 2002 and Vivanco et al., 2002). PI3-K is a heterodimeric 
lipid kinase composed of a regulatory subunit (P85) and a catalytic subunit (p 110). 
IL-3 stimulation also induces phosphorylation of BAD through the AktIPKB 
pathway, resulting in inhibition of apoptosis (del Peso et al., 1997). 
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Stem Cell Factor exhibits two distinct isoforms, the soluble form and the membrane-
bound SCF (Flanagan et al., 1991). Both forms have distinct signalling properties 
from each other, resulting in varied biological functions mediated by the two 
isoforms (Massague and Pandiella, 1993). SCF is the ligand of the receptor tyrosine 
kinase, c-kit, which extracellular domain facilitates the binding of the ligand and the 
cytoplasmic domain serves to transduce the signal (Schlessinger, 2000). The receptor 
is widely expressed in haematopoietic stem cells, myeloid progenitor cells, dentric 
cells, mast cells and pro-B and pro-T cells (Yarden et al., 1987). The binding ofSCF 
induces the homodimerization of the c-kit receptor resulting in the phosphorylation 
of selective tyrosine residues in c-kit, thereby open docking sites for the Src-
homology2 (SH2)-containing signal transducers (Blume-Jensen et al., 1998). c-kit 
signalling has effects in various biological functions such as spermatogenesis, 
melanin formation and erythropoiesis (Reber, et al., 2006 and Ali et al., 2007) and 
can activate PI3-kinase, which is involved in the control of cell proliferation and 
survival (Blume-Jensen et al., 1998). In addition to PI3-kinase activation, c-kit is an 
important regulator of interleukin-6 and binding of SCF to the receptor induces 
activation of multiple additional pathways, including phospholipase C (PLC)-
gamma, Src kinase, Janus kinase (JAK) / Signal Transducers and Activators of 
Transcription (STAT) and mitogen activated protein (MAP) kinase pathways (Reber 
et al., 2006). Recent studies have demonstrated a role for the intracellular second 
messenger, cyclic AMP (cAMP), in the expression of both c-kit and SCF in different 
cell types such as cancer cell lines and dentric cells. Since c-kit plays an important 
role in the development of various cell types, cAMP may playa dual role in up-
regulating c-kitlSCF expression and promoting cell differentiation (Krishnamoorthy 
et al., 2008 and Shaw et al., 2002). 
The downside of both cytokines, IL-3 and SCF, is the fact that they are expensive 
(£200 I litre culture medium), especially the quantity necessary for large scale 
suspension cultures (£1000 for a 5 litre culture). 
Another additive used to protect freely suspended cells from mechanical stress and 
damage is Pluronic F -68, which is a synthetic non ionic surfactant used routinely in 
large-scale mammalian cell culture processes. The function of Pluronic F -68 
supplementation is to protect the cells from shear forces and the detrimental effects 
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of bubble bursting, both which are necessary for oxygenation in large-scale 
suspension culture (Zhang, S. et al., 1992). The protective effect of pluronic is 
attributed to its ability to reduce cell-bubble attachment (Michaels et al., 1995), 
stabilise surface foams (Handa-Corrigan et al., 1989), and increase the cells 
resistance to hydrodynamic shear forces (Murhammer et al., 1990). It is known, that 
Pluronic-F68 is able to integrate artificial lipid bilayer due to its surfactant properties 
(Firestone and Seifert, 2005). Hence there is strong evidence that pluronic interacts 
with the cell plasma membrane. Already Goldblum et al. (1990) hypothesized that 
Pluronic F-68 can adsorb onto cell membranes and thus protect cells from damage. 
Ramirez and Mutharasan (1990) used a fluorescence polarization method to measure 
the plasma membrane fluidity (PMF) of hybridomas throughout a batch culture, and 
found that Pluronic F-68 decreased the plasma membrane fluidity significantly. They 
suggested that the protective mechanism of pluronic relies on its ability to decrease 
the PMF through direct interaction with the plasma membrane. It appears that 
pluronic can both adsorb onto cell membranes and be incorporated into those 
membranes (Clarke et al., 1995). Keeping in mind, that the neutral lipid, cholesterol, 
is the major structural lipid present in the mammalian plasma membrane and is 
responsible for the mechanical stability and cohesiveness (Yeagle, 1985), a small 
increase in membrane cholesterol content can result in an increase in membrane 
rigidity and a decrease in membrane fluidity (Evans and Rawicz, 1990). Conversely, 
a large increase in plasma membrane cholesterol content results in a large increase in 
membrane rigidity and a decreased in membrane fluidity (Clarke et al., 1995). 
Furthermore changes in membrane cholesterol content directly impact 
transmembrane signalling by altering membrane protein function. These effects have 
been attributed to bulk lipid loading of the membrane, by direct interaction of 
cholesterol with the membrane protein resulting in disruption of the ability of the 
protein to undergo the conformational changes required for signalling, or by a 
combination of both phenomena (Bastiaanse et al., 1997). Interestingly, the effect of 
cholesterol enrichment on plasma membrane protein function can be either 
stimulatory (Bastiaanse et al., 1994) or inhibitory (Bolotina et al., 1989). However, 
this theory could not be confirmed by the experiments conducted on MSCs, which 
were expanded in DMEM containing Pluronic F-68 (chapter 4). The study of the 
interactions between pluronic and cultured cells is limited by the lack of a simple and 
sensitive assay for Pluronic F-68. Another theory of how pluronic could protect cells 
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from shear stress was tested by Gigout et al. (2008). They synthesized a fluorescent 
derivative of Pluronic-F68 to quantify and characterise its uptake by CHO cells and 
chondrocytes. It was demonstrated that labelled pluronic accumulates in the cells in 
late endosomes and Iysosomes but not in the cytoplasm or in the nucleus. The 
accumulation in the cell membrane could not be distinguished from auto-
fluorescence. Thus, shear protection conferred by pluronic may be partly due to 
alteration and stiffening of cytoplasmic cell mechanical properties by the high 
pluronic-F68 concentration in intracellular vesicles. 
It is an important criterion when expanding mesenchymal stem cell numbers for 
therapeutic applications to maintain their full differentiation capacity by optimising 
the culture conditions. Besides the culture medium, there are many parameters such 
as cell seeding density, agitation, culture vessel and sampling technique which have 
to be considered as well. Studies on other stem cell types like neural stem cells or 
endothelial cells from human umbilical veins of newborn babies were conducted to 
investigate some of the mentioned parameters. Korff and Augustin (1998) found that 
single endothelial cell in suspension cultures undergo apoptosis if they do not 
establish cell-cell contact. Hence, a minimal cell seeding density is necessary to 
enable cell-cell interaction. In another study, the initial cell density decided if large 
expansion or fast expansion of neural stem cells in stirred suspension cultures was 
achieved (Kallos and Behie, 1998). Sen et al. (2002) used the agitation speed in 
stirred suspension cultures of neural stem cells to control the formation of 
aggregates, and thereby regulated the viability of the culture. 
Taking these findings into account, it can be inferred that the same culture 
parameters may be also be of importance for the cultivation of MSCs. The objective 
of the study presented in this chapter therefore is to develop an optimised protocol 
for large scale expansion of MSCs in stirred suspension cultures by investigating the 
effect of the initial cell seeding density, the sampling method, the agitation method 
and of course the culture medium on the proliferation and differentiation capacity of 
MSCs. Ideally, the suspension culture method should be kept as simple and as cheap 
as possible, to allow easy scale-up and the potential use of these cells for medical 
applications. 
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6.2 Materials and methods 
The methods for general cell culture are given previously in chapter 3. In this 
chapter, the specific methods for growing and expanding bone marrow derived rat 
MSCs in a suspension culture system are described. The protocol for these cultures 
was varied according to the source of MSCs (fresh bone marrow cells or MSCs from 
static cultures), the sampling or agitation method, a~d the culture vessel. 
6.2.1 Different culture media 
The media tested for growing MSCs in a suspension culture were simple variations 
of the standard DMEM and MyeloCult® medium mentioned in section 3.3. The 
following variations were used: 
(1) DMEM supplemented with 0.05% Pluronic F-68 (about £30 per litre), 
(2) DMEM with 0.05% Pluronic F-68 and 10-8 M dexamethasone (about £30 per 
litre), 
(3) MyeloCult® supplemented with 0.05% Pluronic F-68 (about £70 per litre), 
(4) MyeloCult® with 0.05% Pluronic F-68 and 10-8 M dexamethasone (about 
£70 per litre), 
(5) MyeloCult® with 0.05% Pluronic F-68, 10-8 M dexamethasone, 2 nglml 
interleukin-3 and 10 nglml stem cell factor (about £270 per litre), 
(6) MyeloCult® with 0.05% Pluronic F-68, 10-8 M dexamethasone, 2 nglml 
interleukin-3, 10 nglml stem cell factor and 373 nglml heparin sulphate 
(about £300 per litre), 
(7) MyeloCult® with 2.5% gelatine, 10-8 M dexamethasone, 2 nglml interleukin-
3 and 10 nglml stem cell factor (about £270 per litre), 
(8) MyeloCult® with 10-8 M dexamethasone, 2 nglml interleukin-3 and 10 nglml 
stem cell factor (about £270 per litre). 
6.2.2 Starting suspension cultures with Mesenchymal Stem Cells from different 
cell sources 
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Suspension cultures were either started with freshly harvested rat bone marrow cells 
(BMCs), or with MSCs which had already been expanded in static monolayer 
cultures for one passage. Rat bone marrow cells were obtained as described in 
section 3.4. Either 8 ml of BMCs for low initial cell density or 18 ml BMCs for high 
initial cell density were suspended in 40 ml culture medium and seeded into the 
suspension culture vessel. This is equivalent to 4 x lOS BMCs/ml and 9 x lOS 
BMCs/ml respectively. To start the suspension cultures with pre- expanded MSCs, 
the rat BMCs were seeded into a T75 flask and incubated as a static monolayer 
culture, as described in section 4.2.1. The adherent MSCs of the monolayer culture 
were harvested after 90% confluence, and suspended in 40 ml culture medium to 
achieve a initial cell concentration in the suspension culture of either 0.5 x lOs 
MSCs/ml, 1.5 x lOs MSCs/ml, 2.5 x lOs MSCs/ml or 7.5 x lOs MSCs/ml. 
6.2.3 Maintaining Mesenchymal Stem Cells suspension cultures 
Two different agitation methods were applied, either stirred or shaken suspension 
cultures. The culture vessels used for stirred cultures were either 500 ml glass bottles 
with screw caps (Scientific Laboratory Supplies Ltd) containing magnetic stirrer 
bars, or 500 ml spinner flasks (catalogue no. 1965-0010, BelIco) with built in 
magnetic stirrer paddles. For shaken suspension cultures, the 500 ml glass bottles 
without the magnetic stirrer bar were used. Prior to every experiment, the culture 
vessels were cleaned, coated with silicone (Sigmacote from Sigma) to avoid cell 
adhesion to the glass, dried overnight at 80°C and finally autoclaved. Next, the 
vessels were rinsed with sterile Phosphate Buffered Saline (PBS) to wash out liquid 
silicone before fresh BMCs, or trypsin digested MSCs from monolayer cultures were 
seeded into the culture vessels. For the stirred suspension cultures, both bottles and 
spinner flasks were then transferred to a magnetic stirrer plate (from Scientific 
Laboratory Supplies, lKA) within a C02 incubator (from Sanyo, MCO - 15AC) and 
kept at 37°C and 7.5% C02 for 1 to 4 weeks. The stirrer speed was about 40 rpm. For 
the shaken suspension cultures, the glass bottles were transferred into a shaking 
incubator (Infors HT, Multitron) after being inoculated with the BMCs in suspension 
in culture medium, and cultivated for up to 4 weeks. The settings for the shaker were 
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either 20 rpm, 40 rpm or 80 rpm at 37°C in 7.5% C02. The medium was changed and 
samples were taken as explained in section 6.2.4 
6.2.4 Sample methods 
Two different methods were used for changing the culture medium, and collecting 
cell samples for further analyses. 
(l) The whole suspension culture including all cells was transferred into a 50 ml 
Falcon tube and centrifuged for 10 minutes at 1200 rpm (900g). Half the 
supernatant (20 ml) was returned to the culture vessel, which was then 
replenished with fresh culture medium to a volume of 40 ml. The rest of the 
supernatant was used to measure the lactate level in the culture medium 
(chapter 3) before being discarded. The cell pellet was resuspended in 6 ml 
fresh culture medium, 2 ml of resuspended cells were taken out for further 
analysis including cell count, CFU-f / differentiation assays or apoptosis 
assay (all mentioned in chapter 3) and the rest of the cells were put back into 
the culture vessel to continue the culture. 
(2) One third of the suspension culture, including the cells, was taken out of the 
culture vessel, and replaced with the same volume of fresh medium as 
described by Baksh et ale (2003). To ensure the cells were well mixed in 
suspension, when the sample was taken, the vessels were shaken shortly just 
before the medium change. After adding the fresh medium, the suspension 
cultures were immediately put back into the incubator. The sample taken was 
transferred into a 50 ml Falcon tube and centrifuged for 10 minutes at 1200 
rpm (900g). The supernatant was used to measure the lactate level in the 
culture medium (chapter 3) before being discarded and the cell pellet was 
resuspended in 2 to 4 ml medium, according to the pellet size. Resuspended 
cells were further diluted if necessary and used for the cell count, the CFU-f 
and differentiation assays or the apoptosis assay as described in chapter 3. 
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6.3 Results and Discussion 
The following results demonstrate the expansion capacity of MSCs in suspension 
cultures. Different protocols were applied to determine the effect of different culture 
media (DMEM and MyeloCult®), of different medium additives (pluronic, gelatine, 
dexamethasone, heparin sulphate, IL-3 and SCF) and of different cultivation 
strategies (initial cell number, culture vessel, agitation method and sampling 
strategy) on the proliferation capacity and differentiation potential of harvested 
MSCs. Each of these effects was tested sequentially in separate experiments, and the 
best working conditions were then further improved. The total cell number of each 
suspension culture was monitored over a period of 28 days by analysing the cell 
samples, which were taken every time the medium was changed, with the methods 
described in section 3.5. To determine the stem cell character of the expanded MSCs, 
CFU-f and differentiation assays were carried out with the cells taken from the 
suspension. The CFU-f assay was used as a quantitative method to obtain the number 
of colony forming cells in the suspension cultures over time. The differentiation 
assays on the other hand were used only in a qualitative way to show the existence of 
MSCs with the ability to differentiate into osteoblasts or adipocytes. The reason for 
not counting these cells, was the lack of sufficient quantities of cells in the samples 
taken from the stirred suspension cultures. Therefore, differentiation assays were 
only conducted with cell samples from suspension cultures, which actually produced 
enough cells. The information obtained from the CFU-f and the differentiation assays 
for this chapter is summarised in Table 6.1 in the conclusion section of this chapter. 
6.3.1 Establishing a protocol (or expansion of Mesenchymal Stem Cells in 
suspension cultures 
Baksh et 01., (2003) developed a method which allowed the expansion of human 
bone marrow derived MSCs in stirred suspension cultures by using spinner flasks 
and MyeloCult® medium containing 10-8 M dexamethasone, 2 nglml interleukin-3 
(IL-3) and 10 nglml stem cell factor (SCF). Applying this method, Baksh et 01. 
(2003) reported a 7 fold increase in CFU-f number over a period of three weeks. 
Hence, the same method was used and later on optimised in this study to expand 
MSCs in stirred suspension cultures. 
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Figures 6.1 and 6.2 show the results obtained from the study using the same culture 
conditions described by Baksh et al., (2003). The total cell number remained 
unchanged after week one (1.02 fold of the initial cell number). From week two 
onwards the cell numbers dropped by 88% and by 96% after two and three weeks, 
respectively (Figure 6.1). The development of the CFU-f number was even more 
dramatic. Numbers dropped to 73%, 28% and 15% of the initial cell density over the 
whole culture period (Figure 6.2). 
In contrast to the increase in CFU-f number described by Baksh et al. (2003), both 
total cell number and CFU-f number decreased dramatically, indicating something 
must have been fundamentally wrong with the method used to expand rat MSCs in 
suspension cultures. The dramatic decline in total cell number after 7 days can be 
explained by the cell death of BM cells which are not supported by this culture 
conditions (e.g. haematopoietic cells) and is not necessarily a fact to worry about. 
However, stress factors, which are caused by parameters such as the culture medium 
or the cultivation method, may be responsible for the sudden cell death of the colony 
forming cells in in vitro cultures. Using stirred suspension cultures, shear stress is 
most likely the dominant stress factor, especially for MSCs, which are known to be 
shear stress sensitive. An easy and fast way to reduce the shear stress caused by the 
stirrer paddles in the spinner flasks is to change the agitation method and the shape of 
the stirrer in the culture vessel. Instead of taking spinner flasks with a built in 
impeller, simple siliconised glass bottles with screw caps and a magnetic stirrer bar 
were used to stir the culture. Also, some suspension cultures were not stirred at all 
but put onto a shaking platform in a special incubator, as it is common in many 
mammalian cell cultures. Furthermore, 0.05% pluronic, which attaches to the cell 
membrane and thereby helping to protect it from shear stress, was added to the 
culture medium. 
126 
1.8 
1.6 
-.1.4 
"C g1.2 
E yeIOC"", boHle, ,",,'"' J 
G MyeloCult. bottle. shaking 
1!1! MYl!! loCult. spinner flask. stirring 
~1.0 
.c 
5°·8 
c: 
=0.6 
CII 
u O.4 
0.2 
0.0 
° 
7 14 
time (days) 21 
Figure 6.1: Development of total cell number over time in suspension cu ltures started 
with 12 x 106 rat BMCs in MyeloCult® medium containing 0.05% pluronic, 10.8 M 
dexamethasone, 2 nglml IL-3 and 10 nglml SCF. Suspension cultures were either 
stirred in glass bottles or in spinner flasks or shaken in a special incubator. Results of 
all conditions are mean +/- S.D. from 3 different suspension cultures. No s ignificant 
difference in cell number (fold) between the three cultures at any time point. 
By changing the cu lture vessels to glass bottles with magnetic stirrer bars, better 
results for total cell number and CFU-f number were achieved compared to the 
spinner flasks. Shaking the MSC suspension cultures did not have a positive effect. 
Figures 6.1 and 6.2 give a comparison of the best results achieved with stirred 
suspension cultures in glass bottles, stirred suspension cultures in spinner flasks and 
suspension cultures shaken in glass bottles. The total cell number for all methods 
stayed about the same in week one (1.4 fold increase in stirred suspension cultures in 
glass bottles, 1.2 fold increase in shaken cultures and 1.02 fold increase in stirred 
cultures in spinner flasks). After that, the numbers decreased continuously and finally 
dropped by 96 - 98% after three weeks (Figure 6.1). A more obvious difference was 
revealed in the development of the CFU-fnumbers. In the stirred cultures using glass 
bottles the CFU-f number increased for the first two weeks up to 1.4 fold and 
finished at 43% of the initial cell density after three weeks, whereas the stirred 
suspension cultures in spinner flasks dropped to 73%, 28% and 15% of the initial cell 
density over the culture period (Figure 6.2). The development of the CFU-f numbers 
in the shaken suspension cultures were about the same as the cultures in the spinner 
flasks. Thus, the stirred suspension cultures in glass bottles achieved the best result, 
significantly better than the cultures in the spinner flasks and the shaken cultures in 
glass bottles (p = 0.049). 
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Figure 6.2: Development of CFU-f number over time in suspension cultures started 
with 12 x 106 rat BMCs in MyeloCult® medium containing 0.05% pluronic, 10-8 M 
dexamethasone, 2 nglml IL-3 and 10 nglml SCF. Suspension cultures were either 
stirred in glass bottles or in spinner flasks or shaken in a Infors shaking incubator. 
Results of all conditions are mean +/- S.D. from 3 different suspension cultures. **p 
< 0.05, stirred cultures in bottles compared with shaken cultures in bottles and stirred 
cultures in flasks 
The colonies in the CFU-f assays formed from MSCs from stirred spinner flask 
cultures appeared to be similar in size to the ones from shaken suspension cultures. 
Both had smaller colonies compared to the colonies from the stirred suspension 
culture in glass bottles (Table 6.1). Larger colonies are an indicator that either 
multiple CFU-f cells formed one colony, or that the single MSCs forming a large 
colony must have had a better proliferation potential than the single MSCs forming a 
small colony. The round and symmetric shape of the colonies indicated that they 
were most likely formed by single cells only, starting at one centre. Therefore, the 
bigger size of a colony is a sign for a higher proliferation rate of the MSCs which in 
turn is a sign for a healthier cell derived from a suspension culture with lower stress 
levels. 
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All three suspension culture systems generated enough cells to run differentiation 
assays. These assays revealed that MSCs with osteogenic differentiation potential 
were present in the above mentioned suspension cultures for the complete culture 
period. Colonies in the osteogenic differentiation assay staining positively for 
alkaline phosphatase, calcium and collagen could be found on all the plates, 
indicating that osteoblasts were formed. 
The combination of using normal glass bottles (coated with sigmacoat) with 
magnetic stirrer bars and adding pluronic to the culture medium seemed to reduce the 
shear stress and resulted in increasing total cell numbers and CFU-f numbers. The 
magnetic paddle in the spinner flask is a lot larger than the magnetic stirrer bar and 
moves more liquid with every tum it spins, therefore causing more shear stress. 
Changing this paddle to a proper cell culture impeller, which is especially designed 
to mix the liquid by causing the least shear stress possible, could give the spinner 
flask an advantage over the glass bottle. However, all further experiments to improve 
the MSC suspension culture system were conducted in coated glass bottles with 
magnetic stirrer bar. 
6.3.2 Shaken Mesenchymal Stem Cells suspension cultures 
Shaking the suspension cultures, and thereby trying to lower the shear stress did not 
increase the number of MSCs in the culture (Figure 6.2). One more study on MSC 
expansion in shaken suspension cultures was carried out in order to optimise this 
agitation method. A better cell survival should be obtained by altering the shaker 
speed from 40 rpm to either 20 rpm or 80 rpm. 
Shaking the suspension cultures with 80 rpm resulted in a 3.2 fold increase in total 
cell number after the first week. Shaker speeds of 20 rpm and 40 rpm achieved only 
1.3 fold and 1.2 fold increases respectively. By the end of the culture period, the total 
cell number decreased at all shaking speeds to 20%, 3% and to 2% of the initial cell 
number for 80 rpm, 20 rpm and 40 rpm (Figure 6.3). 
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Figure 6.3: Development of total cell number over time in shaken suspension 
cultures started with 12 x 106 rat BMCs in MyeloCult® containing 0.05% pluronic, 
10-8 M dexamethasone, 2 nglml IL-3 and 10 nglml SCF. Results of a ll three 
conditions are mean +1- S.D. from 3 different suspension cultures. **p < 0.05 
For the development of the colony fonning cells in the suspension culture no 
significant effect of the shaking speed was observed. At 40 rpm, the CFU -f numbers 
dropped only by 36%, 46% and 81 % over the whole culture period compared to a 
decrease of 56% I 79% after week one, 57% I 75% after week two and 86% I 82% 
after week three for shaking speeds of 20 rpm I 80 rpm (Figure 6.4). However, the 
probability for the differences between these results is p = 0.46 and therefore not 
significant. 
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Figure 6.4: Development of CFU-f number over time in shaken suspension cultures 
started with 12 x 106 rat BMCs in MyeloCult® containing 0.05%pluronic, 10.8 M 
dexamethasone, 2 nglml IL-3 and 10 nglml SCF. Results of all three conditions are 
mean +/- S.D. from 3 different suspension cultures. **p < 0.05 
A higher shaking rate should allow better mixing of the solution and a better supply 
of nutrients to all the cells, which could result in higher cell proliferation. Even 
though a higher shaking speed assured a better mixing of the culture solution, it also 
caused more shear stress to the MSCs, which are very sensitive to this sort of stress. 
Shaking suspension cultures of MSCs at different speeds did not improve the 
proliferation of colony forming behaviour of the cells in shaken suspension cultures. 
Only by stirring MSC suspension cultures in glass bottles with magnetic stirrer bars 
and using culture medium containing 0.05% pluronic, could an actual increase in 
MSCs be achieved and even this increase (1.4 fold) was lower than the increase (7 
fold) reported by Baksh et aI., (2003). To obtain a higher proliferation of MSCs in 
stirred suspension cultures, the culture medium was further modified. 
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6.3.3 Effect of pluronic, gelatine and heparan sulphate on Mesenchymal Stem 
Cells in suspension 
The improvements focused on the medium additives to help protect the MSCs from 
shear stress. In the last stirred suspension culture experiments, pluronic was used to 
attach to the cell membrane and thereby strengthen it but in chapter 4 it has been 
shown that pluronic also had a negative effect on the proliferation behaviour of 
MSCs in static monolayer cultures. By removing pluronic from the culture medium 
the proliferation of MSCs could be increased and a higher MSC number might be 
achieved. On the other hand the MSCs would not be protected against the shear 
stress caused from the stirrer. Therefore, a more natural compound, gelatine, was 
used to replace pluronic. Gelatine is a breakdown product of collagen, which is 
commonly used to coat culture dishes and to improve the cell adhesion to plastic 
surfaces (Stark et aI., 2008). Furthermore, another compound, heparan sulphate, was 
added to the culture medium to enhance the positive effect of IL-3 and SCF by 
mediating these growth factors to the MSCs, but this would further increase the costs 
of the already expensive culture medium. 
The replacement of pluronic with gelatine in the culture medium had a huge effect on 
the total cell number, which increased by 1.9 fold after one week, then decreased to 
80% and finally to 64% of the initial cell number (Figure 6.5). This was a better 
development for the total cell number, compared to the best result in suspension 
cultures with pluronic (p = 0.005) (1.4 fold increase after week one, then decrease to 
7% and to 4% of the initial cell number (Figure 6.7». As expected, the removal of 
pluronic from the medium did not result in a higher total cell number (1.05 fold 
increase then decrease to 15% and to 6% of the initial cell number after one, two and 
three weeks respectively (Figure 6.5). The addition of heparan sulphate to the 
medium also had no positive influence the development of the total cell number, and 
resulted in a decrease of 97% after three weeks in suspension culture (Figure 6.5). 
132 
3.0 
2.5 
~2. 0 
::. 
... 
..8 E1.5 
:l 
c 
B1.0 
0.5 
0.0 
0 
g MyeloCult + pluronic + Dex + gf 
o MyeloCult + Dex + gf, no pluronic 
~ MyeloCult + pluronic + Dex + gf + hs 
o MyeloCult + gelatin + Dex + gf 
** 
** 
7 14 21 
time (days) 
Figure 6.5: Development of total cell number over time in suspension cultures started 
with ] 2 x 106 rat BMCs in MyeloCult® containing 0.05% pluronic, 10-8 M 
dexamethasone,2 nglml IL-3 and ]0 nglml SCF. This culture medium was changed 
either by removing pluronic, by replacing pluronic with 2.5% gelatine or by adding 
232 nglml heparin sulphate. Results of all conditions are mean +/- S.D. from 3 
different suspension cultures. **p < 0.05, cell number in cultures with gelatine 
compared to cultures without gelatine 
None of the changes to the culture medium in this experiment increased the CFU-f 
numbers. Most noticeably the increase in total cell number in the gelatine cultures 
was not caused by an increase in colony forming cells. The CFU-f numbers in these 
cultures decreased over the 3 week period by 66%, 79% and by 89% (Figure 6.6) and 
in the pluronic free cultures by 29%, 67% and by 88% over the same period of time 
(Figure 6.6). The development of the CFU-f number in the heparan sulphate culture 
(decrease by 50%, 73% and by 90% within three weeks) (Figure 6.6) was the most 
surprising since the control without heparan sulphate actually resulted in higher 
numbers of colony forming cells (p = 0.0] 7). It seemed that the addition of heparan 
sulphate to the culture medium decreased the number of colony forming cells. This 
was not expected and needs further investigation to be fully explained. 
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Figure 6.6: Development of CFU-f number over time in suspension cultures started 
with 12 x 106 rat BMCs in MyeloCult® containing 0.05% pluronic, 10·g M 
dexamethasone,2 nglml IL-3 and 10 nglml SCF. This culture medium was changed 
either by removing pluronic, by replacing pluronic with 2.5% gelatine or by adding 
232 nglml heparin sulphate. Results of all conditions are mean +/- S.D. from 3 
different suspension cultures. **p < 0.05, cultures in MyeloCult® with 0.05% 
pluronic, 10' M dexamethasone, 2 nglml IL-3 and 10 nglml SCF compared to the 
other cultures 
The colonies formed by MSCs from gelatine and heparan sulphate cultures were all 
relatively large (Table 6.1). This is surprising since no healthy colony forming cells 
with good proliferation capacity would be expected to be present in suspension 
cultures with decreasing CFU-f numbers. The gelatine could cause the MSCs to stick 
to each other when attaching to the plastic of the plates. Thus several CFU-f cells 
formed one colony, which would appear larger than colonies formed by single cells. 
The same reason could apply to heparan sulphate, even so heparan sulphate, in 
contrast to gelatine, is not known to help MSCs to attach to each other. MSCs 
derived from suspension cultures without pluronic formed small colonies, and after 
three weeks they were barely recognisable. Cells from all three suspension cultures 
formed large colonies in the osteogenic differentiation assay, which could be stained 
positively for alkaline phosphatase, calcium and collagen. The results from the 
osteogenic differentiation assay for all medium conditions were very similar and did 
not reflect the difference in colony shape and size from the CFU-f assay. 
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The removal of pluronic from the culture medium resulted in a faster decreasing 
CFU-f number in the suspension cultures compared to the same medium conditions 
containing pluronic (p = 0.049). Despite the decrease in MSCs number, the 
osteogenic differentiation assay of these cells showed some nice big colonies of 
osteoblasts, indicating that the proliferation capacity is more affected by the 
increased shear stress than the differentiation behaviour. The rather surprising drop 
in colony forming cell number in the heparan sulphate culture and the drop in CFU-f 
number in the gelatine culture could both be explained by the theory that these 
medium additives enhanced the cluster forming ability of MSCs, as indicated by the 
comparable large number of large colonies in the CFU-f assays. If several MSCs 
stick to each other when forming a colony, then the colony count does not represent 
the actual MSC number, which could be a multiple of the colony number, depending 
on how many MSCs formed one colony. Even after trying to optimise the culture 
medium, the total cell number as well as the CFU-fnumber did not increase as much 
as expected. and the differentiation capacity of the MSCs is still limited since no 
adipocytes were obtained from any suspension culture. Furthermore. the culture 
conditions mentioned so far all require the use of the most expensive culture 
medium. MyeloCult® plus growth factors. High costs are of significant disadvantage 
for future scale-up. therefore further improvement focused on reducing the costs for 
MSC suspension cultures. 
6.3.4 MyeloCult® medium versus DMEM 
Studies with MSCs in static monolayer cultures have shown that the use of 
MyeloCult® medium compared to DMEM did not significantly increase the number 
of expanded MSCs (Table 4.4). And since DMEM is a less expensive culture 
medium. suspension culture experiments with bone marrow derived MSCs in 
DMEM were conducted to compare the MSCs proliferation with the results from 
suspension cultures in MyeloCult® medium. Experiments were run in stirred 
suspension cultures started with 12 x 106 BMCs in 40 ml culture medium (either 
MyeloCult® or DMEM) containing 0.05% pluronic. 10-8 M dexamethasone, 2 nglml 
IL-3 and 10 nglml SCF. 
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With both culture media, a similar development in the total cell number was 
achieved. In the DMEM cultures, the total cell number increased by 1.4 fold in the 
first week, but then dropped to 11 % (at the second week) and to 3% (at the third 
week) of the initial cell number (Figure 6.7). In the MyeloCult® cultures, the total 
cell number also increased by 1.4 fold after the first week and dropped to 7% and to 
4% after weeks two and three (Figure 6.7). 
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Figure 6.7: Development of total cell number over time in suspension cultures started 
with 12 x 106 rat BMCs either in DMEM with 0.05% pluronic, 10·g M 
dexamethasone, 2 nglml IL-3 and 10 ng/ml SCF or in MyeloCult® with 0.05% 
pluronic, 10.8 M dexamethasone, IL-3 and SCF. Results of all conditions are mean 
+/- S.D. from 3 different suspension cultures. No significant difference in cell 
number (fold) between the DMEM and the MyeloCult® cultures at any time point. 
The CFU-f number in suspension cultures with DMEM developed differently than in 
the MyeloCult® cultures. In the DMEM cultures the number of colony forming cells 
stayed steady for the first week (1.07 fold increase) and then decreased by 57% after 
two weeks and by 84% after three weeks (Figure 6.8) whereas in the MyeloCult® 
cultures the CFU-f numbers actually increased for up to two weeks. A 1.4 fold 
increase after one week, no change in CFU-f after week two (still a 1.4 fold 
increase), and a decrease to 43% of the initial cell number at the end of the culture 
period (Figure 6.8). 
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Figure 6.8: Development of CFU-f number over time in suspension cultures started 
with 12 x 106 rat BMCs either in OM EM with 0.05% pluronic, 10-8 M 
dexamethasone, 2 ng/ml IL-3 and 10 ng/ml SCF or in MyeloCult® with 0.05% 
pluronic, 10-8 M dexamethasone, IL-3 and SCF. Results of all conditions are mean 
+/- S.D. from 3 different suspension cultures. **p < 0.05, cultures in MyeloCult® 
compared to the DMEM culture 
Although the numbers of colony forming cells in DMEM and MyeloCult® 
suspension cultures were different from each other, the size and the shape of the 
colonies formed on the plates of the CFU-f assays appeared to be similar for both 
conditions. Some large and numerous small colonies were recognisable, indicating 
that the health of the CFU-f cells in both suspension cultures were similar (Table 
6.1). MSC with osteogenic differentiation potential could be found in both DMEM 
and MyeloCult® suspension cultures. However, the number of osteoblasts derived 
from the MyeloCult® suspension culture was obviously higher than from the DMEM 
cultures. 
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Suspension cultures in MyeloCult® medium produced more MSCs with better 
osteogenic differentiation potential than the comparable DMEM cultures. In addition, 
the proliferation capacity and therefore the health of the colony forming cells in 
MyeloCult® cultures also seemed to be improved as indicated by a larger colony size 
in the CUF-f assays. These findings were different to the results from comparable 
experiments with MSCs in monolayer cultures (chapter 4). Nevertheless, Chen et al. 
(2006) also found that MSCs in suspension cultures with DMEM as culture medium 
did not grow but when changing to MyeloCult® medium, a significant increase in 
MSC numbers were achieved. Thus, the usage of the more cost intensive 
MyeloCult® medium in suspension cultures is necessary in order to achieve 
increasing numbers ofMSCs. 
6.3.5 Effect of IL-3 and SCF on Mesenchymal Stem Cells in suspension cultures 
An even more cost reducing change to the culture medium is the deletion of the 
growth factors IL-3 and SCF. Furthermore, dexamethasone was also removed from 
the medium because studies in MSC monolayer cultures have shown no cell number 
increasing effect of either the growth factors or dexamethasone (chapter 4). The 
influence of IL-3, SCF and dexamethasone was tested in DMEM and MyeloCult® 
medium, both supplemented with 0.05% pluronic. 
The total cell number in the MyeloCult® cultures without dexamethasone and 
without cytokines increased by 2.5 fold in the first week, whereas the total cell 
number in the comparable DMEM cultures had already decreased by 70% at this 
stage. After two weeks, the cell number in the MyeloCult® cultures also dropped by 
30%, and at the end of the culture period not more than 10% of the initial total cell 
number was left in the suspension cultures for both media (Figure 6.9). 
The colony forming cells in both sets of suspension cultures without dexamethasone 
and without cytokines decreased from the beginning as shown in Figure 6.10. The 
number of CFU-f in the MyeloCult® cultures found at each medium change were 
50% (at week one), 28% (at week two) and 10 % (at week three) of the initial CFU-f 
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number. In the DMEM culture, the CFU-f numbers were even lower, 26% (at week 
one), 18% (at week two) and 5% (at weeks three) of the initial CFU-fnumber. 
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Figure 6.9: Development of total cell number over time in suspension cultures started 
with 12 x 106 rat BMCs in different culture media (DMEM with 0.05% pluronic, 
DMEM with 0.05% pluronic and 10,8 M dexamethasone, MyeloCult® with 0.05% 
pluronic and MyeloCult® with 0.05% pluronic and 10'8 M dexamethasone). Results 
of all conditions are mean +/- S.D. from 3 different suspension cultures. *p < 0.01 , 
cultures in DMEM with pluronic compared to the DMEM cultures with pluronic and 
dexamethasone, **p < 0.05, cultures in MyeloCult® with pluronic compared to the 
MyeloCuIt® cultures with pluronic and dexamethasone 
In the MyeloCult® cultures with pluronic and dexamethasone only, the total cell 
number increased by 3 fold after one week, whereas in the DMEM cultures with 
pluronic and dexamethasone only, the total cell number decreased by 40% (Figure 
6.9). For the rest of the culture period, the total cell numbers in cultures with pluronic 
and dexamethasone only developed similarly to the cultures without dexamethasone 
and cytokines. For the whole culture period, the CFU-f numbers decreased over time 
for all conditions. The final value for colony forming cells after three weeks in 
suspension culture with pluronic and dexamethasone only was 12% for the DMEM 
cultures and 17% for the MyeloCult® cultures (Figure 6.10). 
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Figure 6.10: Development of CFU-f number over time in suspension cultures started 
with 12 x 106 rat BMCs in different culture media (DMEM with 0.05% pluronic, 
DMEM with 0.05% pluronic and 10-8 M dexamethasone, MyeloCult® with 0,05% 
pluronic and MyeloCult® with 0.05% pluronic and 10-8 M dexamethasone). Results 
of all conditions are mean +/- S.D. from 3 different suspension cultures. No 
significant difference in CFU-f numbers (fold) between cultures containing 
dexamethasone or not for both culture media, DMEM and MyeloCult® 
Colonies formed from MSCs taken from dexamethasone cultures appeared to be 
similar in size and shape to colonies formed by MSCs from the cultures without 
dexamethasone (Table 6.1). A major difference in colony size is noticeable when 
comparing the colonies formed from MSCs in DMEM cultures with the colonies 
formed from MSCs in MyeloCult® cultures. The colonies formed by cells which 
were derived from MyeloCult® cultures had a larger diameter, which is an indicator 
for healthier MSCs in the suspension cultures. Only suspension cultures with 
MyeloCult® medium and with DMEM containing dexamethasone generated enough 
cells to run differentiation assays. These assays revealed that MSCs with osteogenic 
differentiation potential were present in the above mentioned suspension cultures. 
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The most noticeable effect was the deletion of the growth factors from the culture 
medium. Without IL-3 and SCF, CFU-f numbers decreased from the beginning on 
for both DMEM and MyeloCult® medium (compare Figure 6.10 with 6.8). By 
further removing dexamethasone as well from the culture media, the CFU-f numbers 
decreased even more (Figure 6.10). These finding are little surprising, since IL-3 and 
SCF are known to increase the MSC number in suspension cultures (Baksh et al., 
2003). Dexamethasone is supposed to promote osteogenesis in vitro (Chen et al., 
1994), effect the osteoblast proliferation and differentiation and induce the 
expression of osteogenic markers in MSCs (Shur et al., 2001 and Fried et al., 1996). 
It also inhibits plasminogen activator activity and increases the transcription of genes 
coding for anti-inflammatory proteins, including Iipocortin-l, IL-I0, IL-l receptor 
antagonist, neutral endopeptidase, IGF-I (Kozawa et al., 1993), IGFBP-3, 4, 5 and 
(bovine parathyroid hormone) PTH-mediated cAMP (Chen et al., 1991b and Chen 
and Feldman, 1984). Furthermore, it has been reported to decrease the expression of 
prostaglandin endoperoxide synthase-2 and the synthesis of PGE2 in osteoblasts 
(Brum-Fernandes et al., 1994). Dexamethasone interacts and regulates cell function 
via the glucocorticoid receptors (GR) (Sukhu et al., 1997). The GR plays important 
roles in both physiological and pathological conditions involving cell growth and 
differentiation, lipolysis, control of glucose metabolism, immunity. and inflammation 
(Salvatore et al .• 2007). Dexamethasone binds to GR, which resides in the cytosol 
complexed with a variety of proteins including heat shock protein 90, heat shock 
protein 70 and the protein FKBP52, that then dimerize and either regulates the 
transcription rate of target genes by binding to specific DNA sequences named 
glucocorticoid response elements. or by building a complex with transcription factors 
such as nuclear factor-KB (NF-KB) or activator protein-l (AP-l) and prevent them 
from binding their target genes and hence repress the expression of these genes 
(Hayashi et al., 2004). 
In the present study, it also can be seen that for all culture conditions, the 
MyeloCult® medium achieved higher CFU-f numbers, which is in agreement with 
the results from the previous section (6.3.4). 
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6.3.6 Effect of initial cell source on Mesenchymal Stem Cell proliferation 
Instead of reducing the costs of the culture medium, and thereby compromising the 
expansion potential of the MSCs in suspension, the initial cell source of the 
suspension cultures was changed in order to simplify the culture protocol and thus 
save money. So far, the cultures were started with freshly harvested rat BMCs. The 
alternative was using bone marrow derived rat MSCs, which have already been 
expanded in static monolayer cultures for one passage (following the method 
reported in 3.2). By expanding MSCs in static cultures, most of the other cell types 
from the bone marrow were discarded and the MSCs were already purified by the 
time they were used to start the suspension cultures. This could be an advantage if 
the expanded MSCs from the suspension cultures are supposed to be used for 
therapeutic applications which require a pure stem cell population, e.g. for 
transplantation. 
The development of the total cell number in stirred suspension cultures, started with 
different initial cell densities of bone marrow derived rat MSCs from static cultures, 
is displayed in Figure 6.11. The initial cell number was 2 x 106 MSCs (for low cell 
density), 6 x 106 MSCs (for medium cell density) and lOx 106 MSCs (for high cell 
density) per 40 ml suspension culture. Over the complete period of three weeks, the 
total cell number decreased dramatically for all three initial cell densities. After one 
week, at the first medium change, the cell numbers dropped by 90% in the low and 
high cell density cultures and by 96% in the medium density culture. That means not 
more than 2.3 x lOs MSCs were left in the suspension cultures after one week. This 
dramatic decrease after so short a time indicated that something was fundamentally 
wrong with the culture method. At the end of the culture period, 94% of the MSCs in 
the low density culture and 99% in the medium and high density culture died. The 
MSCs used for the CFU-f assay did not form any colonies at any time point of the 
experiment (data not shown). 
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Figure 6.11: Development of total cell number over time in suspension cultures 
started either with 12 x 106, 25 x 106 and 50 x 106 rat BMCs or with 2 x 106 6 x 106 
and lOx 106 purified, bone marrow derived rat MSCs. The culture medi'um was 
DMEM containing 0.05% pluronic. Results for all 6 cultures conditions are mean +/-
S.D, from 3 different suspension cultures. 
Whole BMCs in suspension cultures provide a more natural environment for the 
MSCs present within the bone marrow. This could be a positive influence on the 
viability of the MSCs, since cell clusters consisting of different cell types can be 
fonned, and cytokines could be secreted by cells present in the bone marrow to 
support the proliferation of MSCs in suspension (Miao et al., 2004) (Eipers el at., 
2000). However, a disadvantage of using BMCs is that the cultures consist of many 
cell types including haematopoietic stem cells, reticular cells, fibroblasts, endothelial 
cells, adipocytes and macrophages (see chapter 2, section 2.3), and therefore the 
cultures would need to be purified before being used for future therapeutic 
applications, which require pure stem cell samples. This adds complexity and costs. 
Experiments with 12 x 106 rat BMCs (low cell density culture), 25 x 106 rat BMCs 
(medium cell density culture) and 50 x 106 rat BMCs (high cell density culture) in 
stirred suspension cultures were conducted following the same protocol used for the 
suspension cultures of already in vitro expanded MSCs. As it can be seen in Figure 
6.11 the total cell number also decreased dramatically after only one week (drop of 
83%, 73% and 92% in low, medium and high density culture, respectively). The final 
% values of the initial total cell number after three weeks in suspension culture were 
2% for the low density culture and 1 % for both medium and high density culture. 
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The total cell number in a suspension culture started with whole BMCs is not as 
important as the number of colony forming cells. Since BMCs consist of different 
cell types, a decreasing total cell number does not necessarily mean that the MSC 
number also decreased. Therefore CFU-f assays were conducted to monitor the 
development of the MSC number in suspension. Colony forming cells were found in 
all suspension cultures started with whole BMCs, which was already an 
improvement compared to the suspension cultures started with purified MSCs only. 
However, the CFU-f number also decreased over time (Figure 6.12). For all three 
cell densities the values were similar, after one week in suspension the CFU-f 
numbers dropped by more than 80%, after two week by 90% and after three weeks 
by 99%. The CFU-f assays conducted show only some recognisable colonies mainly 
at the plate from the first week. Thereafter negligible no colonies were formed any 
more. 
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Figure 6.12: Development of CFU-f number over time in suspension cultures started 
with 12 x 106 (low), 25 x 106 (medium) and 50 x 106 (high) rat BMCs in DMEM 
containing 0.05% pluronic. Results for all 3 cultures conditions are mean +/- S.D. 
from 3 different suspension cultures. No significant difference in CFU-f numbers 
(fold) between the cultures started with different initial cell densities 
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The cell number and the CFU-f number of suspension cultures started with both 
BMCs and MSCs decreased dramatically regardless the initial cell density. However, 
the BMCs cultures contained some colony forming cells and thus seemed to provide 
a more supportive environment for the MSCs. For future studies, only BMCs rather 
than MSCs were taken as initial cell source. 
In the literature, 1 x 106 bone marrow mononuclear cells (MNCs) per millilitre is 
mostly used to initiate suspension cultures (Chen et 01., 2006) (Baksh et 01., 2003). 
As this is even less than the lowest concentration in the experiments shown in 
Figures 6.34 and 6.35, and no beneficial effect of high cell number could be 
observed, the lowest cell density of BMCs used for the experiments was taken for all 
studies on MSC expansion in suspension cultures. 
6.3.7 Sampling strategies for Mesenchymal Stem Cell suspension cultures 
A further attempt to improve the yield of MSCs from stirred suspension cultures was 
to change the sampling method. Stirred suspension cultures with 12 x 106 BMCs in 
DMEM containing 0.05% pluronic were used for the following experiments to 
investigate the effect of two different sampling strategies on MSCs. Both methods 
are described in section 6.2.4. Method (1) has the advantage that the number of cells 
taken out as a sample is independent from the number of medium being changed. 
This can be of benefit if a large quantity of the medium has to be replaced but most 
of the cells have to remain in the suspension culture. The disadvantage is that the 
centrifuge step caused additional stress to all cells in culture. The total cell number 
and CFU-f results for this method are mentioned in the previous section (6.3.1). A 
. 
comparison of these results with the results obtained from sampling method (2) can 
be seen in Figures 6.13 and 6.14. 
By replacing 113 of the culture medium including cells with fresh medium (sampling 
method 2) no additional stress was caused to the remaining cells in the culture. It also 
reduced the risk of contamination since less handling was required. This method was 
successfully applied by Baksh et 01. (2003) to take samples of mono nuclei cells 
(MNCs) from stirred suspension cultures. 
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Figure 6.13: Development of total cell number over time in suspension cultures 
started with 12 x 10 rat BMCs. Sampling was performed by either spinning down 
the whole culture (method 1) or by replacing 113 of the medium including cells 
(method 2). Results are mean +1- S.D. from 3 different suspension cultures. *p < 
0.01 , **p < 0.05; cultures harvested with method 1 compared to cultures with 
method 2 
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Figure 6.14: Development of CFU-f number over time in suspension cultures started 
with 12 x 106 rat BMCs. Sampling was performed either spinning down the whole 
culture (method I) or by replacing 113 of the medium including cells (method 2). 
Results are mean +1- S.D. from 3 different suspension cultures. *p < 0.01 , **p < 
0.05; cultures harvested with method 1 compared to cultures with method 2 
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The total cell number in suspension cultures with medium change method (2) 
dropped over time from 100% (at the start of the suspension culture) to 33% (after 
one week), 16% (after two weeks) and finally to 2% (after three weeks) (Figure 
6.13). The number of colony forming cells in the suspension cultures showed the 
same pattern of decrease, 100% of the initial CFU-f number at the beginning, 26% at 
the first medium change, 19% at the second medium change and finally just 5% at 
the end of the culture period (Figure 6.14). The pictures from the CFU-f assay of 
both sampling methods were similar but some of the colonies formed from cells 
harvested with method (2) seemed to be bigger in size. This can be an indicator for 
healthier colony forming cells in the suspension cultures due to reduced stress levels. 
Comparing the two sampling strategies, higher CFU-f numbers at the end of the 
culture period could be achieved with method 2 (p = 0.029) (Figures 6.13 and 6.14). 
Furthermore this strategy has the advantage that it is less time consuming and the 
risk of contamination is reduced due to less handling. Therefore, this method of 
sampling was applied to all suspension cultures. 
6.4. Conclusions 
In this chapter, studies with bone marrow derived rat MSCs in stirred suspension 
cultures were conducted to determine the best working culture condition. The aim 
was to generate large quantities of MSCs with a higher differentiation capacity than 
MSCs expanded in static monolayer cultures. Furthermore, the cost for this culture 
system should be kept as low as possible so that the expanded MSCs could be used 
for medical applications. Different techniques for sample taking and for medium 
changing, different culture vessels and agitation methods, different culture media and 
different medium additives were tested in order to develop a useful protocol, which 
may also be scaled up. 
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Table 6.1: Summarised infonnation from the pictures of the CFU-fand differentiation assays conducted in the experiments mention in this chapter. 
Culture Time Colony Osteogenic Adipogenic 
Medium conditions rdaysl formation differentiation differentiation 
DMEM + pluronic bottle, stirred 7 medium - -
DMEM + pluronic bottle, stirred 14 medium - -
DMEM + pluronic bottle, stirred 21 medium - -
DMEM + pluronic + Dex bottle, stirred 7 medium small -
DMEM + pluronic + Dex bottle, stirred 14 medium small -
DMEM + pluronic + Dex bottle, stirred 21 small small -
DMEM + pluronic + Dex + gfs bottle, stirred 7 medium medium -
DMEM + pluronic + Dex + gfs bottle, stirred 14 medium small -
DMEM + pluronic + Dex + gfs bottle, stirred 21 small small 
-
MyeloCult + pluronic + Dex + gfs bottle, stirred 7 big big -
MyeloCult + pluronic + Dex + gfs bottle, stirred 14 medium big -
MyeloCult + pluronic + Dex + gfs bottle, stirred 21 medium medium 
-
MyeloCult + pluronic bottle, stirred 7 medium 
-
small 
-
i 
MyeloCult + pluronic bottle, stirred 14 big small 
-
MyeloCult + pluronic bottle, stirred 21 big small -
MyeloCult + pluronic + Dex bottle, stirred 7 big medium 
-
MyeloCult + pluronic + Dex bottle, stirred 14 big medium -
MyeloCult + pluronic + Dex bottle, stirred 21 big small 
-
MyeloCult + pluronic + Dex + gfs + 7 big big hs bottle, stirred -
MyeloCult + pluronic + Dex + gfs + bottle, stirred 14 big big - I 
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hs 
MyeloCult + pluronic + Dex + gfs + 21 very big medium hs bottle, stirred -
MyeloCult + Dex + gfs bottle, stirred 7 medim very big - ! 
MyeloCult + Dex + gfs bottle, stirred 14 small medium -
I MyeloCult + Dex + gfs bottle, stirred 21 barely visible medium 
-
MyeloCult + gelatine + Dex + gfs bottle, stirred 7 very big very big -
MyeloCult + gelatine + Dex + gfs bottle, stirred 14 big big 
-
My~loCult +gelatine + Dex + gfs bottle, stirred 21 medium big 
-
MyeloCult bottle, stirred 7 medium + big big 
-
MyeloCult bottle, stirred 14 small medium -
MyeloCult bottle, stirred 21 medium medium 
-
MyeloCult bottle, shaken 7 medium very big 
- I MyeloCult bottle, shaken 14 small + medium big 
-
MyeloCult bottle, shaken 21 small medium 
-
spinner flask, 7 medium big MyeloCult stirred -
spinner flask, 14 medium medium MyeloCult stirred -
spinner flask, 21 small big MyeloCult stirred -
-~'-- ---- ---
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Since MSCs are sensitive to many forms of stimuli, e.g. shear stress, which can 
either. cause cell death or uncontrolled differentiation into any sort of progenitor 
cells, suspension cultures were started with whole bone marrow cells (BMCs) to 
provide an environment similar to the natural niche within the bone marrow. The 
necessity of the support from the BMCs for the survival of the MSCs in suspension 
culture was proven by the experiment in section 6.3.6. In suspension cultures started 
with BMCs, more MSCs with colony forming ability survived than in the suspension 
cultures started with purified MSCs only. 
Another important parameter for the survival of the MSCs was the choice of culture 
medium. All suspension culture experiments conducted in MyeloCult® medium 
achieved higher MSCs numbers than in the cultures with DMEM regardless any 
further medium additives. Moreover, these cells also had better proliferation and 
differentiation behaviour. 
Further medium additives such as dexamethasone, pluronic F-68, interleukin-3 (IL-3) 
and stem cell factor (SCF) were tested but their positive influence on the 
proliferation of MSCs were always additive to the beneficial effect of the 
MyeloCult® medium. Dexamethasone increased the number of MSCs in suspension 
cultures slightly, and also seemed to improve their differentiation capacity as shown 
by the experiments with DMEM cultures in which MSCs with osteogenic 
differentiation potential were found only when dexamethasone was present in the 
culture medium. Even so, this effect was very small, and could not be shown in static 
monolayer cultures, dexamethasone was used as a regular medium additive for 
suspension cultures. 
Adding the growth factors IL-3 and SCF to the culture medium led to an increase in 
MSC number in the suspension cultures. However, this increase was not only 
dependant on the addition of the growth factors but also on how much shear stress 
was affecting the proliferation of the MSCs. 
Pluronic F-68 played an important role in helping the MSCs to cope with the shear 
stress and therefore was part of the culture medium. Culturing MSCs in suspension 
without pluronic resulted in a decreasing MSCs number, regardless of the kind of 
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culture medium or the presence of growth factors, in it. However, experiments in 
monolayer cultures have shown that pluronic slows down the proliferation of MSCs, 
but it seemed that the protective properties were outbalanced by this negative side 
effect in suspension cultures. Replacing pluronic with gelatine, which was supposed 
to protect the cells form shear stress without altering their proliferation, reduced the 
MSCs number in the suspension culture, and caused the cells to aggregate. The 
addition of heparan sulphate had similar effects, and since both compounds gelatine 
and heparan sulphate, did not increase the MSC number or their differentiation 
capacity, none of it was used in further experiments. 
The results from all the experiments with different culture media have shown that a 
combination of MyeloCult® medium supplemented with pluronic, IL-3 and SCF is 
necessary to increase the MSC number in suspension cultures. Dexamethasone 
seemed to be helpful in order to improve the osteogenic differentiation, had no 
negative side effects and was added only in small quantities, so that increase to the 
total costs of the culture medium was negligible. However, in static monolayer 
cultures the beneficial effect of the different culture media was not significant, 
indicating that a more stressful culture system, such as the suspension culture, 
requires a more supportive culture medium. A summary of the different culture 
media and their effect on the MSCs expansion in both static and suspension cultures 
are listed in Table 6.2. 
Table 6.2: Summary of the results for the maximum fold increase in CFU-f achieved 
in static and suspension culture with different culture media. For the suspension 
cultures, all the media types mentioned included 0.05% pluronic. 
Media type Static cultures Suspension Suspension 
cultures cultures 
CFU-f(fold CFU-f(fold Costs (£) I fold 
increase) increase) increase 
DMEM 460 30 0.06 
DMEM+Dex 460 40 0.05 
. MyeloCult® 460 53 0.09 
MyeloCult® + Dex 440 54 0.09 
MyeloCult® + IL- 470 140 0.13 3+SCF 
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The need to reduce the shear stress is as important for the expansion of MSCs in 
, suspension cultures as the choice of the right medium. Using spinner flasks with big 
paddles or shaking the suspension cultures in special shaking incubators increased 
the shear forces rather then reduced it, as indicated by the decreasing MSC numbers. 
Few publications regarding bone marrow derived MSC expansion in stirred 
suspension cultures can be found. Most noticeable is the publication by Baksh et al., 
(2003) who successfully expanded human bone marrow derived MSCs over a period 
of three weeks in 100 ml stirred suspension cultures. But when the experiment was 
repeated using the same spinner flasks, the same sampling method and the exactly 
same medium containing the cytokines IL-3, SCF and dexamethasone, the MSC 
numbers in the cultures actually decreased. The conducted experiments with rat 
BMCs in suspension culture revealed that a simpler culture vessel, a normal 250 ml 
glass bottle (coated with silicon) with screw cap and magnetic stirrer, and the 
additions of a pluronic F-68 were necessary to protect the MSCs from high shear 
stress and assure an increase in cell number. 
The experiments with bone marrow derived rat MSCs in suspension cultures have 
confirmed that it is possible to expand MSCs in this culture system. However, all 
attempts to use the cheapest culture conditions failed. In addition, the expansion rates 
obtained from static cultures were better than in any tested suspension culture (Table 
6.2). Furthermore, no MSCs with adipogenic differentiation capacity could be found 
in either system, implying that the expanded MSCs did not have their full 
differentiation potential. While in the monolayer cultures the stress from the trypsin 
treatment may have reduced the differentiation potential, in the suspension cultures, 
the shear stress could have done exactly the same. Thus both culture systems are not 
suitable for large scale MSCs expansion. 
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Chapter 7 
Mesenchymal Stem Cells in Pour-off 
Cultures 
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7.1 Introduction 
In chapters 4 and 6, experiments were conducted to investigate the expansion of 
mesenchymal stem cells (MSCs) in vitro in static monolayer cultures and in stirred 
suspension cultures respectively. With both culture systems, an increase in MSC 
number with osteogenic differentiation potential was achieved after a culture period 
of two to three weeks, indicating that a MSC population with the capacity to form 
colonies on culture plastic and to differentiate into osteoblasts can be expanded in 
both adherent culture systems, and non-adherent stirred suspension cultures. The 
advantages of the static cultures are the simplicity, whereas the stirred suspension 
cultures offered the advantages of a trypsin-treatment free culture protocol and a 
potential for automation and scale-up. However, both culture methods exerted either 
chemical stress or physical stress on the MSCs, and thus restricted their proliferation 
potential and their full differentiation capacity. This chapter therefore describes a 
hybrid culture method, named "pour-off culture" which is likely to combine the 
advantages of static and suspension cultures to overcome the disadvantages of both. 
In this study, pour-off cultures were applied to obtain MSCs with high proliferation 
potential and full differentiation ability. This technique was first described by Oreffo 
et 01. (1996), who used pour-off cultures to examine the non-adherent bone marrow 
stromal fraction from human bone marrow samples. Baksh et 01. (2007) also used 
these cultures to characterise human suspension-derived MSCs for therapeutic 
strategies requiring systemic infusion, and concluded that the bone marrow contains 
a CD4ge1ow subpopulation of MSCs, which can grow in suspension while 
maintaining a single and round morphology. Zhang et 01. (2009) applied the pour-off 
culture technique to establish the presence of non-adherent bone marrow derived 
mesenchymal stem cells in adult bone marrow., Zhang et 01. (2009) found that the 
adult rat bone marrow harbours pluripotent non-adherent MSCs which can migrate in 
vivo to any organ of the body through the circulation and, in the appropriate 
microenvironment, can adhere, proliferate and differentiate into specialised cells of 
the target tissue, and thus function in tissue regeneration. 
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Pour-off cultures can be seen as static monolayer cultures, which are re-plated 
regularly without using trypsin to lift off the adherent cells. Thus, only the non-
adherent cells are kept in the culture, whereas the adherent cells can be used to 
analyse the colony forming potential of the non-adherent cells at the time point of re-
plating. Pour-off cultures do not have to be stirred, and do not require the use of 
trypsin. Both were the main stress causing factors in the suspension cultures and the 
static monolayer cultures, respectively. However, in order to expand MSCs in pour-
off cultures successfully, the addition of la,25-Dihydroxyvitamin D3 was necessary. 
1 a,25-Dihydroxyvitamin D3 is known to increase the cell proliferation and the 
osteogenesis of the non-adherent marrow cell fraction (Rickard et al., 1995) and 
(Zhang et al., 2009). Furthermore, Catherwood (1985) described that la,25-
Dihydroxyvitamin D3 reduced the cAMP response to subsequent parathyroid 
hormone (PTH) in osteoblast-like cells, decreased adenylate cyclase stimulated by 
PTH and antagonized the positive regulatory effects of cell treatment with 
glucocorticosteroid on these responses to PTH. Many of the effects of la,25-
Oihydroxyvitamin 03 are mediated by its interaction with the vitamin D receptor 
(VOR), also called calcitriol receptor. The unbound inactive form of the calcitriol 
receptor resides in the cytoplasm. When 1 a,25-Dihydroxyvitamin D3 binds to the 
receptor, the ligand-receptor complex translocates to the cell nucleus, where it acts as 
a transcription factor. Downstream targets of this nuclear hormone receptor are 
principally involved in mineral metabolism though the receptor regulates a variety of 
other metabolic pathways, such as those involved in the immune response and 
cancer. Cells of the osteoblastic lineage have been shown to contain intracellular 
1 a,25-Dihydroxyvitamin D3 receptors (Narbaitz et al., 1983). Zhang et al. (2009) 
found that although 1,25-dihydroxyvitamin D3 facilitates the expansion of BM-
MSC, the absence of either 1,25-dihydroxyvitamin D3 or its receptor, vitamin D 
receptor (VDR), does not appear to impede normal tissue and organ growth and 
development in mice with targeted deletion of the 1 a,25-Dihydroxyvitamin D3 
hydroxylase enzyme or VOR, respectively. This suggests multiple mechanisms of 
action for 1,25-dihydroxyvitamin D3. Rickard el al. (1995) hypothesised that 1 a,25-
Dihydroxyvitamin D3 could effect MSCs in two ways: (l) it could render the MSCs 
more responsive to cytokines through an up-regulation of cytokine receptors, or (2) it 
could effect the release of mitogenic cytokines from cell types within the non-
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adherent marrow cell population, which possess receptors for 1 a,25-
Dihydroxyvitamin D3, such as monocytes, macrophages and lymphocytes. 
In this chapter, the influence of different parameters (such as initial cell density, 
culture medium, and pour-off frequency) on the expansion capacity of MSCs and 
their differentiation potential was investigated. The protocol for culturing MSCs in 
pour-off cultures from Zhang et 01. (2009) was changed in order to optimise the 
proliferation rates and to keep the costs as low as possible. The results from these 
studies were then compared to the cell numbers obtained from the suspension 
cultures and static monolayer cultures (chapters 6 and 4). 
7.2 Materials and methods 
In this chapter, the specific methods for growing and expanding bone marrow 
derived rat MSCs in pour-off cultures are described. The protocol for these cultures 
was changed in terms of initial cell number used to start a pour-off culture, the 
culture medium, and the pour-off frequency. The methods for general cell culture are 
given in chapter 3. To start a pour-off culture, bone marrow cells were seeded into a 
culture dish, and after only 24 hours transferred into a new dish (refer to section 7.2.2 
for further details about the pour-off culture method). The adherent cells will attach 
to the culture plastic within the 24 hour period, whilst the non-adherent cells will stay 
in suspension and may be poured-off into the new dish. The old dish, containing the 
adherent cells, will be kept for 12 days as colony forming unit fibroblast culture 
(CFU-f culture) allowing the cells to form colonies which then can be counted. By 
summing up all counted colonies (each of which originated from a single attached 
cell) from each pour-off level, the total number of CFU-f cells can be determined. 
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7.2.1 Different culture media 
The media tested for growing MSCs in pour-off cultures were simple variations of 
the standard Dulbecco's Modified Eagle Medium (OMEM) and MyeloCult® medium 
mentioned in section 3.3. The following variations were used: 
I. Standard DMEM as described in section 3.3, 
2. Standard OMEM with 10-8 M dexamethasone, 
3. Standard DMEM with 10-8 M dexamethasone and with 10-8 M la,25-
Oihydroxyvitamin 03 
4. Standard MyeloCult® medium with 10-8 M dexamethasone, 10-8 M 1 a,25-
Oihydroxyvitamin 03, 2 nglml interleukin-3 (lL-3) and 10 nglml stem cell 
factor (SCF). 
7.2.2 Bone marrow cell pour-off cultures with different initial cell densities 
Pour-off cultures were started in triplicate with freshly harvested rat bone marrow 
cells (BMCs). These were obtained as described in section 3.4. Either 5 ml, 2 ml, I 
ml or 0.5 ml of BMCs were suspended in 20 ml culture medium, seeded into culture 
dishes and incubated at 37°C in an atmosphere with 7.5% C02. The numbers of 
BMCs used equals a concentration of 5 x lOs BMCs/ml, 2 x lOs BMCs/ml, I x lOs 
BMCs/ml or 0.5 x lOs BMCs/ml respectively. After 24 hours, the non-adherent cells, 
suspended in the culture medium, were removed from the culture dishes with a 10 ml 
pipette and re-plated into new culture dishes (Figure 7.1). The adherent cells were 
retained and cultured further either as CFU-f cultures (see section 3.6), or as 
osteogenic / adipogenic differentiation cultures (section 3.7). This process was 
repeated daily for 7 to 10 days. Every 3 - 4 days the culture medium in the pour-off 
cultures was refilled up to 20 ml with fresh medium. The number of colonies formed 
from the adherent cells in the CFU-f cultures were stained and determined as 
described in section 3.6.1. The colonies in the osteogenic and in the adipogenic 
differentiation assay were also stained in order to verify the formation of osteoblasts 
and adipocytes and thus prove the differentiation capacity of the MSCs. Control 
cultures were started with 0.3 ml freshly harvested BMCs suspended in 10 mt culture 
medium (0.6 BMCs/ml) and kept as CFU-f cultures for 14 days (see section 3.6). 
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These controls were to measure the original number of MSCs present within the rat 
BM used to start the pour-off cultures. 
(A) Freshly harvest BMes 
(B) D 24h 
(C) 
(E) !J 24h CFU 
Figure 7.1: The principle of "pour-off cultures". (A) Freshly harvested bone marrow 
cells are transferred into a cell culture dish with medium and incubated for 24 hours. 
(B) Some of the BMCs have attached to the plastic surface of the dish, others stay in 
suspension. (C) The culture medium, containing the non-adherent cells, is transferred 
to a new culture dish. (D) The adherent cells in the old culture dish are further 
incubated as CFU-f culture and (E) the re-plated non-adherent cells will be poured-
off again after 24 hours. 
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7.2.3 Varying pour-off frequencies 
In this chapter, the effect of the pour-off frequency on the proliferation and 
differentiation capacity of the MSCs was determined by replating the cells in the 
pour-off cultures either daily, every 2 days, every 4 days, or every 7 days using 
otherwise the same culture conditions as described in 7.2.2. 
7.3 Results and Discussion 
The following results demonstrate the expansion capacity of MSCs in pour-off 
cultures. The original protocol by Zhang et al. (2009) was changed several times in 
order to determine the effect of different culture media (DMEM and MyeloCult® 
medium), of different medium additives (la,25-Dihydroxyvitamin D3 and 
dexamethasone) and of different cultivation strategies (initial cell number and pour-
off frequency) on the proliferation capacity and the differentiation potential of 
MSCs. The accumulative CFU-f number, which resembles the total cell number, of 
each pour-off culture was obtained over a period of 7 to 12 days by summing the 
counted colonies formed in each culture dish after every re-plating step as described 
in section 7.2.2. The fold increase for the accumulative CFU-f number was 
calculated by comparing accumulative CFU-f number with the numbers of MSCs 
present in the volume of bone marrow used to start the pour-off culture (which was 
determined by the control CFU-f cultures started with 0.3 ml of bone marrow cells). 
L CFU-fs 
Fold increase (accumulative CFU-f) = ---------- 7.1 
initial CFU-f number in BM 
Furthermore, the number of colonies at each passage level was recorded. This helps 
to visualise at what time point the pour-off culture was the most productive. For the 
development of the CFU-f number per dish the fold increase was calculated by 
comparing CFU-f number per dish from every day with the CFU-f number on the 
dish from day 1. 
1.59 
CFU-f per dish 
Fold increase (CFU-fperdish) = 7.2 
CFU-fnumber on dish from day 1 
To determine the stem cell character of the expanded MSCs, differentiation assays 
were started at each pour-off level after the cells were transferred to new dishes. The 
differentiation assay was used in a qualitative way to prove the existence of MSCs 
with the ability to differentiate into osteoblasts or adipocytes. The information 
obtained from the CFU-f -, the differentiation assays and the pour-off culture plates 
is summarised in Table 7.1 in the conclusion section of this chapter. 
7.3.1 The effect of dexamethasone and la,2S-Dihydroxyvitamin D3 on 
Mesenchymal Stem Cells in pour-off cultures 
Dexamethasone and 1 a,25-Dihydroxyvitamin D3 have been shown to increase the 
cell proliferation and the osteogenesis of the non-adherent marrow cell fraction 
(Rickard et 01., 1995) (Akavia et 01., 2006). The protocol used to investigate the 
effect of dexamethasone and la,25-dihydroxyvitamin D3 on MSCs in pour-off 
cultures was the same as that described by Zhang et 01. (2009). They expanded bone 
marrow derived rat MSCs in pour-off cultures by culturing 1 x 107 bone marrow 
cells in a 55cm2 petri dish with DMEM, containing 10% foetal calf serum, 50 ).lg/ml 
ascorbic acid, 10-8 M dexamethasone and 10-8 M la,25-Dihydroxyvitamin D3. The 
non-adherent cells were re-plated every 24 hours. With this technique, Zhang et 01. 
(2009) achieved an increase in MSC number of 2.3 fold after 4 days compared to 
their initial MSC number at day 1 before the first pour-off. 
Figures 7.2 and 7.3 show the results obtained from this study. After one week, 
accumulative CFU-f numbers in any of the pour-off cultures was approximately the 
same as the numbers ofMSCs present in the volume of bone marrow used to start the 
cultures. A 1.2 fold increase was observed in the pour-off cultures with DMEM, 
dexamethasone and la,25-Dihydroxyvitamin 03, and an increase by 1.1 fold in the 
pour-off cultures with OMEM and dexamethasone after one week. In the pour-off 
cultures with standard OMEM, a slight decrease of 2% was recorded for the same 
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period of time (Figure 7.2). However, only the change in the pour-off culture with 
DMEM, dexamethasone and la,25-Dihydroxyvitamin 03 was significant different to 
the numbers of MSCs present in the volume of bone marrow used to start the culture 
(p = 0.011) and different to the increase of the other two cultures from day 6 onwards 
(p = 0.009). 
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Figure 7.2: Development of accumulative CFU-f number over time in pour-off 
cultures started with I x \07 rat BMCs in either standard DMEM, OMEM containing 
10·s M dexamethasone, or OMEM containing 10-8 M dexamethasone and 10-8 M 
I a,25-Dihydroxyvitamin 03. The cultures were re-plated every 24 hours. Results of 
all conditions are mean +/- S.D. from 3 different pour-off cultures. ++p < 0.05, 
compared to the numbers of MSCs present in the volume of bone marrow used to 
start the culture; *p < 0.0 I, **p < 0.05; DMEM, dexamethasone and I a,25-
Dihydroxyvitamin 03 culture compared to the two other cultures 
The highest colony numbers per dish for each pour-off culture was achieved after 5 
days in the pour-off culture with OMEM, dexamethasone and I a,25-
Dihydroxyvitamin 03 (457 colonies = 2.0 fold increase), and after 4 days in the 
cultures with OMEM containing dexamethasone and with standard OMEM (395 
colonies = 1.9 fold increase and 381 colonies = 1.8 fold increase, respectively) 
(Figure 7.3). After these days, the colony number per dish dropped slowly for the 
cultures in DMEM with dexamethasone and la,25-0ihydroxyvitamin 0 3 and in 
DMEM with dexamethasone. The colony number in the culture with standard 
DMEM stayed about the same after day 4 for the rest of the culture period. 
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Figure 7.3: Development of CFU-f number per dish in pour-off cu ltures started with 
I x 107 rat BMCs in either standard DMEM, DMEM containing 10-8 M 
dexamethasone, or DMEM containing 10-8 M dexamethasone and 10-8 M I (1,25-
Dihydroxyvitamin D3. The cultures were re-plated every 24 hours. Results of all 
conditions are mean +/- S.D. from 3 different pour-off cultures. *p < 0.0 I, **p < 
0.05; the three different pour-off cultures compared to each other 
By comparing the result from this study with the resu lt from Zhang el af. (2009), it 
can be seen that a similar maximum increase in colony number per dish was 
obtained. Zhang et af. (2009) achieved an increase of2.3 fold +/- 0.2, whereas in this 
study the increase was 2.0 fold +/- 0.1. To determine the stem ce ll character of these 
cells, differentiation assays were conducted and the colonies formed in the pour-off 
cultures were analysed. The majority of the colonies formed by the adherent cells in 
these pour-off cultures appeared to be similar in shape and size for the whole culture 
period. This indicates that the cells forming the colonies kept the same proliferation 
behaviour, which in turn is an indication of constant culture conditions with low 
stress levels for the cells. 
In order to determine the differentiation capacity of the adherent cells on the culture 
dishes, they were incubated in osteogenic conditions for 14 days, or in adipogenic 
conditions for 21 days. The adherent cells from the pour-off cultures in standard 
DMEM and in DMEM with ) 0-8 M dexamethasone did not form any adipocytes or 
osteoblasts. Consequently, these cells were already too mature and did not have any 
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differentiation potential left. The colonies fonned on the dishes from the pour-off 
culture in DMEM with 10-8 M dexamethasone and 10-8 M 1 a,25-Dihydroxyvitamin 
D3 stained positive for alkaline phosphatase, calcium and collagen. Thus, these cells 
had at least the potential to differentiate into osteoblasts under the right culture 
conditions. 
Finally, the best working culture medium for pour-off cultures was detennined by 
comparing the differentiation and proliferation results from the cultures with DMEM 
and dexamethasone and with DMEM, dexamethasone and la,25-Dihydroxyvitamin 
D3 to cultures in standard DMEM. The addition of 10-8 M dexamethasone to the 
DMEM had no positive effect on the proliferation or differentiation potential of the 
colony fonning cells. This finding was also true for MSCs in static monolayer 
cultures (chapter 4) and in stirred suspension cultures (chapter 6). Dexamethasone is 
a very controversial medium additive. Depending on the concentration used, it has 
been reported that it can either induce adipogenesis and reduce cell proliferation and 
osteogenesis in bone marrow derived MSCs (Yin et al., 2006) or it can have the 
exact opposite effect, increase cell proliferation and osteogenesis and decrease 
adipogenesis (Akavia et al., 2006) and (Hong et al., 2009). However, the combined 
use of 10-8 M dexamethasone and 10-8 M la,25-Dihydroxyvitamin D3 in DMEM 
seemed to improve the differentiation capacity since cells derived only from this 
medium condition differentiated into osteoblasts (Figure 7.7). It has been shown 
before that dexamethasone and 1 a,25-Dihydroxyvitamin D3 can have a combined 
effect on cells. Chen et al. (1991) found that only in combined treatments of 10-7 
Dexamethasone and 10-8 M of la,25-Dihydroxyvitamin D3, primary cultures of rat 
osteoblast-like cells released insulin-like growth factor-I into the medium. 
Although DMEM containing dexamethasone and la,25-Dihydroxyvitamin D3 was 
found to be the best culture medium for pour-off cultures with regard to the 
differentiation potential of the cultured MSCs, the highest fold increase in 
accumulated CFU-fnumber from this study {1.2 fold} cannot compare to an increase 
of 4.6 fold for MSCs in static monolayer cultures (chapter 4, Figure 4.5). A 
hypothesis to improve the expansion rate of MSCs in pour-off cultures is to reduce 
the quantity of initial bone marrow cells. This will allow the cells to have more space 
and nutrients to proliferate, and thus will increase the efficiency of this culture 
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system. Furthermore, the adherent cells will also have more space to form bigger 
colonies on the dishes. ' 
7.3.2 Different initial cell densities 
In order to try to improve the efficiency of the pour-off cultures and the proliferation 
of colony forming cells, different initial cell densities were used to start the cultures. 
In section 7.3.1, the pour-off cultures were started with 5 ml bone marrow cell 
suspension containing lOx 106 BMCs and achieved a maximum increase in 
accumulated CFU-f number of only 1.2 fold. In this experiment lower initial cell 
densities of 4 x 106 BMCs, 2 x 106 BMCs and 1 x 106 BMCs (2 ml, 1 rol and 0.5 ml 
bone marrow cell solution respectively) were used. 
The development of the accumulative CFU-fnumber is displayed in Figure 7.4. For 
the first 7 days, pour-off cultures with lower initial cell densities had a better fold 
increase of CFU-f numbers. After 8 days, however, the pour-off culture started with 
2 x 106 BMCs resulted in the highest increase of accumulated CFU-f (3.8 fold). The 
pour-off culture started with 1 x 106 BMCs achieved a 3.3 fold increase of 
accumulated CFU-f and only a 1.9 fold increase was observed in the pour-off culture 
with 4 x 106 BMCs. 
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Figure 7.4: Development of accumulative CFU-f number over time in pour-off 
cultures started with 10 x 106, 4 X 106,2 X 106 and I x 106 rat BMCs in DMEM 
containing 10-8 M dexamethasone and 10-8 M I a ,25-Dihydroxyvitamin 0 3. The 
cultures were re-plated every 24 hours. Results of all conditions are mean +/- S.D. 
from 3 different pour-off cultures. +p < 0.01, ++p < 0.05, compared to the numbers 
of MSCs present in the volume of bone marrow used to start the culture; *p < 0.01 , 
**p < 0.05; each culture compared to the rest of the other three cultures 
The development of the CFU-f number per dish is displayed in Figure 7.5. In the 
pour-off culture with the highest initial cell density of lOx 106 BMCs, there were 
225 colonies on the dish of day 1 and this number increased continuously for 4 days 
up to 457 colonies per dish (2.0 fold increase) before it decreased to 273 colonies at 
day 7 (Figure 7.5). The numbers and development in the culture with 4 x 106 BMCs 
were similar, 266 colonies at the first day, 446 colonies at day 5 (1.7 fold increase) 
and 336 colonies on the dish from day 7 (Figure 7.5). A lower initial cell number of2 
x 106 BMCs and of 1 x 106 BMCs resulted in fewer colonies on the dishes (58 and 
126 colonies on the first dish, respectively). These numbers increased to 222 colonies 
at day 4 and further to 288 colonies (5.0 fold increase) at day 7 for the pour-off 
culture with 2 x 106 BMCs. In the culture with I x 106 BMCs, the number of colonies 
shortly increased to 171 colonies (104 fold) at day 2 and then continuously decreased 
to 28 colonies at day 7 (Figure 7.5). 
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Fi~ure 7.5: Development of CFU-f number per dish in pour-off cultures started lOx 
10 , 4 x 106, 2 x 106 and I x 106 rat BMCs in DMEM containing 10-8 M 
dexamethasone and 10-8 M la,25-Dihydroxyvitamin 03. The cultures were re-plated 
every 24 hours. Results of all conditions are mean +/- S.D. from 3 different pour-off 
cultures. *p < 0.0 I, **p < 0.05; each culture compared to the rest of the other three 
cultures 
Both the increase in accumulative CFU-f number (3.8 fold) and in CFU-f number per 
dish (5.0 fold) was higher in the pour-off cultures with a lower initial cell density of 
2 x 106 BMCs compared to the cultures started with lOx 106 BMCs (1.2 fold 
increase in accumulative CFU-f (p = 0.01) and 2.0 fo ld increase in CFU-f number 
per dish (p = 0.005». With this improved culture method, the result for the CFU-f 
number per dish was higher than the reported increase from Zhang et al. (2009) of 
2.3 fold +/- 0.2. In addition, the increase in accumulative CFU-f number (3.8 fold) 
was in the same range than the expansion rates in the monolayer culture mentioned 
in chapter 4 (4.6 fold increase). 
To further investigate the effect of the initial cell density on the colony size and 
shape pictures of the stained dishes from the pour-off cultures were taken and 
analysed. fn the pour-off cultures with the highest cell density (lOx 106 BMCs), the 
colonies were quite small for the whole culture period and with increasing colony 
number, more small colonies seemed to appear. On day I, the colonies in the pour-
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off culture started with 4 x 106 BMCs were bigger in size than the colonies in the 10 
x 106 BMC pour-off culture but more small colonies appeared as well, with 
increasing colony number. This observation also applied to the development of the 
colony number and size in the pour-off cultures started with 2 x 106 BMCs and with 
I x 106 BMCs. A confluent layer of adherent cells, which made accurate counting of 
the colony number very difficult, was found at day 5 in the culture with 4 x 106 
BMCs and at day 7 in the culture with 2 x 106 BMCs. This was due to a huge number 
of colonies on the dishes, which merged together as they were growing. In the pour-
off culture with the lowest ce]] density (l x 106 BMCs), the colonies were larger in 
size than in any of the other pour-off cultures and big colonies could be found on the 
dishes for up to 5 days. This proved that the decreasing colony size over time in the 
other pour-off cultures was caused by too many colonies on the dish, where they did 
not have enough space and hindered each other growth. 
Osteogenic and adipogenic differentiation assays were conducted to determine the 
stem cell character of the MSCs. All colonies formed on the pour-off culture dishes 
stained for alkaline phosphatase, calcium and collagen after being incubated in 
osteogenic medium. Thus, MSCs with osteogenic differentiation potential were 
present throughout the whole culture period. The colonies from the pour-off cultures 
started with 4 x 106 BMCs and with 2 x 106 BMCs were so numerous that they 
formed a monolayer of cells, which stained very well for alkaline phosphatase and 
calcium but seemed to produce very little co]]agen. The colonies in the pour-off 
culture started with 1 x 106 BMCs did not merge to a monolayer but stayed as single 
colonies, which stained very well for all three osteogenic markers. Although it was 
proven that MSCs could differentiate into osteoblasts after one week in culture, no 
adipocytes were found in the adipogenic differentiation assays, indicating that the 
MSCs did not have their full differentiation potential under these culture conditions. 
The results obtained from this experiment demonstrated no effect of the initial cell 
density on the differentiation potential of MSCs in pour-off cultures, but showed that 
a low starting cell density of 2 x 106 BMC per culture resulted in an increased cell 
proliferation. In general, fewer cells need fewer nutrients and have more space to 
expand in a given volume. Furthermore, the volume of culture medium changed with 
the pour-off cultures was small (only 15% every 3 - 4 days) which means that only 
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few new nutrients were added to the culture and thus a low initial cell density was of 
advantage in order to achieve a high increase in cell number. In addition, a higher 
cell density in the culture, and consequently an increased cell-cell interaction, could 
also have reduced the proliferation potential of the MSCs. 
Starting the pour-off cultures with not enough cells (1 x 106 BMCs) caused a 
slowdown of the increase in CFU-fnumbers towards the end of the culture period. A 
possible explanation for this slowdown can be the fact that, with every re-plating, 
cells will be removed from the cultures and by removing more cells than being 
reproduced, the culture will run out of cells at some point. Hence, it was important to 
find the right initial cell density for the culture conditions used with the pour-off 
technique. 
7.3.3 MyeloCult® medium with interleukin-3 and stem cell factor 
Experiments with MSCs in stirred suspension cultures (chapter 6) have shown that 
the use of MyeloCult® medium containing the cytokines interleukin-3 (lL-3) and 
stem cell factor (SCF) increased the cell proliferation and led to higher cell numbers. 
However, in static monolayer cultures (chapter 4), the increase of MSCs number was 
not improved significantly when DMEM was replaced by MyeloCult® medium 
containing IL-3 and SCF. To assess whether MyeloCult® medium with 2 ng/ml IL-3 
and 10 nglml SCF will have an effect on the expansion potential of MSCs in pour-ofT 
cultures, this culture medium was tested in pour-off cultures with two different cell 
densities, 4 x 106 BMCs per culture and 1 x 106 BMCs per culture. By the time this 
experiment was started, the results from the experiments investigating the effect of 
the initial cell density were not available. Thus the lower cell density was chosen to 
offer the cells more space and nutrients for expansion, in case the new medium 
conditions would actually improve the cell proliferation. The higher cell density was 
used to be able to obtain results even though the new culture conditions would not 
improve the cell growth. 
By replacing DMEM with MyeloCult® medium containing cytokines, an increase in 
accumulated CFU-f number was achieved (Figure 7.6). This effect was less obvious 
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in the pour-off culture with the higher cell density of 4 x 106 BMCs (1.9 fold increase 
after 8 days in the DMEM culture versus 2.6 fold increase in the MyeloCult® 
culture). In the low cell density pour-off cultures with I x 106 BMCs, the effect was 
more noticeable (3.3 fold increase of accumulated CFU-f after 8 days in the DMEM 
culture versus 8.6 fold increase in the MyeloCult® culture). 
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Figure 7.6: Development of accumulative CFU-f number over time in pour-off 
cultures started with 4 x 106 and I x 106 rat BMCs either in OM EM containing 10-8 
M dexamethasone and 10-8 M 1 a,25-Dihydroxyvitamin 03 or in MyeloCult® 
medium containing 10-8 M dexamethasone and 10-8 M I a,25-Dihydroxyvitamin 0 3, 
2 nglml IL-3 and 10 nglml SCF. The cultures were re-plated every 24 hours. Results 
of all conditions are mean +/- S.D. from 3 different pour-off cultures. +p < 0.01, ++p 
< 0.05, compared to the numbers of MSCs present in the volume of bone marrow 
used to start the culture; *p < 0.01, **p < 0.05; DMEM and MyeloCult® cultures 
with the same initial cell density compared to each other 
The colony numbers per dish also achieved a higher increase in the pour-off cultures 
with MyeloCult® medium compared to the cultures with DMEM (Figure 7.7). Pour-
off cultures in MyeloCult® medium which were started with 4 x 106 BMCs had 245 
colonies on the dish of day 1 and reached a maximum of700 colonies per dish at day 
5. This equals an increase of 2.9 fold whereas the pour-off cultures in DMEM started 
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with the same cell density achieved an increase of only 1.7 fold (267 colonies at day 
I and 446 colonies at day 5). The highest increase in colonies per dish (4.8 fold) was 
achieved with MyeloCult® pour-off cultures having an initial cell number of I x 106 
BMCs (76 colonies at day I and 366 colonies at day 6). The maximum fold increase 
in colonies per dish in DMEM pour-off cultures of the same initial cell density was 
lower, only 1.4 fold (Figure 7.7). It is also worth noticing that the quantity of 
colonies formed at day 1 was always higher in the DMEM pour-off cultures than in 
the MyeloCult® cultures (267 colonies compared to 245 colonies in the high cell 
density cultures and 126 colonies compared to 76 colonies in the low cell density 
cultures). However, over time, the colony number per dish increased faster in the 
MyeloCult® pour-off cultures, indicating that this culture medium supported the 
proliferation of the non-adherent cells better, which is supported by chapter 6. 
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Figure 7.7: Development of CFU-f number per dish in pour-off cultures started with 
4 x 106 and 1 x 106 rat BMCs either in DMEM containing 10-8 M dexamethasone 
and 10-8 M la,25-Dihydroxyvitamin D3 or in MyeloCult® medium containing 10-8 
M dexamethasone and 10-8 M la,25-Dihydroxyvitamin D3, 2 nglml IL-3 and 10 
nglml SCF. The cultures were re-plated every 24 hours. Results of all conditions are 
mean +/- S.D. from 3 different pour-off cultures. *p < 0.0 I, **p < 0.05; DMEM and 
MyeloCult® cultures with the same initial cell density compared to each other 
The positive influence of MyeloCult® medium on the proliferation ofMCSs in pour-
off cultures is recognisable on the number of colonies formed on each cu lture dish. 
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The dishes of the MyeloCuIt® pour-off cultures contained noticeably more colonies 
than the dishes of the DMEM pour-off cultures with the same initial cell density. The 
colony forming cells in the high density MyeloCult® pour-off cultures attaching to 
the plastic surface of the dishes were so numerous that the growing colonies were 
merging into one monolayer of cells rather than forming individual colonies. 
Counting single colonies on these plates was very difficult and the values obtained 
from the image analysis software 'Gene Tools' (Syngene, Cambs.) were not very 
accurate. For that reason the effect of the MyeloCult® medium containing growth 
factors on the MSCs expansion was also determined in low cell density pour-off 
cultures, started with 1 x 106 BMCs. The quantity of colony forming cells in these 
cultures allowed the formation of individual colonies, which could be counted 
accurately. Furthermore, the colony size in these cultures could be observed. For up 
to 5 days, the colony size stayed unchanged but with dropping CFU-f number per 
dish, the colony size, too, declined, indicating a decreasing proliferation potential of 
the MSCs. 
The differentiation capacity of MSCs expanded in MyeloCu1t® pour-off cultures was 
determined by culturing the adherent cells in osteogenic and adipogenic 
differentiation assays. MSCs from all pour-off cultures in MyeloCult® medium were 
able to differentiate into both osteoblasts and adipocytes. All colonies could be 
stained for all three osteogenic markers, alkaline phosphatase, calcium and collagen. 
However, the cultures with low cell density seemed to produce more collagen, 
noticeable by a better staining of the individual colonies Figure 7.8 illustrate the Oil-
Red-O stained adipocytes formed by MSCs, which were re-plated in pour-off 
cultures for 5 days. During the adipogenic differentiation assay, the adherent MSCs 
formed a monolayer on the dish (visible in the background of the pictures in Figure 
7.8) and only a few cells differentiated into adipocytes. 
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(A) 
(8) 
Figure 7.8: Oil Red 0 stained adipocytes originated from MSCs, which were 
eXFanded in MyeloCult® pour-off cultures started with (A) 4 x 106 BMCs or (B) 1 x 
10 BMCs. 
In this study, a positive effect of MyeloCult® medium containing IL-3 and SCF on 
the cell proliferation and therefore also on the colony formation of the MSCs in pour-
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off cultures has been shown. The pour-off cultures in MyeloCult® medium started 
with 1 x 106 BMCs achieved the best increase in accumulated CFU-f for all pour-off 
cultures conducted so far (8.6 fold increase). This is reflected in a high maximum 
increase of colonies per dish of 4.8 fold in these pour-off cultures. In all MyeloCult® 
pour-off cultures fewer colonies were present on the dishes of day 1 compared to the 
control pour-off cultures in DMEM, but the number of colonies increased fast and at 
day 3, more colonies could be found on the dishes of MyeloCult® pour-off cultures 
than on the dishes of DMEM pour-off cultures. This indicates that the MyeloCult® 
medium supported the proliferation of the non-adherent cells in suspension rather 
than just increased the adherence of these cells to the plastic surface and the colony 
formation. After an increase in non-adherent cell number, more and more of these 
cells attached to the surface and formed colonies, hence the delayed increase in CFU-
f on the dishes of the MyeloCult® pour-off cultures. This influence of MyeloCult® 
medium on the proliferation of MSCs in suspension could also explain why 
MyeloCult® medium had a positive effect on the proliferation of MSCs in stirred 
suspension cultures (chapter 6), but not on the proliferation of MSCs in static 
monolayer cultures (chapter 4). 
The values for the fold increase of MSCs achieved in the low cell density 
MyeloCult® pour-off cultures were higher than in both, static monolayer cultures or 
stirred suspension cultures. This is even more impressive, considering that this result 
was accomplished in only one week instead of two weeks (static monolayer culture) 
or three weeks (suspension culture). Furthermore, only MSCs expanded in pour-off 
cultures had the capacity to differentiate into adipocytes. A lower stress level could 
be the reason for this increased differentiation potential. Pour-off cultures exert 
neither chemical stress by using trypsin nor physical stress by using a stirrer system 
on the MSCs in culture. The main disadvantages of the pour-off cultures are the work 
intensity and the limited cell culture area of the dishes. Thus, the actual quantity of 
MSCs harvested from these cultures was lower than the cell number obtained from 
static monolayer cultures in T-flasks. In order to improve the pour-off culture 
technique both issues have to be addressed. 
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7.3.4 Pour-off frequency 
One way to reduce the work intensity of the pour-off cultures, and thereby make this 
culture system more attractive, is to reduce the re-plating frequency. Experiments to 
determine the effect of a reduced pour-off frequency on the proliferation of MSCs 
were conducted in MyeloCult® pour-off cultures with 1 x 106 BMCs. Instead of re-
plating the non-adherent cells every 24 hours, they were transferred into new culture 
dishes every 2, 4 or 7 days. 
Figure 7.9 shows the fold increase of the accumulated CFU-fnumber after each time 
the cultures were poured-off. The value "0" for number of pour-off at the x-axes of 
the graph displays the results from the first dish before the cells were re-plated into a 
new culture dish. Depending on the pour-off frequency, this value was obtained at 
day 2, 4 or 7 after starting the pour-off cultures. The best increase in accumulated 
CFU-f number was achieved by the pour-off cultures being re-plated daily. After 5 
pour-offs (6 days), the accumulated CFU-f number increased by 5.7 fold compared 
to an increase of either 5.2 fold (p = 0.778) in the 4 days pour-off cultures after 4 
pour-offs (20 days), 3.7 fold (p = 0.001) in the 7 days pour-off cultures after 2 pour-
offs (21 days) or 2.1 fold (p = 0.000) in the 2 days pour-off culture after 3 pour-offs 
(8 days). 
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Figure 7.9: Development of accumulative CFU-f number at each time the cells in the 
pour-off cultures were re-plated. Cultures were started with I x 106 rat BMCs in 
MyeloCult® medium containing 10.8 M dexamethasone and 10-8 M I a,25-
Dihydroxyvitamin 03, 2 nglml IL-3 and 10 nglml SCF. The cultures were re-plated 
either every 24 hours, every 2 days, every 4 days or every 7 days. Results of all 
conditions are mean +/- S.D. from 3 different pour-off cultures. +p < 0.0 I, ++p < 
0.05, compared to the numbers of MSCs present in the volume of bone marrow used 
to start the culture; *p < 0.0 I, **p < 0.05; any culture compared to the pour-off 
culture being re-plated daily 
The number of colonies per dish after each re-plating is presented in Figure 7.10. 
Before the first pour-off, 76 colonies were formed in the daily pour-off culture, 206 
colonies in the 2 days pour-off culture, 240 colonies in the 4 days pour-off culture 
and 273 colonies in the 7 days pour-off culture. Due to the different pour-off 
frequencies, these results were obtained at different time points after the cultures 
were started. That means, the number of colonies on the first dish would be taken 
after ] day for the daily pour-off cultures, after 2 days for the 2 days pour-off 
cultures and so on. Therefore, it is not surprising that on the first dish of the cultures 
which were re-plated less often, more colonies were present than on the dish of the 
cultures which were poured-off more frequently. The colony forming cells in the 
pour-off cultures with low re-plating frequency had more time to adhere to the 
surface and form colonies. 
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An initial increase in colony number per dish for at least 1 pour-off followed by a 
later decrease in colony number is common for all pour-off strategies (Figure 7.10). 
For the daily pour-off culture this decrease appeared after 9 pour-offs (results in 
Appendix 0). This indicates that the proliferation potential of the non-adherent 
colony forming cells was slowing down over time. The maximum increase in 
colonies per dish observed in this study was achieved by the 2 days pour-off culture 
after 2 pour-offs (6 days) with an increase from 206 colonies to 713 colonies, that 
equals a 3.5 fold increase(Figure 7.10). 
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Figure 7.10: Development of the CFU-f number per dish at each time the cells in the 
pour-off cultures were re-plated. Cultures were started with I x 106 rat BMCs in 
MyeloCult® medium containing 10.8 M dexamethasone and 10-8 M I a,25-
Oihydroxyvitamin 03, 2 nglml IL-3 and 10 nglml SCF. The cultures were re-plated 
either every 24 hours, every 2 days, every 4 days or every 7 days. Results of all 
conditions are mean +/- S.D. from 3 different pour-off cultures. *p < 0.0 I, **p < 
0.05; the four different cultures compared to each other 
By keeping the BMCs in the same culture dish for more than 24 hours, more of the 
adherent cells attached to the plastic surface and formed colonies. This resulted in a 
confluent monolayer of cells in the dishes of the 2 days pour-off culture after 4 days 
and in the 4 days pour-off culture after 8 days. Counting the colonies on a confluent 
dish using the image analysis software 'Gene Tools ' can result in inaccurate values. 
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It is likely, that the accurate number of colonies on the confluent dishes was higher 
than actually determined and that the expansion potential of these pour-off cultures 
may be higher. In order to determine the full proliferation capacity of cells in these 
pour-off cultures, bigger culture dishes and an even lower initial cell density have to 
be used. 
After the number of colony forming cells dropped in all pour-off cultures, single 
colonies could be detected in the 4 days pour-off culture after 16 days. The dishes of 
the 2 days pour-off culture were covered with a monolayer of cells till the end of the 
culture period. In the 7 days pour-off culture, single colonies could be detected 
throughout the whole culture period, although for the first two weeks several 
colonies merged together. 
Adherent cells from the 2 days, the 4 days and the 7 days pour-off cultures were used 
to run osteogenic and adipogenic differentiation cultures. MSCs from all three pour-
off cultures formed colonies, which could be stained positive for alkaline 
phosphatase, calcium and collagen and thus consisted of osteoblasts. Adipogenic 
differentiation was only observed for MSCs from the 7 days pour-off culture after 2 
weeks in culture (Figure 7.11). 
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Figure 7.11: Oil Red 0 stained adipocytes originated from MSCs, which were 
expanded in MyeloCult® pour-off cultures started I x 106 BMCs and being re-plated 
every 7 days. 
By comparing the proliferation and differentiation results from this study, the effect 
of different pour-off frequencies on the expansion capacity of MSCs in pour-off 
cultures was determined. Increasing accumulated CFU-f numbers were achieved 
with a ll pour-off cultures tested in this study. The best expansion was obtained with 
the daily pour-off culture (8.6 fold increase versus 5.2 fold with the 4 days pour-off 
culture). It is note worthy that non-adherent cells with colony forming potential were 
present in all cultures for the first two pour-offs. Regardless of the time these cells 
spent in the same plastic culture dishes (either I day only or up to 14 days), they 
were still able to form colonies and differentiate into osteoblasts and adipocytes after 
being transferred into new culture dishes. The high increase in levels of accumulated 
CFU-f in all pour-off cultures and the increasing colony number per dish after the 
first pour-offs indicate that the non-adherent MSCs proliferate in suspension. 
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These findings suggest that there may be a population of cells with colony forming 
capacity as well as osteogenic and adipogenic differentiation potential present in the 
non-adherent cell fraction of the bone marrow. These cells have the possibility to 
adhere to a plastic surface and form colonies or stay in suspension in order to 
proliferate and adhere at a later time point. Baksh et al. (2007) also found, with the 
same culture system, that the bone marrow must contain MSCs which can be found 
in the non-adherent cell fraction and which are able to proliferate in suspension while 
maintaining a single and round morphology. Yet, Baksh et al., (2007) did not 
observe any colony formation of the adherent cells in pour-off cultures when the 
suspension cell fraction was removed after 24 hours. Therefore they concluded that 
the remaining adherent cells either require the present of further non-adherent cell 
types to initiate their cell cycle or that the adherent cells are a mature cell type which 
is not able to proliferate and fonn colonies. However, in the present studies it was 
shown that the adherent cells grew into colonies although the non-adherent cells 
were removed every 24 hours in all daily pour-off cultures. Consequently, it seems 
that the adherent MSCs had their full osteogenic and adipogenic differentiation 
potential, and did not need the presence of further non-adherent cells to form 
colonies and differentiate into osteoblasts or adipocytes. 
In order to improve the efficiency of the pour-off cultures and establish them as a 
standard culture system for MSCs expansion, the work intensity has to be reduced 
and the actual number of MSCs obtained has to be increased. This could be achieved 
by enlarging the culture volume and the surface area and by automating the re-
plating process. The fact that the non-adherent cells in the pour-off cultures did not 
have to be transferred into new dishes every 24 hours to prevent the complete 
adherence of all MSCs to the plastic surface will help to automate this culture 
technique. 
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7.4 Conclusions 
In this chapter, experiments with bone marrow derived rat MSCs in pour-off cultures 
were conducted to determine the possibility of using this culture system for the in 
vitro expansion of MSCs. The aim was to achieve a large increase in MSCs number 
with high differentiation capacity over a short period of time. Furthermore, this 
culture technique should also prove that MSCs can proliferate in suspension as non-
adherent cells. Different culture media and pour-off frequencies were tested in order 
to develop a useful protocol, which allows a possible automation of the whole 
process. 
All experiments conducted with bone marrow cells in pour-off cultures resulted in an 
increasing accumulated CFU-f number over the whole culture period and in an 
increasing colony number per dish for a maximum of up to 7 days. Moreover, it has 
been shown that the non-adherent MSCs fraction is proliferating in suspension, able 
to adhere to the culture plastic, and has the potential to form colonies and to 
differentiate into osteoblasts and adipocytes. 
In order to obtain an increasing CFU-f number, the addition of 10-8 M 1a,25-
Dihydroxyvitamin D3 and 10-8 M dexamethasone to the culture medium is required. 
The addition of dexamethasone alone did not have a significant effect on the 
proliferation ofMSCs. 
The type of culture medium was an important factor when expanding MSCs in vitro. 
Pour-off cultures in DMEM generate a maximum increase in CFU-f of 3.8 fold 
whereas the pour-off cultures in MyeloCult® medium with 2 nglml IL-3 and 10 
nglml SCF achieved an 8.6 fold increase in CFU-funder the same culture conditions. 
The MyeloCult® medium seemed to support the proliferation of the non-adherent 
cell fraction in suspension rather than their adherence to the plastic surface. This 
conclusion is based on the observation that the colony numbers on the culture dishes 
from day 1 were lower in the MyeloCult® cultures compared to the DMEM cultures. 
Over time the colony number per dish in the pour-off cultures with MyeloCult® 
medium increased faster and resulted in higher values. 
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Table 7.1: S o d infc 
------------ - ~ -
from the CFU-f -0 diffi 
- 7 
Of d 
.... 
ffolat .~ dueted in th ' .... -- ts in this ch - -
Time Colony Osteogenic Adipogenic 
Medium Culture conditions rdaysl formation differentiation differentiation 
daily, 10 x lOt) 3 medium DMEM BMes - -
daily, lOx 106 5 medium DMEM BMes - -
daily, 10 x 106 7 medium DMEM BMes - -
daily, 10 x lOb 1 medium DMEM+ Dex BMes - -
daily, 10 x 106 3 medium DMEM+Dex BMes - -
daily, lOx 106 5 medium DMEM+Dex BMes - -
daily, 10 x 106 7 medium DMEM+ Dex BMes - -
daily, 10 x 10° 1 medium big DMEM + Dex + VitD BMes -
daily, 10 x 106 3 small big DMEM + Dex + VitD BMes -
daily, 10 x 106 5 medium DMEM + Dex + VitO BMes medium -
daily, 10 x 106 7 medium DMEM + Dex + VitD BMes medium -
DMEM + Dex + VitO 
daily, 4 x lOb 1 big small BMes -
DMEM + Dex + VitD 
daily, 4 x 106 3 medium small BMes -
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daily, 4 x 106 5 confluent confluent DMEM + Dex + VitO BMCs -
daily, 4 x 106 7 small confluent DMEM + Dex + VitO BMCs -
daily, 2 x lOb 1 medium DMEM + Dex + VitD BMCs small -
daily, 2 x 106 3 medium DMEM + Dex + VitD BMCs small -
daily, 2 x 106 5 medium confluent DMEM + Dex + VitD BMCs -
daily, 2 x 106 7 small confluent DMEM + Dex + VitD BMCs -
daily, 1 x lOb 1 big DMEM + Dex + VitD BMCs medium -
daily, 1 x 106 3 medium DMEM + Dex + VitD BMCs medium -
daily, 1 x 106 5 big DMEM + Dex + VitO BMCs big -
daily, 1 x 106 7 medium big DMEM + Dex + VitD BMCs -
MyeloCult +Dex + VitD + daily, 4 x lOb 1 gfs BMCs big medium yes 
MyeloCult +Dex + VitD + daily, 4 x 106 medium-
gfs BMCs 3 confluent medium yes 
MyeloCult +Dex + VitO + daily, 4 x 106 
gfs BMCs 5 confluent medium yes 
MyeloCult +Dex + VitD + daily, 4 x 106 
gfs BMCs 7 confluent medium yes 
MyeloCult +Dex + VitO + daily, 1 x 106 1 big big ~es 
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gfs BMCs 
MyeloCult +Oex + VitO + daily, 1 x 106 3 big big yes gfs BMCs 
MyeloCult +Oex + VitO + daily, 1 x 106 5 medium medium yes gfs BMCs 
MyeloCult +Oex + VitD + daily, 1 x 106 7 medium - small medium yes gfs BMCs 
MyeloCult +Dex + VitO + 2 days, 1 x 10° 2 big medium 
-gfs BMCs 
MyeloCult +Dex + VitO + 2 days, 1 x 106 4 confluent big 
-gfs BMCs 
MyeloCult +Oex + VitO + 2 days, 1 x 106 6 confluent big 
-gfs BMCs 
MyeloCult +Oex + VitO + 2 days, 1 x 106 8 confluent big 
-gfs BMCs 
MyeloCult +Dex + VitD + 4 days, 1 x 106 4 very big confluent 
-gfs BMCs 
MyeloCult +Oex + VitO + 4 days, 1 x 106 8 confluent confluent 
-gfs BMCs 
MyeloCult +Oex + VitO + 4 days, 1 x 106 12 small confluent 
-gfs BMCs' 
MyeloCult +Oex + VitO + 4 days, 1 x 106 16 medium-big confluent 
-gfs BMCs 
MyeloCult +Oex + VitO + 7 days, 1 x 106 7 big - confluent big -gfs BMCs 
MyeloCult +Oex + VitO + 7 days, 1 x 106 14 medium medium yes gfs BMCs 
MyeloCult +Oex + VitO + 7 days, 1 x 106 21 medium medium yes gfs BMCs 
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The cell density appeared to have an influence on the proliferation of MSCs in pour-
off cultures. A lower initial cell density led to a higher increase of CFU-f and 
therefore improved the efficiency of the cultures, whereas a high initial cell density 
seemed to reduce the proliferation capacity of the non-adherent cells. Furthermore, a 
smaller number of cells attached to the surface in the low density pour-off cultures, 
allowing the formation of large colonies without merging into a monolayer of cells. 
In order to reduce the inconvenience caused by re-plating the cell every 24 hours, the 
pour-off frequency was changed. Non-adherent cells were transferred into new 
culture dishes either every 2 days, 4 days or 7 days. This resulted in a lower fold 
increase of CFU-fs but it could be shown, that, even after 7 days in the same culture 
dish, some bone marrow derived cells stayed in suspension and were able to form 
colonies after being re-plated. This is reflected in the colony numbers per dish, which 
were increasing in all pour-off cultures for at least two pour-offs. 
MSCs expanded in pour-off cultures differentiated into osteoblasts and adipocytes, 
indicating that they had both osteogenic and adipogenic differentiation capacity. 
MSCs cultured in static monolayer cultures and in stirred suspension cultures had 
only osteogenic differentiation potential and did not form adipocytes. Cells in pour-
off cultures do not have to be agitated to assure a sufficient supply with nutrients, 
and they do not have to be treated with trypsin to transfer them into the new cultures 
dishes, thus less chemical and physical stress is exerted on the MSCs, allowing them 
to keep a better differentiation and proliferation potential. Table 7.2 compares the 
best results for MSCs expansion in static monolayer cultures, stirred suspension 
cultures and pour-off cultures. 
Pour-off cultures are very work-, consumable- and time- intensive and require plenty 
of incubator space. All these disadvantages increase the costs and need to be 
improved upon before pour-off cultures can be used as an alternative culture system 
to expand MSCs in a large scale. A cost comparison is given in Table 7.3, however, 
these numbers are only based on medium consumption and do not take into account 
the time and other consumables used. The fact that the non-adherent MSCs can stay 
and proliferate in suspension for up to 7 days, although being exposed to tissue 
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culture plastic, suggests that systems like perfusion cultures or roller bottles may to 
be a possible candidate for automating pour-off cultures. 
Table 7.2: Summary of the results for the maximum fold increase in CFU-f achieved 
in static cultures, suspension cultures and pour-off cultures with different culture 
media. For the suspension cultures, all the media types mentioned include 0.05% 
pluronic, whereas the medium of all pour-off cultures included dexamethasone and 
1 a,25-Dihydroxyvitamin D3. 
Media type Static cultures Suspension cultures Pour-off 
cultures 
CFU-f(fold CFU-f(fold CFU-f(fold 
increase) increase) increase) 
DMEM 460 30 
-
DMEM+Dex 460 40 380 
MyeloCult® 460 53 -
MyeloCult® + Dex 440 54 
-
MyeloCu1t® + IL-3 470 140 860 
+SCF 
Table 7.3: Comparison of the costs for the achieved fold increase in CFU-f in static 
cultures, suspension cultures and pour-off cultures with different culture media. For 
the suspension cultures, all the media types mentioned include 0.05% pluronic, 
whereas the medium of all pour-off cultures included dexamethasone and la,25-
Dihydroxyvitamin D3. 
Media type Static cultures Suspension cultures Pour-off 
cultures 
Costs (£) I fold Costs (£) I fold Costs (£) I fold 
increase increase increase 
DMEM 1.3 0.06 -
DMEM+Dex 1.3 0.05 0.02 
MyeloCult® 3.0 0.09 -
MyeloCult® + Dex 3.2 0.09 -
MyeloCult® + IL-3 3.3 0.13 0.01 
+SCF 
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Chapter 8 
Conclusions and Future Work 
186 
In this thesis, culture techniques have been developed to help amplify rat bone 
marrow derived mesenchymal stem cells (MSCs) using various culture systems. Two 
different suspension based systems, stirred suspension cultures and pour-off cultures, 
have been employed to achieve a large scale expansion and different culture 
conditions were tested for each of the systems in order to optimise the proliferation 
and differentiation capacity of MSCs. The results obtained from bone marrow MSC 
expansion in static monolayer cultures were used as a control, against which the 
findings from the suspension cultures and the pour-off cultures were compared. The 
static culture system was chosen as a control because it is the traditional and most 
commonly used method to amplify MSCs in vitro. In this chapter, the results from 
each study are summarised and the findings from the comparison of these are 
presented. Finally a discussion on future directions in suspension cultures of bone 
marrow derived MSCs is given. 
8.1 Culture systems 
The culture systems applied in this thesis to amplify MSC numbers were static 
monolayer cultures (Chapter 4), stirred suspension cultures (Chapter 6) and pour-off 
cultures (Chapter 7). 
8.1.1 Static monolayer cultures 
The results from the static monolayer cultures in chapter 4 were taken as a control 
against which the findings from the suspension and the pour-off cultures were 
compared. Furthermore, the static monolayer cultures were used to study how 
changes of the culture medium would affect the proliferation and differentiation 
potential of MSCs in a well defined culture system. The effect of pluronic F -68 on 
the membrane of MSCs, for example, was investigated by Fourier Transform 
Infrared Spectrometry (FTIR), and by measuring the electrophoretic mobility I net 
surface charge of MSCs with the zetaPALS from Brookhaven. 
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Regarding the cell proliferation and the colony forming capacity, the best results in 
static monolayer cultures were achieved in MyeloCult® medium supplemented with 
interleukin-3 (IL-3) and stem cell factor (SCF). The final increase in cell number was 
5.3 x lOs fold after 29 days, and the highest increase in colony numbers (CFU-f) was 
4.7 fold after 14 days. The huge discrepancy between increase in total cell number 
and in CFU-f could be observed in all static monolayer cultures, regardless of the 
medium conditions. This might be an indication that a MSCs monolayer culture 
comprising of different progenitor cell types, which have different proliferation and 
differentiation capacities and that the tested culture conditions could have supported 
the expansion of early osteogenic precursor cells with limited differentiation and 
colony forming capacity (Sekiya et 01., 2002). This theory is supported by the fact, 
that all MSCs taken from any static culture at any time point only differentiated into 
osteoblasts, and did not form adipocytes when cultured in the appropriate 
differentiation assays. 
In addition to these studies, the effect of pluronic F-68 on the MSC membrane was 
determined using FTIR, and net surface charge measurements. However, with these 
techniques no pluronic induced difference in the cell membrane could be detected. 
Furthermore, the implications of serial subculturing on the proteome of bone marrow 
derived rat MSCs was investigated (chapter 5). During the culture period of 29 days, 
a small decrease in the proliferation speed and a more obvious decline in the colony 
forming potential and in the colony size was observed. The proteome of MSCs from 
passage 2 was compared to that of MSCs from passage 4 using an isobaric tag 
methology for relative and absolute quantitation (iTRAQ). A total of 105 
differentially regulated proteins were identified, of which 33 proteins could be 
related to each other in different regulator networks as calculated by the MetaCore TM 
software. 18 of these 33 proteins were described in MSCs for the first time. Most 
interestingly, the proteins related with cell proliferation such as tumour protein, 
translationally-controlled 1 (TPTI), prothymosin alpha (PTMA) and dyne in light 
chain 1 (D LC I) were down-regulated, whereas proteins identified as regulation 
factors between proliferation and differentiation such as proteins Y box protein I 
(YB I), heterogenous nuclear ribonucleoprotein Al (hnRP AI) and cysteine and 
glycine rich protein2 (CRP2) were up-regulated. These observations suggested that 
serial subculturing may stimulate the differentiation of MSCs into early progenitor 
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cells, and thus reduce their proliferation and colony forming capacity. This theory 
thereby further supports the earlier mentioned idea, that the tested culture conditions 
could have supported the expansion of early osteogenic precursor cells with limited 
differentiation and colony forming capacity. This idea was based on the observed 
discrepancy between increase in total cell number and decrease in colony number. 
8.1.2 Stirred suspension cultures 
Since it was shown that the static culture system had only a limited productivity for a 
given surface area, and seemed to interfere with the proliferation and differentiation 
capacity, as indicated by the results from chapter 4 and 5, stirred suspension cultures 
were used to achieve a large scale expansion ofMSCs (chapter 6). The main problem 
to overcome in suspension cultures was to reduce the shear forces caused by 
agitating the culture. The agitation was necessary for the equal distribution of 
nutrients throughout the culture medium. Furthermore, it helped to keep the MSCs in 
suspension by stopping them from sinking to the bottom of the culture vessel. 
However, MSCs are known to be sensitive to physical stimuli including shear stress, 
which can stimulate uncontrolled differentiation or even damage the cells. In order to 
improve the survival of undifferentiated MSCs, the protocol for running suspension 
cultures was changed several times, i.e. using different agitation mechanisms and 
different culture vessels as well as optimising the culture medium. 
The best results for proliferation and colony formation were observed in 40 ml 
suspension cultures with MyeloCult® medium, containing pluronic F -68, 
dexamethasone, IL-3 and SCF, which were stirred by a magnetic bar in a 250ml 
glass bottle. Applying this culture method a maximum increase in MSCs / CFU-f of 
1.4 fold after 7 days was obtained. After 3 weeks in stirred suspension, both the total 
cell number and the CFU-f number decreased dramatically. Hence, the stirred 
suspension culture is not a useful tool for long-term large scale expansion of MSCs, 
although the suspension based proliferation of these cells could be proven. Taking 
into account that the slight increase in cell number was only achieved after adding 
expensive growth factors to the culture medium, this makes this culture system even 
less useful for the large scale production of MSCs for medical applications. 
Furthermore, the surviving MSCs did not have their full differentiation potential. As 
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with the static monolayer cultures, the harvested MSCs from the stirred suspension 
cultures only differentiated into osteoblasts, but did not form any adipocytes when 
cultured in differentiation assays. The lack of the full differentiation potential can be 
an indication that the stirred suspension cultures, too, cause the MSCs to differentiate 
into early progenitor cells. The most likely factor responsible for that would be the 
shear stress caused by the agitation. 
8.1.3 Pour-off cultures 
The pour-off cultures described in chapter 7 were a combination between static 
cultures and suspension cultures. They offer some of the cells the possibility to 
adhere to a surface whilst others stay in suspension. However, only the non-adherent 
cells were re-plated and therefore kept in culture. Thus, any increase in MSC number 
I CFU-fmust derive from the non-adherent fraction. For that reason, the results from 
the pour-off cultures can also be seen as evidence for suspension based proliferation 
of MSCs. In order to establish the best working protocol for this culture system, the 
culture medium, the initial cell density and the pour-off frequency was optimised. 
An increase in CFU-f I MSCs was observed in all pour-off cultures. The highest 
increase of 8.6 fold after only 8 days was achieved in low density pour-off cultures 
with 1 x 106 rat bone marrow cells per dish, which were re-plated every 24 hours. 
The culture medium was MyeloCult® containing la,25-dihydroxyvitamin D3, 
dexamethasone, IL-3 and SCF. Besides obtaining a high increase in cell number, the 
MSCs harvested from pour-off cultures were also able to form both, osteoblasts and 
adipocytes, an indication that this culture system exerts low levels of physical or 
chemical stress, and therefore does not trigger uncontrolled differentiation. The down 
side of pour-off cultures is the enormous amount of time and work which is required 
to keep them running. A much needed automation might be possible but would 
require further adaptations to the protocol. 
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8.1.4 Comparison ofthe different culture systems 
As mentioned earlier, static monolayer cultures were used as a control in order to 
compare the findings from the suspension cultures and the pour-off cultures to the 
results from the standard method for expanding MSCs in vitro. The highest MSC 
numbers obtained from the static monolayer cultures were about 460% of the initial 
cells. The differentiation capacity of these cells was restricted, so they only fonned 
osteoblasts. In stirred suspension cultures, the increase in MSC number varied for the 
different culture media. The best result was achieved in MyeloCult® medium with 
Pluronic F-68, IL-3 and SCF, however, reaching only 140% of the initial cell density, 
this result was significantly worse than in the control monolayer cultures. Taking into 
account that the differentiation capacity of MSCs derived from stirred suspension 
cultures was as good as the differentiation capacity of the control cells in the static 
cultures, the stirred suspension cultures failed to provide a culture system for large 
scale expansion of bone marrow derived MSCs. The pour-off cultures supported an 
increase in MSC number, which resulted in 860% of the initial cell number. In 
addition, MSCs expanded in this culture system were able to differentiate into 
ostoblasts and adipocytes. Thus, pour-off cultures worked significantly better than 
the control and better than the stirred suspension cultures and so far are the most 
promising culture system for large scale expansion of MSCs with high differentiation 
potential. A summary of all the proliferation related results described can be found in 
chapter 7, Table 7.2. 
8.2 Culture conditions 
Throughout the thesis, the culture conditions for static cultures, stirred suspension 
cultures and pour-off cultures were changed in order to achieve the best possible 
increase in cell number. These optimisations mainly focused on the culture medium 
but, depending on the culture system, also involved changing in the agitation method 
or the initial cell number. Two different basic culture media were used, Dulbecco's 
Modified Eagle Medium (DMEM) and MyeloCult® medium (for medium definition 
see Chapter 3). To both media types various medium additives were added, i.e. 
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dexamethasone. Pluronic F-68 and a combination of the growth factors IL-3 and 
SCF. 
8.2.1 DMEM vs. MyeloCult® medium 
DMEM is commonly used for growing MSCs in static culture systems. It is cheaper 
than the MyeloCult® medium. which was first mentioned in connection with MSCs 
by Baksh et al. (2003). In static monolayer cultures. the choice of culture medium 
had no influence on the proliferation and differentiation capacity of MSCs (chapter 
4). whereas in stirred suspension cultures the usage of MyeloCult® medium resulted 
in slightly higher MSC numbers (chapter 6). 
8.2.2 Dexamethasone 
Dexamethasone is mostly related with enhanced differentiation potential rather than 
improved proliferation. Nonetheless. Baksh et al. (2003) used dexamethasone in their 
suspension culture studies and reported a successful expansion of bone marrow 
derived MSCs. The beneficial effect of dexamethasone on the proliferation could not 
be proven in static cultures (chapter 4) or in suspension cultures (chapter 6) but in the 
pour-off cultures. a mixture of dexamethasone with I a,25-dihydroxyvitamin D3 was 
essential for the cell growth (chapter 7). All MSCs from cultures containing 
dexamethasone. however. showed improved osteogenic differentiation potential. 
8.2.3 Interleukin-3 and Stem Cell Factor 
Baksh et al. (2003) found that both cytokines. IL-3 and SCF. were necessary for the 
expansion of MSCs in stirred suspension cultures. This was confirmed by the 
suspension culture and pour-off culture studies conducted in this thesis. When a mix 
of IL-3 and SCF was added to the culture medium of these cultures. a significant 
increase in MSC number was observed (chapter 6 and 7). In contrast. no positive 
effect was noticeable in static monolayer cultures (chapter 4). The downside to an 
IL-3 and SCF mediated increase in proliferation are the extra costs caused by these 
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cytokines. Large scale up would require vast quantities of growth factors, which 
increases the production costs of MSCs and thus makes them less attractive for 
medical applications. 
8.2.4 Pluronic F-68 
Pluronic F-68 is known to bind to the cell membrane, and thereby strengthen it 
(Zhang, Z. et al., 1992). Hence, pluronic can be used in agitated culture systems to 
protect sensitive cells from shear stress. In static monolayer cultures, it could be 
shown, that the addition of pluronic to the culture medium slowed down the 
proliferation of MSCs. However, no evidence of altered functional groups in the 
cells' membrane were seen using FITR and zetaPALS analysis (chapter 4). In 
suspension cultures, pluronic F-68 was necessary to achieve increasing cell numbers 
(chapter 6). The different effects of pluronic F-68 on the proliferation potential of 
MSCs in static and suspension cultures indicated that the protective benefits of 
pluronic outbalanced the negative side effects only in the more stressful culture 
conditions. 
8.2.5 Further culture parameters 
Further culture parameters that have been studied in this thesis and that can influence 
the proliferation and differentiation capacity of MSCs in vitro are the initial cell 
density, the culture vessel and the medium change frequency. It was found, that in 
suspension cultures, the best working cell density was 3 x 10s bone marrow cells per 
ml, whereas in pour-off cultures the optimal cell density was 0.5 x 10s bone marrow 
cells per ml. In general it can be said that the culture conditions have to be optimised 
for each culture system accordingly, aiming to provide the most supportive 
environment, which should be most similar to the in vivo niche of the cells. 
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8.3 Future work 
It has been shown that MSCs are able to proliferate in suspension. Nevertheless, 
, stirred suspension bioreactors are not a suitable culture system for large scale 
expansion of MSCs due to the shear forces caused by agitating the medium. It seems 
that in such an environment, the addition of growth factors is required to amplify the 
cells. Future studies on MSC expansion in suspension cultures have to be conducted 
with a focus on automation and scale-up. These studies should aim to develop a 
culture system with low physical and chemical stress levels for the cells, 
guaranteeing MSCs with high proliferation and differentiation capacities. Ideally, the 
cells should be able to support each other by secreting cytokines, superseding the 
necessity of adding any additional growth factors. This could reduce the production 
costs for MSCs. 
In this thesis, pour-off cultures were presented as a culture system, which allowed a 
suspension-based expansion of bone marrow derived MSCs with a high 
differentiation potential. However, this culture system lacked automation and 
therefore was very work intensive. Furthermore, experiments with pour-off cultures 
were conducted in small 20 ml cultures. In order to get large quantities of MSCs for 
medical applications, future studies would need to find a way to scale-up and 
automate pour-off cultures. One possibility of how an automated pour-off culture 
could look like would be a perfusion system, consisting of a culture vessel filled with 
medium in which the bone marrow cells are seeded. During the expansion period, the 
medium would be continuously, but very slowly, replaced with fresh medium, so no 
shear forces are exerted on the cells. This culture system would allow some cells to 
stay in suspension while others could adhere to the vessel surface and support cell 
proliferation by secreting cytokines. A scale-up of such a culture system would easily 
be possible. The main focus when developing this culture system should be on 
optimising the flow rate and the culture medium, which should be free of additional 
growth factors. 
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Appendix A 
Complete list of all identified proteins from the proteomic analysis of mesenchymal stem cells described in chapter 5. 
Accession 
, 
Protein identity %Cov 
no. I 
gill 57786926 actin related protein 2/3 complex, subunit 3 [Rattus norvegicus] 14.044943 
gil6981326 S 1 00 calcium-binding protein A4 [Rattus norvegicus] 55.445546 
gil54036318 Protein S100-All (SIOO calcium-binding protein All) (Calgizzarin) 37.755102 
gil77404363 nucleosome assembly protein I-like 1 [Rattus norvegicus] 12.276215 
gill 09509465 PREDICTED: similar to pyrophosphatase [Rattus norvegicus] 20.049505 
gil81884568 Macrophage-capping protein (Actin regulatory protein CAP-G) 15.472779 
gil62666588 PREDICTED: similar to RNA binding motif protein 3 [Rattus norvegicus] 31.410256 
gil6831527 N(G}.N(G)-dimethylarginine dimethylaminohydrolase 1 25.964913 
gi154400716 proteasome 26S non-ATPase subunit 12 [Rattus norvegicus] 14.254385 
gil81889864 Tubulin alpha-4A chain (Tubulin alpha-4 chain) (Alpha-tubulin 4) 70.089287 
gil149018217 rCG25732. isoform CRA d [Rattus norvegicus] 15.486726 
gil56388799 Ckb protein [Rattus norvegicus] 39.460784 
gil57127 unnamed protein product [Rattus norvegicus] 63.636363 
gil70912366 ARP3 actin-related protein 3 homolog [Rattus norvegicus] 16.267942 
gill09502513 PREDICTED: similar to Nuclear transport factor 2 (NTF -2) 21.897811 
gil 149040541 eukaryotic translation initiation factor 3. subunit 10 (theta) 24.815361 
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gil8393610 karyopherin (importin) beta 1 [Rattus norvegicus] 23.085715 
gil56605666 proteasome (prosome, macropain) 26S subunit, non-ATPase, 3 13.773584 
gi176677911 similar to RIKEN cDNA 281 0409H07 [Rattus norvegicus] 13.636364 
gil76779404 Tubulin, beta 2b [Rattus norvegicus] 47.865167 
gil77417616 Ubiquitin-conjugating enzyme E2 N (Ubiquitin-protein ligase N) 29.605263 
gil47605935 Transforming protein RhoA precursor 48.186529 
gil54607147 ras-related C3 botulinum toxin substrate 1 30.208334 
gil396431 rab GDI alpha [Rattus norvegicus] 44.071588 
gil3914232 Transmembrane emp24 domain-containing protein 2 precursor 30.348259 
gil37805239 Enolase 2, gamma [Rattus norvegicus] 28.1106 
gi155977470 Tubulin alpha-1A chain (Tubulin alpha-l chain) (Alpha-tubulin 1) 74.057651 
gil8515734 trax [Rattus norvegicus] 9.6551724 
gil8394009 peptidylprolyl isomerase A [Rattus norvegicus] 82.317072 
gil157822753 phosphoglucomutase 2 [Rattus norvegicus] 7.5313807 
gil46485440 glucose phosphate isomerase [Rattus norvegicus] 39.605734 
gi174355722 Capping protein (actin filament) muscle Z-line, alpha 2 15.384616 
gil399660 aldehyde reductase [Rattus norvegicus] 36.307693 
gill 09495090 PREDICTED: similar to High mobility group protein 1 (HMG-l) 40.927419 
gil157822919 alpha glucosidase 2 alpha neutral subunit [Rattus norvegicus] 20.953576 
gil157819651 chaperonin subunit 7 (eta) [Rattus norvegicus] 21.691176 
gil7242160 nucleophosmin 1 [Rattus norvegicus] 35.958904 
gil149018891 rCG25923, isoform CRA a [Rattus norvegicus] 49.736148 
gil49065780 26S protease regulatory subunit 4 (Proteasome 26S subunit ATPase 1) 28.863636 
gil59709467 CAP, adenylate cyclase-associated protein 1 [Rattus norvegicus] 31.223628 
gil33086552 Ab2-076 [Rattus norvegicus] 14.330219 
---- -
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! gil55562869 Tumor protein, translationally-controlled 1 [Rattus norvegicus] 31.395349 
gil81910041 WD repeat-containing protein 1 32.178217 
gil81890517 Heat shock protein 105 kDa (Heat shock 110 kDa protein) 8.5081585 
gil81885333 Seryl-tRNA synthetase, cytoplasmic (Seryl-tRNA(SerISec) synthetase) 8.203125 
gil81884348 Cytosol aminopeptidase (Leucine aminopeptidase) (LAP) 21.387284 
gil8392971 branched chain aminotransferase I, cytosolic [Rattus norvegicus] 23.600973 
gil407164 heat shock protein 70 [Rattus norvegicus] 58.50234 
gil48675845 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferasellMP 20.777027 
gil81886881 Heat shock 70 kDa protein 4 (Ischemia responsive 94 kDa protein) 18.452381 
gill09512218 PREDICTED: similar to SH3 domain-binding glutamic acid-rich-like protein 22.162162 
gil 149034971 rCG42612. isoform eRA b [Rattus norvegicus] 21.501014 ! 
gil40254781 GDP dissociation inhibitor 2 [Rattus norvegicus] 53.932583 
gil6978505 annexin A5 [Rattus norvegicus] 60.50157 
gil28933457 glutathione S-transferase, mu 2 [Rattus norvegicus] 24.770643 
gil 149039602 rCG57402, isoform eRA a [Rattus norvegicus] 43.333334 . 
gi191771192 Asparagine synthetase (Glutamine-dependent asparagine synthetase) 21.033868 
gil81910365 Acidic leucine-rich nuclear phosphoprotein 32 family member E 24.031007 
gil 14549433 calcium binding protein NEF A [Rattus norvegicus] 17.857143 
gil 149024253 chloride intracellular channel 4, isoform CRA b [Rattus norvegicus] 56.126481 i 
gi171051777 Heat shock protein 8 [Rattus norvegicus] 68.421054 
gil37654308 LRRGT00046 [Rattus norvegicus] 14.166667 
gil6978501 annexin A 1 [Rattus norvegicus] 70.520234 
gil 149029682 rCG42490, isoform eRA f [Rattus norvegicus] 79.470199 
gil 149049470 rCG29914, isoform eRA b [Rattus norvegicus] 50 
gi132527715 Ac2-048 [Rattus norvegicus] 19.933555 
233 
gil 149033381 rCG52521, isofonn CRA a [Rattus norvegicus] 43.40176 J 
gil56605938 thioredoxin domain containing 4 (endoplasmic reticulum) 30.295566 ! 
gil81885359 Lactoylglutathione lyase (Methyl glyoxalase ) (Aldoketomutase) 14.673913 I 
gil149045167 rCG43947 [Rattus norvegicus] 42.925659 I 
gil38382858 Protein disulfide isomerase associated 3 [Rattus norvegicus] 59.009904 ! 
gill0720174 Hypoxia up-regulated protein 1 precursor (I50 kDa oxygen-regulated protein) 15.615615 
gil67078526 UDP-glucose pyrophosphorylase 2 [Rattus norvegicus] 11.023622 
gi\54673763 Heat shock protein I, alpha [Rattus norvegicus] 43.929058 
gil149061561 ribonuclease/angiogenin inhibitor I, isoform CRA b [Rattus norvegicus] 19.715448 
gil52783577 Dynein light chain 1, cytoplasmic (Dynein light chain LC8-type I) 32.584271 
gill 57786744 dihydropyrimidinase-like 2 [Rattus norvegicus] 27.797204 
gil56754676 Tubulin beta-5 chain 60.585588 
gil81883543 Astrocytic phosphoprotein PEA-15 22.307692 
gil62648070 PREDICTED: similar to Aldose reductase (AR) (Aldehyde reductase) 13.92405 
gil51948402 peptidylprolyl isomerase C [Rattus norvegicus] 47.64151 
gil81885266 Dihydrolipoyl dehydrogenase, mitochondrial precursor 10.805501 
gil56336 unnamed protein product [Rattus norvegicus] 52.380955 
gil58865656 lymphocyte cytosolic protein 1 [Rattus norvegicus] 23.604466 
gil38181546 Macrophage migration inhibitory factor [Rattus norvegicus] 53.043479 
gil62641808 PREDICTED: similar to FK506-binding protein 2 precursor 52.105266 
gi\38303969 Heat shock 70kDa protein 5 (glucose-regulated protein) [Rattus norvegicus] 61.009175 
gil8393296 eukaryotic translation elongation factor 2 [Rattus norvegicus] 62.820512 
gil6981324 prolyI4-hydroxylase, beta polypeptide [Rattus norvegicus] 76.574802 
gil3288594 26S proteasome subunit p112 [Rattus norvegicus] 13.116474 
gill09~81425 PREDICTED: similar to MIR-interacting sapos in-like protein precurso~ ___ 43.606558 
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gil62665288 PREDICTED: similar to alanyl-tRNA synthetase [Rattus norvegicus] 22.004132 
gil7209586 DA41 [Rattus norvegicus] 21.993127 
gil8394328 superoxide dismutase 1 [Rattus norvegicus] 61.68831 
gi\48428789 ADP-ribosylation factor 4 27.222222 
I gil55855 precursor (AA -17 to 399) [Rattus norvegicus] 77.644229 
gil8394082 proteasome (prosome, macropain) subunit, beta type 3 [Rattus norvegicus] 8.7804876 
gi162899645 Actin-related protein 2 (Actin-like protein 2) 46.192893 I 
gil149027310 threonyl-tRNA synthetase, isoform CRA a [Rattus norvegicus] 21.745153 i 
gi\32363196 Moesin (Membrane-organizing extension spike protein) 53.032929 I 
gil I 09504084 PREDICTED: similar to palladin [Rattus norvegicus] 23.899999 ' 
gill09481608 PREDICTED: similar to Calponin-2 (Calponin H2, smooth muscle) 24.626866 
gil34849734 Thioredoxin 1 [Rattus norvegicus] 55.238098 
gilI58I86672 neural precursor cell expressed, developmentally down-regulated gene 4 25.309336 
gil73532768 coatomer protein complex, subunit gamma [Rattus norvegicus] 26.773456 
gil62078893 ubiquitin-activating enzyme E I, Chr X [Rattus norvegicus] 12.759924 
gil56789700 Peroxiredoxin 1 [Rattus norvegicus] 53.266335 , 
gil 149029720 rCG42522, isoforrn CRA a [Rattus norvegicus] 21.875 
gil68085421 Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein 72.653061 
gil54037164 Guanine nucleotide-binding protein subunit beta-2-like I 35.646689 
gil21666559 TUC-4b [Rattus norvegicus] 36.749634 
gil4753894 calcyclin [Rattus norvegicus] 83.146065 
gil 149025903 calciumlcalmodulin-dependent protein kinase 11, delta, isoform CRA c 23.849373 
gil57381 T -plastin [Rattus norvegicus] 32.057416 
gil62646949 PREDICTED: similar to Filamin-C (Gamma-filamin) (Filamin-2) 33.712399 
~iI78~1435_~ ~yste~l!e alld glycine-rich protein 2 [Rattus norvegicus] ____ 17.098446 
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gil158081781 hypothetical protein LOC362115 [Rattus norvegicus] 13.119143 
gil8394432 peroxiredoxin 2 [Rattus norvegicus] 33.333334 
gil61556967 eukaryotic translation elongation factor 1 delta [Rattus norvegicus] 28 
gil55583766 Protein phosphatase 1 regulatory subunit 14B 36.05442 
gil81907772 PDZ and LIM domain protein 7 (LIM mineralization protein) (LMP) 25.164112 
gil71051349 Eukaryotic translation elongation factor 1 gamma [Rattus norvegicus] 40.503433 
gil67846074 EH-domain containing 2 [Rattus norvegicus] 17.495395 
gil37194821 Ribosomal protein S27a [Rattus norvegicus] 53.205127 I 
gil158706420 Protein ARMET precursor (MANF) (Arginine-rich protein) 21.787709 
gil57087 unnamed protein product [Rattus norvegicus] 56.395346 
gi151261175 Peroxiredoxin 5 [Rattus norvegicus] 47.41784 
gi145478134 LRRGTOO 147 [Rattus norvegicus] 11.157456 
gil55926145 expressed in non-metastatic cells 2 [Rattus norvegicus] 90.789473 
gil50927605 Suppression of tumorigenicity 13 [Rattus norvegicus] 17.663044 
gil8393381 glucose-6-phosphate dehydrogenase [Rattus norvegicus] 29.902911 
gil 149066032 myosin, heavy polypeptide 9, non-muscle [Rattus norvegicus] 73.418367 
gil 109476367 PREDICTED: similar to ribosomal protein S 13 [Rattus norvegicus] 52.903223 
gil149031250 vinculin (predicted), isoform CRA a [Rattus norvegicus] 76.455027 
gil603877 transgelin [Rattus norvegicus] 84.577113 • 
gil9798638 glyceraldehyde-3-phosphate dehydrogenase [Rattus norvegicus] 83.783782 
gil157818179 eukaryotic translation elongation factor 1 beta 2 [Rattus norvegicus] 34.666666 
gill09468300 PREDICTED: similar to Alpha-enolase (2-phospho-D-glycerate hydro-lyase) 61.010098 
gil51859516 Heat shock 90kDa protein I, beta [Rattus norvegicus] 45.856354 
gi16093729 Procollagen-Iysine,2-oxoglutarate 5-dioxygenase 1 precursor 10.989011 
gil8393206 cysteine and glycine-rich protein 1 [Rattus norvegicus] 46.632123 
--- -------
236 
gil 13928824 tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein 53.725493 
gil8394158 fatty acid synthase [Rattus norvegicus] 14.091817 
gil55742827 Rho GOP dissociation inhibitor (GDI) alpha [Rattus norvegicus] 37.254903 
gil 14904575 I rCG55135, isofonn CRA a [Rattus norvegicus] 45.789677 
. gil68566301 Dynamin-l-Iike protein (Dynamin-like protein) 21.589404 
gil 109487680 PREDICTED: similar to Myosin-II (SMMHC) [Rattus norvegicus] 49.505979 
gi\l49036104 6-phosphogluconolactonase (predicted), isofonn CRA a [Rattus norvegicus] 31.099194 
gi\50926121 Dncic2 protein [Rattus norvegicus] 13.449366 
gi\149029877 filamin, alpha (predicted), isoform CRA a [Rattus norvegicus] 67.222434 
gil81910761 T -complex protein 1 subunit epsilon (TCP-I-epsilon) (CCT -epsilon) 35.489833 
gil81884451 SUMO-activating enzyme subunit I (Ubiquitin-like I-activating enzyme 36.389685 EIA) 
gil149067833 aldolase A, isoform CRA e [Rattus norvegicus] 60.526317 
gi181861572 Malate dehydrogenase, cytoplasmic (Cytosolic malate dehydrogenase) 19.760479 
gil41350889 Pgam 1 protein [Rattus norvegicus] 37.007874 
gil9506501 calponin 3, acidic [Rattus norvegicus] 39.090911 
gil62078969 hypothetical protein LOC360627 [Rattus norvegicus] 7.0567988 
gi\70778952 RAD23b homolog [Rattus norvegicus] 19.277108 
gi\149036910 actin related protein 2/3 complex, subunit 4 (predicted), isofonn CRA a 33.333334 
gi\8393706 lactate dehydrogenase A [Rattus norvegicus] 78.915662 
gi\82546819 heterogeneous nuclear ribonucleoprotein F [Rattus norvegicus] 21.204819 
gil8393693 laminin receptor 1 [Rattus norvegicus] 32.881355 
gil81884336 Gelsolin precursor (Actin-depolymerizing factor) (ADF) (Brevin) 21.025641 
gil91207082 Eukaryotic translation initiation factor 5A-l (elF-SA-I) (elF-SAl) 38.961038 
gil51316969 Actin, aortic smooth muscle (Alpha-actin-2) 82.758623 
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gil56090273 ribosomal protein S4, X-linked [Rattus norvegicus 1 30.79848 
gil38454206 proteasome, 26S, non-ATPase regulatory subunit 6 [Rattus norvegicus 1 15.167095 
gil55742755 catenin (cadherin-associated protein), alpha I, 102kDa [Rattus norvegicus1 18.722467 
I gil149033633 nucleoside phosphorylase (mapped), isoform CRA c [Rattus norvegicus] 33.910036 I 
gil5 I 859448 Adaptor protein complex AP-2, alpha 2 subunit [Rattus norvegicus 1 11.075612 ! 
gil47605563 PDZ and LIM domain protein 5 (Enigma-like PDZ and LIM domains 31.472081 I j>rotein) 
gi\421 0985 non-muscle alpha-actinin I [Rattus norvegicus] 70.964128 
gil149040761 trans gel in 2, isoform CRA b [Rattus norvegicus] 74.253732 
gi178097100 microtubule-associated protein, RPIEB family, member 1 [Rattus 13.805971 
norvegicus 1 
gi\57528425 hypothetical protein LOC494445 [Rattus norvegicus 1 40.271494 
gi1149041736 reticulocalbin 2 [Rattus norvegicus 1 27.179489 
gil 149046800 SEC31-like I (S. cerevisiae). isoform CRA c [Rattus norvegicus 1 27.097315 
gi\81883342 Twinfilin-l 7.9999998 
gil58865400 pleckstrin homology domain containing. family C member 1 16.764706 
gil 109489498 PREDICTED: similar to Actin. cytoplasmic 2 (Gamma-actin) 64.899713 
gil8393038 cal pain 2 [Rattus norvegicus] 28.857142 
gil81902430 Septin-2 (Vascular endothelial cell specific protein II) 51.246536 
gil61889115 phospho serine aminotransferase I [Rattus norvegicus] 18.108109 
gi151316981 ADP-ribosylation factor 1 27.624309 
gil83301602 Collagen alpha-l (III) chain precursor 74.231035 
gill09483719 PREDICTED: similar to Collagen alpha-l (XII) chain precursor 35.055822 
gi120138815 Alpha-parvin (Actopaxin) 9.4086021 
gil22024394 fatty acid binding protein 5, epidermal [Rattus norvegicus] 48.888889 
---
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gil57858 ribosomal protein S24 [Rattus norvegicus] 32.330826 I 
i gi161889112 cell division cycle 42 [Rattus norvegicus] 20.418848 I 
gil5305687 pro-alpha-2(I) collagen [Rattus norvegicus] 78.352767 ! 
gil6911221 CArG-binding factor A [Rattus norvegicus] 24.210526 . 
gil61557085 spectrin beta 2 [Rattus norvegicus] 17.260391 
gil6981248 nucleolin [Rattus norvegicus] 27.629733 
gil55575 beta-actin [Rattus norvegicus] 90.133333 
gil462690 Nucleoside diphosphate kinase A (NDK A) (NDP kinase A) 83.552629 
gil 1729977 Transketolase (TK) 19.743179 
gil62296810 Protein disulfide-isomerase A6 precursor (Protein disulfide isomerase P5) 51.81818 
gil8394168 calmodulin 2 [Rattus norvegicus] 94.630873 
gil62658155 PREDICTED: similar to eukaryotic translation initiation factor 4 20.901126 
gil56090441 ddx5 [Rattus norvegicus] 24.552846 
gil 149052999 myosin, heavy polypeptide 10, non-muscle, isoform CRA b 51.26518 
gil55250051 Txnrd 1 protein [Rattus norvegicus] 20.069204 
gil39850096 Rps16 protein [Rattus norvegicus] 39.751554 
gil8394079 proteasome (prosome, macropain) subunit, beta type 2 [Rattus norvegicus] 23.880596 I 
gil149018456 microtubule-associated protein 4 [Rattus norvegicus] 19.005328 
gil81885353 Basic leucine zipper and W2 domain-containing protein 1 15.274464 ' 
gil44888314 Heterogeneous nuclear ribonucleoprotein Q (hnRNP Q) (hnRNP-Q) 40.712947 I 
gil33086672 Cc2-27 [Rattus norvegicus] 19.191919 ! 
gil61556832 adenine phosphoribosyl transferase (predicted) [Rattus norvegicus] 28.333333 
gil393203 calcium-binding protein [Rattus norvegicus] 18.506998 
gil58865872 enabled homolog [Rattus norvegicus] 40.114069 
gil71122383 Chloride intracellular channel 1 [Rattus norvegicus] 60.580915 
- ------ -
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gil51980641 Ribosomal protein L4 [Rattus norvegicus] 21.140142 
gi\158711704 collagen, type I, alpha I [Rattus norvegicus] 83.138335 
gil I 09502869 PREDICTED: similar to RAN binding protein 5 [Rattus norvegicus] 17.86691 
I gil61889092 adenylate kinase I [Rattus norvegicus] 23.71134 
gil149016579 ribosomal protein S5, isoform CRA b [Rattus norvegicus] 30.882353 
gi\38014694 Valosin-containing protein [Rattus norvegicus] 42.059553 
gi\90 III 077 Prolyl4-hydroxylase subunit alpha-I precursor (4-PH alpha-I) 30.149812 
gi\149044126 rCG27764, isoform CRA a [Rattus norvegicus] 25.473729 
gi\67460104 Cullin-associated NEDD8-dissociated protein I 13.170731 
gi\53733394 NAD(P)H dehydrogenase, quinone I [Rattus norvegicus] 11.313868 
gi\38014563 Proteasome (pro some, macropain) subunit, alpha type 5 [Rattus norvegicus] 13.278009 
gi\206205 M2 pyruvate kinase [Rattus norvegicus] 72.128057 
gil38181888 Proteasome (pro some, macropain) 26S subunit, ATPase 2 31.408775 
gi19507245 tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein 59.109312 
gil17539178 alpha actinin 4 [Rattus norvegicus] 71.679473 
gil78000190 tropomyosin I, alpha isoform b [Rattus norvegicus] 80.281693 
gi\157818975 filamin, beta [Rattus norvegicus] 33.66951 
gil61227509 Latexin (Endogenous carboxypeptidase inhibitor) (ECI) 13.901345 
gil157818781 protein kinase C substrate 80K-H [Rattus norvegicus] 22.285715 
gil8394063 proteasome (prosome, macropain) subunit, alpha type 2 [Rattus norvegicus] 26.495728 
gil157817229 actin related protein 2/3 complex, subunit 2 [Rattus norvegicus] 16.666667 
gil763182 fibroblast tropomyosin 4 [Rattus norvegicus] 83.870965 
gil157819579 hypothetical protein LOC363886 [Rattus norvegicus] 11.740891 
gil157786714 SEC23A (S. cerevisiae) (predicted) [Rattus norvegicus] 18.169935 
gil78103212 Thymosin beta-4 (T beta 4) 88.636363 
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gil42476181 malate dehydrogenase. mitochondrial [Rattus norvegicus] 60.946745 
gil9506497 clathrin. heavy polypeptide (Hc) [Rattus norvegicus] 28 
gil76253725 chaperonin subunit 6a (zeta) [Rattus norvegicus] 30.32015 
gil6981022 hexokinase 1 [Rattus norvegicus] 12.200436 
gil45478130 LRRGT00145 [Rattus norvegicus] 14.953271 
gil 149028892 tropomyosin 1, alpha. isoform CRA c [Rattus norvegicus] 72.183096 
. gil149041248 rCG27551, isoform CRA a [Rattus norvegicus] 68.586385 
gil75832035 small inducible cytokine subfamily E. member 1 [Rattus norvegicus] 24.444444 
gil66793366 glutamyl-prolyl-tRNA synthetase [Rattus norvegicus] 11.911171 
gil149067319 rCG49111 [Rattus norvegicus] 45.024875 
gi1157823877 cytoskeleton-associated protein 4 [Rattus norvegicus] 27.300614 
gil78126139 ribosomal protein S12 [Rattus norvegicus] 31.818181 I 
gil149037631 procollagen. type VI. alpha 3 (predicted). isoform CRA_c [Rattus 21.977638 I 
norvegicusJ 
gil2498032 Myosin regulatory light chain 2, smooth muscle isoform 74.269009 
gil56090475 S-phase kinase-associated protein lA [Rattus norvegicus] 41.717792 
gil56404680 Protein DJ-l (Parkinson disease protein 7 homolog) 22.751322 
gil149068231 coatomer protein complex. subunit beta 1. isoform eRA b 27.455121 
gil71153827 Myb-binding protein lA (PAR-interacting protein) (PIP) 14.806548 
gil149057332 IQ motif containing GTPase activating protein 1 (predicted), isoform CRA b 37.77912 ! 
gi162648896 PREDICTED: similar to 40S ribosomal protein S20 [Rattus norvegicus] 41.176471 . 
gil8393910 phosphatidylethanolamine binding protein [Rattus norvegicus] 42.780748 
gil157819753 reticulocalbin 1 [Rattus norvegicus] 22.153845 
gil52001084 Serine/threonine-protein phosphatase PP I-gamma catalytic subunit 44.582042 
gil56585024 Phosphoglycerate kinase 1 [Rattus norvegicus] 55.875301 
--_._--
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i gil 1 09463545 PREDICTED: similar to AHNAK nucleoprotein isoform 1 isoform 1 56.550646 I 
gil8393153 LIM protein [Rattus norvegicus] 55.657494 ! 
gi142476045 cathepsin D [Rattus norvegicus] 24.078624 I 
gil81884182 FK506-binding protein 9 precursor (Peptidyl-prolyl cis-trans isomerase) 22.456141 
gil149066132 rCG59523, isoform CRA c [Rattus norvegicus] 41.263068 
gil 149047669 transmembrane emp24 protein transport domain containing 4 (predicted) 25.991189 
gil149021114 vimentin, isoform CRA b [Rattus norvegicus] 87.339056 
gil543922 Calnexin precursor 19.458544 
gil56090277 ribosomal protein, large, PI [Rattus norvegicus] 19.298245 
gil157819755 hypothetical protein LOC364073 [Rattus norvegicus] 20.789075 
gil81910374 T-complex protein 1 subunit beta (TCP-l-beta) (CCT-beta) 21.495327 
gil62906896 Transmembrane emp24 domain-containing protein 10 precursor 30.593607 
gil50403574 60S ribosomal protein L 1 0 20.093457 
gil 157787018 adenylosuccinate synthetase, non muscle [Rattus norvegicus] 30.701753 
gi1312928 tropomyosin isoform 6 [Rattus norvegicus] 72.983873 
gil31543764 alpha-spectrin 2 [Rattus norvegicus] 28.883496 
gil38197650 Hnrpk protein [Rattus norvegicus] 49.353448 
gil63101555 Sec61 alpha 1 subunit (S. cerevisiae) [Rattus norvegicus] 24.579832 
gil400429 myosin I heavy chain [Rattus norvegicus] 20.719844 
gil149040721 rCG20221, isoform CRA b [Rattus norvegicus] 19.281046 
gil40786436 eukaryotic translation initiation factor 4A 1 [Rattus norvegicus] 28.57143 
gil50403587 60S ribosomal protein L 18a 28.977272 
gi155926139 alpha isoform of regulatory subunit A, protein phosphatase 2 21.052632 
gil149032606 vacuolar protein sorting 35 (mapped), isoform CRA b [Rattus norvegicus] 11.43216 
gil92090591 Glutamate dehydrogenase 1, mitochondrial precursor 18.100359 
-- ----------
- ---- .. _---- ----- --- --- -.-.~.- .. --- ..... _------
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gil6981712 tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein 41.224489 ! 
gil158631214 arginyl-tRNA synthetase [Rattus norvegicus] 17.272727 
gil76096306 vesicle amine transport protein 1 homolog (T califomica) [Rattus 33.168316 
norvegicus] 
gil46397778 Peptidyl-prolyl cis-trans isomerase B precursor (PPlase) (Rotamase) 36.538461 
gil66911068 Pcbp2 protein [Rattus norvegicus] 27.761194 
gil149033299 rCG52516 [Rattus norvegicus] 19.093406 
gil38197632 Ptbp 1 protein [Rattus norvegicus] 31.834534 
gil61556835 thrombospondin 1 [Rattus norvegicus] 22.393163 
gil77993298 signal sequence receptor, alpha [Rattus norvegicus] 17.421603 
gil51980308 Heterogeneous nuclear ribonucleoprotein A3 [Rattus norvegicus] 33.773088 
gil77415419 Serpina6 protein [Rattus norvegicus] 16.019417 
gil9910214 eukaryotic translation initiation factor 5 [Rattus norvegicus] 10.02331 
gil57164151 ribosomal protein S3 [Rattus norvegicus] 44.855967 
gil62653926 PREDICTED: similar to 60S ribosomal protein L12 [Rattus norvegicus] 33.939394 
gil149059759 chaperonin subunit 8 (theta) (predicted), isoform CRA a [Rattus norvegicus] 11.861314 
gil52000745 T-complex protein 1 subunit delta (TCP-l-delta) (CCT-delta) 27.643785 
gil158303324 integrin beta 1 [Rattus norvegicus] 4.3859649 
gil81902084 Citrate synthase, mitochondrial precursor 18.240343 
gil584953 Calponin-l (Calponin HI, smooth muscle) (Basic calponin) 62.28956 
gil68565369 Isocitrate dehydrogenase [NAD] subunit alpha, mitochondrial precursor 13.661203 
gi16978725 cytochrome c, somatic [Rattus norvegicus] 40.952381 
gil78126159 ribosomal protein S2 [Rattus norvegicus] 52.218431 
gil66730475 hypothetical protein LOC500450 [Rattus norvegicus] 85.915494 
gil76559925 _ ~,!lumenin isoform b [Rattus norvegicus] 62.857145 
-_._-
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gil8393101 cofilin I [Rattus norvegicus] 60.240966 
gil61889071 RAB I 0, member RAS oncogene family [Rattus norvegicus] 16.500001 
gil149016180 aspartyl aminopeptidase. isoform CRA b [Rattus norvegicus] 20.416667 
gi176364171 A TP-dependent RNA helicase DDXI (DEAD box protein I) 14.864865 
gil157817664 hypothetical protein LOC500987 [Rattus norvegicus] 46.153846 
gil149030883 glutathione synthetase, isofonn CRA c [Rattus norvegicus] 17.366412 
gil56346 H2B histone [Rattus norvegicus] 78.399998 
gil154816168 heat shock 70kDa protein 9A [Rattus norvegicus] 22.091311 
gil58865844 fusion (involved in t(12;16) in malignant liposarcoma) (predicted) 30.115831 
gi171795613 ribosomal protein, large P2 [Rattus norvegicus] 71.304345 
gil9845261 lectin, galactose binding, soluble I [Rattus norvegicus] 94.074076 
gil38454246 ribosomal protein L3 [Rattus norvegicus] 19.602978 
gil 149048132 lam in A, isoform CRA b [Rattus norvegicus] 72.781956 
gil149016893 rCG23030, isoform CRA ~ [Rattus norvegicus] 32.367149 
gil55824765 Serpinh 1 protein [Rattus norvegicus] 53.717029 
gil57012987 PRAI family protein 3 (ARL-6-interacting protein 5) 10.638298 
gil48675371 complement component I, q subcomponent binding protein 23.655914 
gil34786047 Niemann Pick type C2 [Rattus norvegicus] 17.449665 
gil85057089 Eukaryotic translation elongation factor I alpha 1 [Rattus norvegicus] 74.025977 
gil85541036 Myosin-Id (Myosin heavy chain myr 4) 10.337972 
gil 149064471 rCG4660 1. isoform CRA b [Rattus norvegicus] 20.071685 
gil157821523 septin 6 [Rattus norvegicus] 27.777779 
gil62201921 Prothymosin alpha [Rattus norvegicus] 37.5 
gil56971262 Hnrpal protein [Rattus norvegicus] 33.437499 
gil81910340 Protein SEC 13 homolog (SEC 13-like protein 1) 8.0745339 
-- -
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gil149015978 fibronectin I, isoform CRA a [Rattus norvegicus] 35.849819 
gil 10950492 I PREDICTED: similar to germinal histone H4 gene [Rattus norvegicus] 72.115386 
gil8393057 serine (or cysteine) proteinase inhibitor, clade H, member I 53.237408 
gil33086478 Abl-205 [Rattus norvegicus] 11.59618 
gi162647139 PREDICTED: similar to zyxin [Rattus norvegicus] 16.94153 
gil54261673 Ribosomal protein L 18 [Rattus norvegicus] 22.340426 
gi\730581 60S acidic ribosomal protein PO (LI0E) 43.217665 
gi\58865778 dolichyl-di-phosphooligosaccharide-protein glycotransferase (predicted) 10.657597 
gi\149063427 rCG21664, isoform CRA b [Rattus norvegicus] 38.811189 
gi\8394060 proteasome (pro some. macropain) subunit, alpha type 1 [Rattus norvegicus] 9.5057033 
gi\54041951 40S ribosomal protein S 17 55.555558 
gi\149041246 rCG27487, isoform CRA a [Rattus norvegicus] 18.410042 
gi\57129 unnamed protein product [Rattus norvegicus] 47.019866 
gi\44888251 Phosphatidylinositol-binding clathrin assembly protein 16.875 
gi\6981424 prosaposin [Rattus norvegicus] 33.754513 
gi\109510179 PREDICTED: similar to Myristoylated alanine-rich C-kinase substrate 47.75641 
gil 109463591 PREDICTED: similar to H3 histone, family 3B isoform 2 [Rattus 47.058824 
norvegicus] 
gi\6981052 heat shock 10 kDa protein 1 [Rattus norvegicus] 16.666667 
gi\6981420 pancreatic trypsin 1 [Rattus norvegicus] 13.821138 1 
gi\62638830 PREDICTED: similar to 60S ribosomal protein L17 (L23) 11.413044 
gi\157818451 hypothetical protein LOC498234 [Rattus norvegicus] 34.946236 
gil157821467 SH3 domain binding glutamic acid-rich protein-like 3 [Rattus norvegicus] 22.580644 
gi\33086566 Ab2-162 [Rattus norvegicus] . 20.839694 
gil728810 ADP/ATP translocase 2 (Adenine nucleotide translocator 2) (ANT 2) 37.919462 
---
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gil145566928 Polymerase I and transcript release factor (Calvin) (cav-p60) 20.408164 
gil6822247 Nogo-A protein [Rattus norvegicus] 21.324162 
gil92373398 Y box protein 1 [Rattus norvegicus] 27.639753 
gil763181 annexin VI [Rattus norvegicus] 41.456166 i 
gil74474102 unnamed protein product [Rattus norvegicus] 55.743879 
gil730110 Brain acid soluble protein 1 (Neuronal axonal membrane protein NAP-22) 66.818184 I 
gil33086658 Cc 1-6 [Rattus norvegicus] 13.810742 
gil81870810 Myeloid-associated differentiation marker (Myeloid up-regulated protein) 11.63522 ; 
gil157823041 integrin, alpha 11 [Rattus norvegicus] 12.809564 I 
gil158186676 calumenin isoform a [Rattus norvegicus] 66.984129 
gil9845234 annex in A2 [Rattus norvegicus] 58.702064 
gil66730357 hypothetical protein LOC497813 [Rattus norvegicus] 39.690721 
gil157820787 NADH dehydrogenase (ubiquinone) 1, alphalbeta subcomplex, 1 19.23077 
gil23396766 Ectonucleotide pyrophosphatase/phosphodiesterase family member 1 21.633554 
gil62512124 Dolichyl-diphosphooligosaccharide-protein glycosyltransferase precursor 8.3993658 
gil50403620 40S ribosomal protein S 18 53.289473 
gil78214309 ribosomal protein L8 [Rattus norvegicus] 36.18677 ! 
gi171681130 A TP synthase, H+ transporting, mitochondrial F I complex, beta polypeptide 38.941398 
gill 0950580 I PREDICTED: similar to Histone H1.2 (HI VAR.I) (Hlc) [Rattus 16.666667 
norvegicus] 
gi\83300587 A TP synthase subunit alpha, mitochondrial precursor 30.198914 
gi\77628163 AHNAK 1 [Rattus norvegicus] 29.281768 
---
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Appendix B 
Complete list of all regulatory and metabolic protein networks as calculated by MetaCore TM. 
2 
PUR9, NAP1, GOl2, PPase (inorganic), 
MTAP (Rattus norvegicus) 
vitamin catabolic process (5.9%; 1.430e-04), vesicle fusion (5.9%; 
4.140e-04), cAMP biosynthetic process (5.9%; 6.00ge-04), 
nucleoside phosphate metabolic process (14.7%; 7.284e-04), 
nucleotide metabolic process (14.7%; 7.284e-04) 
norvegicus) 
,CRMP2, NQ01 (Rattus I intracellular transport (31.4%; 1.702e-06), generation Of neurons 
(28.6%; 3.041e-06), regulation of apoptosis (31.4%; 4.882e-06), 
neurogenesis (28.6%; 5.44ge-06), regulation of cell death (31.4%; 
5.508e-06) 
3 I YB-1, RhoA, ACTR3, hnRNP A 1, 
(Rattus norvegicus) 
regulation of developmental process (54.3%; 6.237e-13), regulation 
of biological quality (54.3%; 1.714e-12), regulation of localization 
(37.0%; 1.675e-11), regulation of cell migration (23.9%; 2.175e-11), 
regulation of Signal transduction (39.1 %; 2.416e-11) 
01 1.17E-23 42.35 
01 9.17E-23 39.24 
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4 G3P2, CapG, lamin AlC, OlC1 (Oynein negative regulation of biological process (50.0%; 3.190e-08), 0 2.66E-21 3S.S 
LCSa), TMSB4X (Rattus norvegicus) negative regulation of cellular process (47.5%; 5.121e-OS), regulation 
of biological quality (45.0%; 1.04Se-07), regulation of cell death 
(32.5%; 4.991e-07), regulation of programmed cell death (32.5%; 
4.991e-07) 
5 PTMA, hnRNP A 1, TPT1, Fibronectin, positive regulation of cellular process (45.S%; 3.326e-OS), positive 0 1.71E-20 35.94 
Prostasin (Rattus norvegicus) regulation of biological process (47.9%; 3.762e-OS), regulation of cell 
proliferation (31.2%; 2.08ge-07), regulation of developmental process 
(39.6%; 2.707e-07), regulation of biological quality (39.6%; 5.450e-
07) 
6 Fibronectin, Annexin V, TPT1, OJ-1, eEF1B regulation of biological quality (65.9%; 1.867e-17), wound healing 5 4.0SE-16 29.35 
(Rattus norvegicus) (34.1%; 6.804e-17), blood coagulation (27.3%; 3.03ge-16), 
coagulation (27.3%; 3.03ge-16), hemostasis (27.3%; 5.947e-16) 
7 PUR9, ASNS, OLC1 (Oynein LC8a), multicellular organismal process (69.0%; 2.3S0e-OS), collagen o 2.07E-17 34.21 
GC10BP, TCP1-eta (Rattus norvegicus) biosynthetic process (6.9%; 4.333e-05), multicellular organismal 
macromolecule metabolic process (10.3%; 6.760e-05), multicellular 
organismal metabolic process (10.3%; 1.426e-04), positive regulation 
of biological process (41.4%; 4.004e-04) 
I 
8 CRP2, GC10BP, Fibronectin, Annexin I, anatomical structure development (S7.4%; 9.712e-09), actomyosin 1 2.S2E-18 32.65 
MTS1 (S100A4) (Rattus norvegicus) structure organization (12.S%; 1.031e-OS), lipoprotein catabolic 
process (S.5%; 1.134e-08), lipoprotein particle clearance (8.5%; 
9.704e-08), organ morphogenesis (29.8%; 2.691e-07) 
-- --
- ~ 
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9 ENPP1 , NQ01 , Lamin NC , Fibronectin, homeostatic process (37.0%; 3. 572e-06) , ossification (18.5%; 0 7.77E-16 33.23 
HSP47 (Rattus norvegicus) 8.143e-06), bone development (18.5%; 1.011e-05), regulation of 
biological quality (44.4%; 1.688e-OS), multicellular organismal 
process (70.4%; 2.419e-OS) 
! 
10 MDH2, SURF1 , ATP5A, PLOD1 , ITGA11 aerobic respiration (16.7%; 1.542e-OS), ribonucleoside diphosphate 0 2.77E-14 32.4 
(Rattus norvegicus) biosynthetic process (11.1%; 3.04ge-05), ADP biosynthetic process 
(11.1 %; 3.04ge-05), purine ribonucleoside diphosphate biosynthetic 
process (11 .1 %; 3.04ge-05), oxygen homeostasis (11.1 %; 3.04ge-
OS) 
11 CAP1, hnRNP A 1, PTMA, G3P2, DLC1 cAMP biosynthetic process (21 .7%; 3.717e-22), cAMP metabolic o 3.3SE-16 29.66 
(Dynein LCBa) (Rattus norvegicus) process (21.7%; 1.66Se-19), cyclic nucleotide biosynthetic process 
(21.7%; 3.862e-18), cyclic nucleotide metabolic process (21.7%; 
3.398e-16), activation of adenylate cyclase activity (21.7%; 2.331e-
14) 
12 Fibronectin, DJ-1, AHNAK, CapG, CAP-G regulation of developmental process (S8.0%; 8.286e-16), positive o 4.08E-16 29.35 
(Rattus norvegicus) regulation of cellular process (S8.0%; 9.852e-14), cell communication 
(7B.0%; 1.17Se-13), positive regulation of biological process (60.0%; 
1.496e-13), signal transduction (74.0%; 1.964e-13) 
13 Lamin NC, PTMA, Reticulon 4, Annexin I, regulation of developmental process (62.1 %; 5.27 4e-11), regulation 0 1.S0E-13 29.05 
GRP75 (Rattus norvegicus) of cell differentiation (34.5%; 1.49ge-07), positive regulation of 
developmental process (37.9%; 1.62Se-07), negative regulation of 
developmental process (34.5%; 4.236e-07), regulation of apoptosis 
(37.9%; 5.701e-07) 
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14 RhoA, ARF1, PKNbeta, PTMA, Lamin NC cell differentiation (52.2%; 1.390E!T 1 O), intracellular signaling cascade 0 4.7BE-12 23 
(Rattus norvegicus) (45.7%; 3.570e-10), cellular developmental process (52.2%; 5.0B3e-
10), positive regulation of developmental process (34.8%; 1.093e-
09), system development (56.5%; 5.62ge-09) 
15 OJ-1, hnRNP A1 , Annexin II, Karyopherin positive regulation of biological process (47.7%; 1.603e-07), 0 4.7BE-12 23 
beta 1, Annexin V (Rattus norvegicus) response to steroid hormone stimulus (20.5%; 2.766e-07), regulation 
of multicellular organismal process (34.1 %; 4.30ge-07), generation of 
neurons (27.3%; 5.43Be-07), positive regulation of cellular process 
(43.2%; B.98ge-07) 
16 YB-1, HSP47, PRNP, HSP10 (mitochondrial), positive regulation of cellular process (6904%; 1.901e-19), positive 0 5.55E-12 22.76 
NQ01 (Rattus norvegicus) regulation of biological process (71.4%; 3.193e-19), regulation of cell 
proliferation (53.1%; 1.491e-1B), regulation of developmental process 
(63.3%; 2.316e-1B), negative regulation of biological process (65.3%; 
6.752e-17) 
17 Fibronectin, Lamin NC, Karyopherin beta 1, regulation of cell proliferation (47.9%; 2.694e-15), positive regulation 0 5.55E-12 22.76 
NQ01, MTS1 (S100A4) (Rattus norvegicus) of biological process (62.5%; 3.128e-14), regulation of apoptosis 
(43.8%; 1.423e-13), regulation of cell death (43.8%; 1.B18e-13), 
regulation of programmed cell death (43.B%; 1.B1Be-13) 
18 TPT1, HSC70, OLC1 (Oynein LCBa), positive regulation of biological process (66.0%; 1.444e-16), 0 5.55E-12 22.76 
Reticulon 4, PPase (inorganic) (Rattus regulation of developmental process (58.0%; 8.286e-16), positive 
norvegicus} regulation of cellular process (60.0%; 1.024e-14), negative regulation 
of biological process (60.0%; 1.842e-14), negative regulation of 
cellular process (56.0%; 1.B10e-13) 
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19 RhoA, Annexin II, Annexin VI, Annexin V, intracellular signaling cascade (62.S%; 5.324e-19), regulation of 0 5.5SE-12 22.76 
AHNAK (Rattus norvegicus) multicellular organismal process (54.2%; 3.502e-17), regulation of 
developmental process (S8.3%; 2.127e-1S), positive regulation of 
biological process (64.6%; 3.026e-15), negative regulation of 
biological process (62.5%; 3.761e-15) 
20 Prostasin, PGK1, SEC61 alpha, G3P1, PPase glucose metabolic process (26.1%; 5.91ge-08), hexose metabolic 0 3.76E-09 20.35 
(inorganic) (Rattus norvegicus) process (26.1%; 2.82Se-07), monosaccharide metabolic process 
(26.1%; 3.730e-07), cellular carbohydrate metabolic process (26.1%; 
8.768e-(6), response to hypoxia (21.7%; 1.065e-05) 
21 ARF1, GOl2, POIA3, Rab-1A, RNP24 (Rattus protein transport (62.2%; 8.840e-25), establishment of protein 0 3.13E-08 16.52 
norvegicus) localization (62.2%; 1.094e-24), vesicle-mediated transport (57.8%; 
1.472e-24), protein localization (64.4%; 2.698e-24), macromolecule 
localization (64.4%; 1.427e-23) 
22 Gapdh, FKBP6 (Rattus norvegicus) peptidyl-proline modification (50.0%; 7.171e-04), pachytene (SO.O%; o 3.69E-03 16.41 
9.561e-04), meiotic prophase I (SO.O%; 2.270e-03), prophase 
(SO.O%; 2.38ge-03), glycolysis (50.0%; 6.44Se-03) 
23 ATP5B, PRNP, Caveolin-1, gamma-ENaC, localization of cell (62.5%; 4.917e-06), cell motion (62.5%; 4.917e- o 9.39E-05 16.35 
Fyn (Rattus norvegicus) 06), chemical homeostasis (62.S%; 7.266e-06), protein kinase 
cascade (50.0%; 4.8S9e-OS), homeostatic process (62.5%; 5.182e-
05) 
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24 YB-1, hnRNP A1, 14-3-3 theta, PRNP, RPS7 positive regulation of cellular process (82.0%; 4.173e-28), positive 0 3.86E-08 16.17 
(Rattus norvegicus) regulation of biological process (82.0%; 2.174e-26), regulation of 
developmental process (74.0%; 1.963e-2S), positive regulation of 
macromolecule biosynthetic process (56.0%; 1.272e-23), positive 
regulation of nucleobase, nucleoside, nucleotide and nucleic acid 
metabolic process (54.0%; 8.177e-23) 
25 Lamin AlC, PTMA, YB-1, ARF1, MTS1 positive regulation of cellular process (70.8%; 6.658e-20), positive 0 3.86E-08 16.17 
(S100A4) (Rattus norvegicus) regulation of biological process (72.9%; 1.060e-19), regulation of cell 
proliferation (52.1%; 1.242e-17), positive regulation of nucleobase, 
nucleoside, nucleotide and nucleic acid metabolic process (45.8%; 
7.750e-17), positive regulation of transcription (43.8%; 1.686e-16) 
26 PRNP, Annexin II, PDlA3, AHNAK, SP1 regulation of immune system process (40.9%; 2.486e-15), positive 0 1.84E-06 13.3 
(Rattus norvegicus) regulation of biological process (65.9%; 1.073e-14), positive 
regulation of immune system process (31.8%; 1.73ge-13), regulation 
of response to stimulus (36.4%; 1.744e-13), interspecies interaction 
between organisms (31.8%; 3.554e-13) 
27 YB-1, RhoA, Karyopherin beta 1, HSC70, positive regulation of biological process (83.7%; 4.548e-27), positive 0 2.36E-06 12.88 
EGFR (Rattus norvegicus) regulation of cellular process (77.6%; 1.704e-24), organ development 
(71.4%; 5.915e-20), response to chemical stimulus (65.3%; 1.846e-
17), regulation of developmental process (61.2%; 3.12ge-17) 
_ ._ . - ~~----~ 
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28 HSC70, G3P2, Lamin AlC, Annexin VI, Fyn immune response-activating cell surface receptor signaling pathway 0 2.36E-06 12.88 
(Rattus norvegicus) (26.5%; 1.933e-21), immune response-regulating cell surface 
receptor signaling pathway (26.5%; 5.734e-21), immune response-
activating signal transduction (26.5%; 3.950e-20), immune response-
regulating signal transduction (26.5%; 1.534e-19), antigen receptor-
mediated signaling pathway (22.4%; 1.778e-18) 
29 PGMU, alpha-D-Glucose-6-phosphate = glucose metabolic process (100.0%; 9.503e-03), hexose metabolic 0 1.00E+00 -0.06 
alpha-D-Glucose 1-phosphate, alpha-D- process (100.0%; 1.237e-02), monosaccharide metabolic process 
Glucose 1-phosphate = alpha-D-Glucose-6- (100.0%; 1.297e-02), response to radiation (100.0%; 1.680e-02), 
phosphate, alpha-D-Glucose 1-phosphate, cellular calcium ion homeostasis (100.0%; 1.745e-02) 
alpha-D-Glucose-6-phosphate (Rattus 
norvegicus) 
- -------
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Appendix C 
Legend for the diagrams in Figures 5.9 and 5.10 of the proteins networks calculated by MetaCore™ . 
.-. Positive effect 
.-. Negative effect 
. .. Unspecified effect 
.. Technical link 
Expression data 
Overexpressed gene(s) 
Genes dth hl!;herconcltional expression level comparee to the expenmental "control ' 
Underexpressed gene(s) 
Genes Ith 10. ''2r .:ondltional expression level compare to the experimental ~contrcl 
Mixed-expressed gene(s) 
GeniH >Jith conC:itional expression level statisticall." cifferent from the experimental ".:ontrol ', with the "sign" of 
ElXpres~ion varying in cifferent experiments 
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Appendix D 
I an 1 x 10A6 BMCs. MyeloCult. daily I 
I11Iin 
..-
5 6 7 6 9 10 11 12 13 
time (days) 
Development of CFU-f number per dish in pour-off cultures started with 1 x 106 rat 
BMCs in MyeJoCult® medium containing 10.8 M dexamethasone, 10.8 M J a,25-
Dihydroxyvitamin D3, 2 nglml IL-3 and 10 nglml SCF. The cultures were re-plated 
every 24 hours for up to 13 days. Results of all conditions are mean +/- S.D. from 3 
different pour-off cultures. 
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